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ABSTRACT
The Development and Characterization of Markers For the Variable Regions
of Mouse DNP Binding Antibodies
Jerome Bernard Zeldis
Yale University, 1973
To study the expression and inheritance of immunoglobulins, methods
must be developed to identify specific variable regions (V-regions).
V-regions of 2,4 dinitrophenyl (DNP) binding antibodies were identi
fied by two approaches based on three properties:

a) serological

determinants (idiotypic markers); b) antigen specificities; and c) the
isoelectric point of the antibodies.
For the "idiotypic” approach, rabbit anti-idiotypic antibodies
complementary to the combining region of two distinct DNP and menadione
binding myeloma proteins, 315 (a, A) and 460 (a,

k ),

were generated.

These antibodies were characterized as follows; both anti-460 and anti315 antibodies are composed of two populations:

a) antibodies with

public specificities, that is, they bind equally well to the three
distinct DNP binding myeloma proteins, S23, 315, and 460; b) anti
bodies with private specificities which bind determinants only present
on the myeloma proteins to which the antibodies were made.

All three

anti-idiotypic antibodies (public and two private specificities) recog
nize determinants on the heavy chains of the idiotype positive myeloma
proteins.

While the light chain is required for the full expression of

the public idiotypic marker, there is no requirement for the type of
mouse light chain in the idiotype positive protein.

With both private

460 and private 315 idiotypic determinants, the type of light chain in
the immunoglobulin modulates the expression of these markers such that
'
I

«}
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the idiotypic determinants may be completely, partially, or not expressed.
In a survey of 18 inbred mouse strains, no serum was found to contain
immunoglobulins that were positive for the private 315 idiotype.

All

strains of inbred mice produced DNP binding antibodies that are positive
for the public and private 460 idiotypic determinants.

The concentration

of these idiotype positive immunoglobulins and the number of splenic
lymphocytes with public idiotype positive surface markers increases
after DNP-BGG immunization.

The shape of the inhibition curves in radio

immunoassays (RIAs) of the private 460 idiotype positive immunoglobulins
divides the mouse strains into two groups:

a) mice with the heavy chain

£-f-

allotypic locus of Balb/c (Ig-1
locus.

); and b) mice with any other allotypic

The private 460 idiotypic determinants of mouse immunoglobulins

from both sets of mice seem antigenically different from protein 460.
In a Balb/cN (Ig-la+) x C57BL/6 (Ig-1^) mating, the Balb/c-like private
460 idiotypic marker appears to be inherited as an autosomal dominant
trait.

Two idiotype positive immunoglobulins have been isolated from

Balb/c sera.

One immunoglobulin is an IgA that has both public and

private 460-like idiotypes and which has an identical isoelectric point
to protein 460.
idiotype.

The other is an IgGl that only has the private 460

Like protein 460, both mouse immunoglobulins bind DNP and

menadione.
For the second approach, V-regions were identified by their ability
to bind more than one antigen and by their isoelectric points in poly
acrylamide gels using autoradiography.

The sequential immunization with

DNP and menadione containing proteins and with RNase and DNP-BGG elicits
double binding antibodies.

Only menadione containing proteins that are

able to be bound by proteins 460 and 315 are antigenic for an anti
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menadione response in Balb/c mice.

Even after identical immunization

protocols, individual BaIjg/c mice yield distinct and different iso
electric focusing banding patterns of DNP binding antibodies.

Further

more, it was not possible to identify the isotype and idiotype of
individual immunoglobulins cross-linked inside these gels.

Thus, ad

ditional techniques are needed to characterize the immunoglobulins
identified by the polyacrylamide analytical isoelectric focusing technique.
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INTRODUCTION
The Problem:
The Elucidation of the Expression and Inheritance of
Immunoglobulin Genes Is Difficult Because of the Complexity of
the Immune Response
The inheritance and expression of immunoglobulin genes still remains
one of the great problems of immunology.

The major reason is that the

immune response while highly specific is also exceedingly complex.

It

is complex from the standpoint of the number of different antigens that
can elicit an immune response; complex in the number of different ways,
humoral and cellular, in which an organism can react to antigenic chal
lenge; and complex in the number of different antibodies which are speci
fic for the same antigen.

For example, it has been estimated that over

2 x 10^ different antigens can induce a humoral response (140).

Comple

tely different antibody populations can be elicited to chemical moieties
that differ by as little as a hydroxyl or nitro group (102, 7, 133).
Yet only rarely is a humoral response composed of highly restricted antibody
species directed against the antigen to which an animal is challenged.
Fundamental to the problem of the inheritance of immunoglobulin
genes is the question of whether the genome of the fertilized ovum
contains the information to code for all the antibodies which an adult
animal is able to express during its lifetime.

This problem has been

investigated both at the level of the DNA content and organization of
the genome and at the level of the phenotypic expression of specific
immunoglobulin molecules.

Implicit to the study of any protein's

genetics is the problem of the lack of expression of structural genes
that are present in the genome.

Thus a combination of both levels of

evaluation are required to ascertain the inheritance and control of
expression of immunoglobulin genes.

1
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2

Evaluations of the Number and Organization of Immunoglobulin Genes
In the first approach labeled mRNAs and labeled cDNA transcripts
of mRNAs of immunoglobulin light chains were hybridized to an organism's
genome derived from various tissues and the hybridization kinetics
(CQt plot) were measured.

These probes of the light chain genome

contained the sequence for the entire immunoglobulin chain or just the
sequences of the constant (C) or variable (V) regions.

Presumably,

these polynucleotides are able to hybridize to all DNA sequences that
are similar or identical to that of the probe.

If the genome codes

for all the V-regions which an animal is capable of synthesizing, then
the hybridization kinetic data should indicate this by demonstrating a
large number of sequences complementary to the probe.

In these studies,

however, only between three and five copies of the sequences for both
the C-region (105, 106, 166) and the V-region (106, 166, 179) of light
chains were found.
While these results appear to support the hypothesis that the
genome does not contain enough information to code for all possible
immunoglobulin molecules an animal is able to produce, the validity and
interpretation of these experiments are being debated (179, 157) .
Before a molecular probe derived from the mRNA of a myeloma protein
may be used to determine the number of V-region DNA gene copies in exis
tence, it must be established that the probes are able to hybridize to the
DNA which codes for other V-regions with the same kinetics as the probe is
able to anneal to its homologous genome.

The variability of the tripli

cate code third base must be taken into account as a source of variation
among mRNA's that code for the immunoglobulin chains, even in cases in
which the amino acid compositions of the chains are similar or identical
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3

(179, 106).

The investigators who do these experiments often present

hybridization data to demonstrate that good cross-hybridization occurs
between cDNA or mRNA for one myeloma protein and the DNA for another.
Williamson states that these results actually show that the kinetics of
cross-hybridization (in a CQt plot) are different from those obtained
when the molecular probes are used against the homologus genome.

He

concludes that the data obtained to date may actually only describe the
number of germ line genes that are very similar or identical to the
probe.

Melting data of homologous and heterologous hybrids lend support

to this contention (179).

Thus the conclusion that there are three to

five V-region genes per haploid genome is consistent either with:

a) a

model of few V-region genes with expansion of the V-region genetic
repertoire during ontogeny; or b) a model for the number of V-region
genes equal to that which an animal is able to express.

Smith (157) has

suggested that small experimental errors in the data or in plotting the
CQt curves can greatly change the estimation of the number of different
genes hybridizable with the molecular probe.
The use of nucleotide probes has also provided information about
the organization and expression of immunoglobulin genes.

Ever since Dreyer

and Bennett (34) proposed that separate genes for the V and C regions
code for single immunoglobulin chain structures, have studies been
performed to investigate this hypothesis.

A number of studies have

demonstrated that the mRNAs from myeloma cells are large enough to code
for both the C and V regions of the heavy and light chains (105, 166).
Furthermore, Milstein et al. (80) have demonstrated a nucleotide sequence
in the mRNA of the light chain of the mouse myeloma protein HOPC 21 which
codes for the amino acid sequence that bridges the variable and constant
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regions of the light chain molecule.

Thus if there are few C-region gen's

and many V-region genes, the pairing of V and C region sequences
probably occurs before the translation of the immunoglobulin molecule.
This conclusion is substantiated by the work of Milstein and Kohler
(95) who demonstrated that hybrid cell lines of two myeloma protein
producing plasmacytomas failed to synthesize immunoglobulins that had
exchanged V and C regions of the two tumor proteins (i.e., all gene
expression was cis to the genome which codes for the structural genes
in these cell lines).
In a provocative paper, Tonegawa et a l . (66) labeled the mRNA for
the

k

chain of MOPC 321 plasmacytoma and measured the probe's ability

to hybridize to restriction enzyme digestion fragments of DNA from the
genome of "early" (12, 13 day old) mouse embryos and to the DNA fragments
from the plasmacytoma MOPC 321.

With the genome of the early mouse

embryo, the probe annealed to two fragments— one 6 x 10^ dalton segment
containing the C-region gene sequence, while the other fragment (3.4 x
106 dalton) had the V-region sequence.

In contrast, the plasmacytoma

DNA produced only a single fragment (2.4 x 10^ dalton) which contained
both V and C region sequences.

The authors maintained that this result

was highly suggestive of the separation of V and C region genes in the
embryo which eventually pair during ontogeny.
results has been questioned (180).

The validity of these

The authors failed to account for

the aneuploidy of the plasmacytoma cell line.

While the data indicated

that the plasmacytoma line was either haploid or homozygous in its
immunoglobulin gene composition, it is unclear how the genetic organi
zation of this myeloma line relates to that of an adult mouse.

No

hybridization data was presented using the mRNA probe with adult mouse
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tissue DNA.
The Two Gene —

One Polypeptide Theory

While the data from the above experiment for the translocation of
V and C region genes of the light chain is questionable, investigations
of the phenotypic expression of immunoglobulin genes have led to the
generalized acceptance of the concept that there are separate genes
that code for the variable and constant regions of light and heavy
chains of immunoglobulins (34).
one immunoglobulin.

Some plasmacytomas produce more than

A few of these have been reported to secrete

paraproteins that differ only by the subclass of the heavy chain, not
by the proteins' light chains or V^ region (156, 65, 58).

Other sug

gestive evidence for the two gene-one polypeptide theory is that single
lymphocytes have on their surface IgM and IgD with the same antigenic
specificity (131) and idiotypic serological markers (47).

Furthermore

a single spleen cell clone is able to produce more than one class of
laimunoglobulins with the same V region (51).

Thus part of the diversity

of the physical properties of immunoglobulins depends upon the class of
Immunoglobulin which is paired to a particular V-region.

The fact that

anti-y serum can suppress the production of IgM, IgG, and IgA anti
bodies is indirect evidence that a "switch" of V-regions from one Cregion to another is an integral part of the maturation of the immune
response (104).
The molecular mechanism by which variable and constant region
sequences can be paired is now under intensive investigation.

Using

the genetic code to translate the amino acid sequence of the light
chain of the MOPC 41 plasmacytoma into triplicate codon sequences,

i
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

6

Leder et al. (106) postulated that the region of the V-C junction may
be coded by a 25 base palindrome which might serve as a signal for
restriction and modification-like enzymes.

Wuilmart ej: al.

(181)

substantiated this analysis with sequence data from other myeloma
proteins.

Furthermore, the genomes for ovalbumin, the X light chain of

myeloma protein HOPC 2020, the 8-chain of globin (81, 10, 103) have
recently been found not to be coded by a single continuous cistron, but
the structural genes contain at least a 600 base pair untranslated
sequence which must be deleted in order to produce the mRNA for these
proteins.

This means that the mechanism of joining genetic material to

produce message may be a common molecular process of eukaryotic organ
isms, a process not only restricted to immunoglobulin genes.
Recently techniques have been developed to clone eukaryotic message
and to isolate and clone eukaryotic structural genes (103, 165).

This

may allow the production of chemically homogeneous probes of genes for
the light chains and for the heavy chains of immunoglobulins.

This is

especially important since much of the data for the genetic organization
and number of V-region genes has been based upon RNA-DNA hybridization
curves which are not as reliable as cDNA-DSA hybridization data (106, 166).
Thus while the data on the number and organization of the immunoglobulin
genes that is based on the work with polynucleotide probes of the genome
of eukaryotic cells remains preliminary and controversial, the technology
being developed will in the near future allow the determination of this
important information about the genome of the light and heavy immuno
globulin chains.

i
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Phenotypic Markers Used To Detect Immunoglobulin Gene Products
Another fruitful approach to the problem of immunoglobulin in
heritance has been the characterization of markers that are able to
distinguish the expression of specific antibody molecules in the low
concentrations in which they can be found in serum.

Phenotypic, as

well as, genotypic information is needed to study the expression and
inheritance of immunoglobulins.

There is ample evidence which suggests

that immunoglobulin genes are present in the genome which are not
expressed during the life of the organism.

Even after investigations

using DNA hybridization have elucidated the molecular organization of
the immunoglobulin genes, well characterized immunoglobulin markers
will be required to study the mechanisms by which antibodies are
expressed.
Undoubtedly the amino acid sequence is the most reliable means, of
identifying the presence of a particular V-region.

However, the immune

response has a large number of the antibodies with specificity for the
same antigen.

This diversity of the immune response makes the purifi

cation of specific anti-hapten antibodies extremely difficult in most
cases.

For example, Kreth and Williamson (98) estimated that in CBA/H

mice, each mouse is capable of producing between 3000 and 30,000 dif
ferent antibodies directed against a synthetic hapten, (5-iodo-4hydroxy-3-nitrophenyl) acetyl (NIP), an antigen to which it is
doubtful the organism had exposure during its evolution.

This conclu

sion is based on the results of an experiment in which irradiated mice’s
immunological responses were reconstituted with single clones of immuno
globulin producing cells.

On the average each recipient mouse possessed

one clone of anti-NIP antibody producing cells which could be

i
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identified by the unique banding pattern of the antibody after iso
electric focusing (its spectrotype).

Of 337 mice studied, only five

pairs of identical isoelectric focusing spectrotypes were recorded.
Statistically the incidence of finding this many identical clones among
337 mice enabled the calculation that the genetic repertoire of antiNIP antibodies was in the order of thousands.

The estimation of the

number of different antibodies which a mouse can make was based on a
number of assumptions which may or may not be correct.

First of all,

it was assumed that all clones of anti-NIP antibodies had an equal
opportunity to be expressed.

If one clone had a tendency to be expressed

more often than others, the repeat frequency of identical clones would
be artificially elevated which would lower the estimation of different
anti-NIP antibodies that the animal is capable of producing.

More than

one antibody that binds the same hapten can have identical isoelectric
focusing spectrotypes (183), so the scoring of identical antibodies
only by spectrotype analysis may falsely lower the estimation of
different antibodies coded in the genome that can bind NIP.
In a similar experiment, Pink and Askonas (133) sequentially
immunized mice with antigens containing DNP (2, 4 dinitrophenyl-) and
TNP (2, 4, 6 trinitrophenyl-), a procedure that had been demonstrated
to produce a less heterogeneous anti-DNP response (158).

Using an

isoelectric focusing spectrotype analysis, the authors were able to
estimate that the number of DNP binding antibodies that a mouse can
make is in the order of thousands.

It must be emphasized that the

conclusions of both Kreth and Williamson's and Pink and Askonas'
experiments are underestimates not only due to the objections already
put forward, but also because in these studies it was assumed that the
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entire repertoire of hapten binding V-regions is able to be expressed ; t
the time of antigenic challenge.

Much evidence has been produced which

has demonstrated that as an organism matures the repertoire of antibody
producing cells changes (154, 152, 33).

Thus in most immune responses

the large number of different antibodies and their low concentrations in
sera precludes the identification of naturally raised antibodies only by
primary sequence analysis.
The primary sequences of myeloma proteins produced by plasmacytomas
have been studied as prototype immunoglobulin molecules.

An example of

the many studies performed with myeloma proteins which demonstrated the
large heterogeneity of their V-regions is the investigation by Quattrochi,
Cioli, and Baglioni (135).

Of 102 Bence Jones proteins, no two were

found which had an identical peptide map of their tryptic digests.
Despite the difficulty in obtaining reproducible results by this technique,
these results indicated to the authors that there are at least a few
thousand V^-region sequences encoded in the genome.

The authors assumed

that the expression of particular myeloma proteins by plasmacytomas is
random and that each V-region sequence is encoded in the genome.
These results of Quattrochi ejt al . (135) are even more impressive
when they are examined in the light of other data which indicate

that

the transformation of lymphoid cells to myeloma protein producing
plasmacytomas is not a random process.

NZB and Balb/c strains of mice

are the only strains in which myeloma protein producing plasmacytomas
can be consistently induced.

Table 1 summarizes the work of Morse et

al. (173) and Loh jet al. (173) with Balb/c and NZB pristane induced
plasmacytomas.

These studies show that different populations of V-

regions are expressed by the NZB and Balb/c plasma cell tumors.

...I

§
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TABLE 1

A COMPARISON OF NZB AND BALB/c MYELOMA PROTEINS (173, 64)
Balb/c Protein
Antigen specificity

NZB Protein

. PC, DNP, a(l-<-3) Dextran,
o(l->6) galactan,
8(2-*-l) levans

about 2/3 of all myelomas

rarely

Z H chain blocked

3

Z

z

1.1
45.7

2
69

1.7
20.9

2
27.

6.4
4.5
8.1
0.7

10
7
12
1

9.1
15.2
25.7
2.2

12
20
34

total 9 of tumors
studied
N-terminal analysis
of k chains to
position 23
unique sequences
2 with same sequences
3

ii

H

it

4

H

n

ii

total 9 of sequences

2.0
0.2

0.

6.6

9.6
3.9
10.

1.7

24.9

0.

100Z

100Z

558

230

Balb/c

NZB

Both

21

14

33

5

4

10

1

1

^

35

3

loo;

looz
ic chains only
X chains only
more than one Immuno
globulin
no paraprotein detected
untypable

Z

Z

Class Distribution
IgM
IgA
IgG
1
2a
2b

only anti-DNA Antibodies
also bind DNP;
DNA, RNA, ct(l->6) dextran,
3(2-i-l) levan

25

] only one sequence is common to the
1
k chains of both NZB and Balb/c
60
proteins
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many Balb/c myeloma proteins bind DNP and phosphorycholine (PC), no NZB
protein has been found which does.

Instead the NZB proteins bind RNA

tumor viruses and DNA, which no Balb/c protein does.

Balb/c tumor

proteins are predominately of the IgA subclass, while the class distri
bution of NZB tumors resembles more closely that found in normal NZB
sera.

Rarely are the H chains of Balb/c tumors blocked by the pyrroli-

done carboxylic acid (PCA) residue.
mice are blocked.

Two-thirds of the H chains of NZB

Furthermore, of 25 NZB k chains sequenced, only one

light chain has its 23 N-terminal amino acid sequence identical to one
of the Balb/c < chains.

These results indicate that there is probably

a difference in the Vu and VT gene pools from which the NZB and Balb/c
fci

L

myeloma proteins are elicited.

Also, the process of myelomatosis in

general therefore is not a random transformation process involving the
entire immunoglobulin germ line.

Thus it seems likely that any esti

mation of the number of germ line immunoglobulin genes based on the
diversity of the V-region sequences of myeloma proteins will be an
underestimate.
This conclusion is especially relevant to the analysis of the
primary structure of the X light chains of mouse myeloma proteins (2,
171, 172).

Of 21 X chains sequenced to position 113, twelve had

identical amino acid sequences.
less than four residues.

The other nine X chains differed by

The lack of variability of the X chains’

primary sequences may reflect either the preferential induction of a
sub-population of X chains encoded by the genome, or a limited genetic
repertoire for X chain sequences.

Leder eit £l (106) found that the

hybridization kinetics of the cDNA transcript of the mRNA for the RPC
20 plasmacytoma's X chain to the DNA of this tumor is consistent with
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the presence of one copy of the A structural gene per haploid genome.
Thus this cDNA probe may be a valid marker for the structural genes of
the A chains of this plasmacytoma.

It is not known how diverse the

natural mouse A chains are; therefore, this cDNA probe may not hybridize
to all A-like V-region structural genes.

It will be interesting to

compare the V-region sequences of the A chains of natural mouse immuno
globulins to those of the 21 myeloma proteins sequenced.
A series of properties of immunoglobulins have been employed to
identify specific V-regions in sera because it is not practical to
isolate and sequence the V-regions of antibodies in small samples of
serum.

These properties are the antibodies' binding constant for more

than one hapten (fine specificity) (71), the physical properties of the
immunoglobulin (e.g. isoelectric focusing spectrotype) (28), and sero
logical markers for the V-region (idiotype) (99).

These three properties

of immunoglobulins can be used as markers for the variable region because:
a) antibodies of the same immunoglobulin class should have identical
physicochemical properties except for the variability inherent to the Vregion; b) the constant region of an antibody does not contribute to the
binding of an immunoglobulin for its haptens; and c) the constant region
is not involved directly with serological markers that distinguish one Vregion from another.
Allotypic Markers in Mice
Until recently, serological markers have only been described for
the C-region of immunoglobulins.

These "allotypic" markers have been

shown to represent inheritable amino acid sequence differences in the
C-region, presumably marking germ line genes.

In mice, allotypic

markers have been extensively developed for H chain determinants (63,

i
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125).

Only recently have efforts to detect serological markers for the

C and V regions of L chains been made (173).

Before, the L chains of

mice had been only identified by the C-region isotype, as either

X or k constant regions.

On the other hand, each heavy chain class has

its own set of allotypic serological markers.

The largest set of

determinants are the markers for the IgG2a subclass which is represented
by the Ig-1 genetic locus.

In over 2000 matings and backcrosses, no

recombinants have ever been detected among the various mouse allotypic
loci (63, 164).

Thus the C„-region genes are assumed to be tightly
rl

linked in the chromosome and any mouse allotypic marker for any C^region can be employed to study the linkage of each of the C^-region
gene to any other genetic marker.

Since the Ig-1 locus has the most

extensive repertoire of allotypic determinants, most studies use this
set of alleles to test the linkage of V-region markers to the CH ~
region genes.

Table 2 identifies the Ig-1 allotypic loci of the more

commonly used strains of inbred mice.
The Use of Fine Antigenic Specificity Preferences to Identify
V-Region Gene Products
The fine specificity of an immunoglobulin for various haptens has
been used as a marker for particular V-regions in a number of studies
by MMkel'd and associates (71, 116, 114, 73, 74, 77, 137) and recently
by Dutton and McCarthy (173).

Fine specificity characteristics of a

serum are measured by determining a serum’s relative avidity for one
hapten compared to a series of other haptens.

Certain strains of mice

produce antibodies with a unique fine specificity compared to other
strains.

Genetic studies are then performed to follow the inheritance

of these antigenic preferences.

MMkelh and associates have developed

i
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TABLE 2
The Ig-1 Allotypic Loci of the More Commonly
Employed Inbred Strains of Mice (173 , 37)

a+

a

b

c

d

e

Balb/c

CBA

C57BL

DBA

AL/N

A/J

129

C3H

SJL

RF

AKR

A/He

C58

C57Br

LP

SWR

C57

IAH

SM

A/NySn
NZB

MA
PL/J
ST
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three sets of V„ markers based on the fine specificity of immunoglobuH.
lins:

V„NP; V„NBrP; and V^ABA-HOP, summarized in Table 3.
H

n

ti

In the V„NP system, certain strains of mice immunized with (4H
hydroxy-3-nitrophenyl) acetyl (NP) produce a "heteroclitic" response
for NIP and NNP*, i.e., the anti-NP antibodies have a higher avidity
for NIP and NNP than for NP.

These assays were performed on whole

serum by a very sensitive phage-inhibition assay which measures the
ability of antibodies to inactivate bacteriophage T4 that has hapten
conjugated to it (116, 71).

Only the strains of mice which have the

Ig-1*5 allotype produced a heteroclitic response for NNP and NIP in
their anti-NP sera (137, 73).

Furthermore, in the sera of Ig-1^ mice

the anti-NP antibodies of the IgM, IgA, and IgG subclasses were all
heteroclitic.

Using isoelectric focusing it was determined that one

spectrotype, "N-l", composed of heteroclitic IgGl antibodies could be
detected in 92% of C57BL mouse anti-NP sera.
found to coinherit with the Ig-1*5 allele.

The "N-l" spectrotype was

Since an antibody's specificity

is both a function of the V-regions of heavy and light chains, it was
somewhat surprising that the anti-NP heteroclitic response inherited
with a H chain marker, until Jack et al. (77) demonstrated that the
heteroclitic anti-NP antibodies in the Ig-1^ strains all contained X
light chains.

Consistent with this finding is that one

strain, SJL,

which has the Ig-1** allele lacks both X chains and the ability to make
heteroclitic antibodies to NP.

In a Balb/c (Ig-la+) x SJL (Ig-1^)

mating, the offspring were able to respond to a NP antigenic challenge
with the same fine specificity of other Ig-l^ strains.

This result

*NIP is (5-iodo-4-hydroxy-3 nitrophenyl) acetyl and NNP is (4-hydroxy3,5 dinitrophenyl) acetyl.
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TABLE 3

V-REGION MARKERS DISTINGUISHED BY FINE SPECIFICITY (173, 179)

Marker
name

Reference
Antibody

NP

anti - NP

C57BL/6

NBrP

anti-NBrP

Balb/c +

Reference Strain

Ig-1
Linkage

Distance
from Ig-1
Locus

a,?e,?c,?f

C57BL/6 ABA-HOP

anti-ABA-HOP

C3H, CBA - I

a

Balb/c, C57BL/6 - II

b (?a)

A/J - III
ESE

anti-SRBC

C57BL/6-discriminator
.

DBA/2, Balb/c, C3H
non-discriminator

sii
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suggests that the heavy chain was provided by the SJL parent and the A
chain by the Balb/c parent.
Although not as extensively characterized, Makela's group was able
to demonstrate that heteroclitic responses to two other antigens were
Ig-1 allotype linked:

NBrP ((5-Bromo-4-hydroxy-3 nitrophenyl) acetyl)

(74) and ABA-HOP (azobenzenearsonate coupled to carbon atom 3 of 4hydroxyl phenylacetic acid) systems (117).
in table 3, as well as

These results are summarized

those of the fine specificity marker, V ESE, of
rl

Dutton and McCarthy (142) which is based on the ability of anti-SRBC
sera of certain strains to "discriminate" in specificity between two
antigenically different types of SRBCs.
The difficulty in employing fine specificity alone as a marker for
V-region gene products was first demonstrated by Pincus ej: al (132).
They found that rabbit sera directed against pneumococcal polysaccharides
(type III or VIII) had homogeneous binding characteristics (Sips hetero
geneity index of 1.0), yet the sera were heterogeneous in their compo
sition of immunoglobulin molecules as demonstrated by electrophoresis.
Thus just because a preparation binds an antigen with homogeneous
characteristics, it does not mean the antibodies are identical.

Claflin

and Davie were able to demonstrate the same point with different mouse
myeloma proteins that have the same fine specificity for PC and related
antigens (22, 24, 26).

Thus the linkage of fine specificity to Ig-1

allotype might represent the genetics of a single V„ gene or the
inheritance of a family of V

rl

genes representing anywhere from one to

hundreds of different antibodies with similar antigen binding specifi
cities.

The use of other markers in conjunction with the fine speci

ficity characteristics of the V-region, such as isoelectric focusing
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spectrotype (114), limits the set of different antibodies which can have
the same specificity and charge; however, two different rabbit anti
bodies with the same antigenic specificities and isoelectric focusing
patterns have been reported (183).
The Application of Isoelectric Focusing Patterns To Identify VRegion Gene Products
Despite the limitations mentioned above, numerous workers have
attempted to use isoelectric focusing to distinguish different antibody
V-regions.

Gibson (53) has demonstrated that the isoelectric focusing

pattern of light chains of sera from unimmunized mice can be stained to
produce a very complicated set of over 50 bands.

Of the different mouse

strains surveyed, he could divide the strains into two groups:
that had a certain pattern of bands; and those which did not.

those
The FI

generation of matings of mice from each group produced a codominance
of each isoelectric focusing pattern.

Although Gibson did show that one

banding pattern appeared to be linked to a genetic locus that codes for a
lymphocyte surface marker (the Ly-2,3 marker), he failed to determine
whether V or C region differences accounted for the various banding
patterns observed.
immunized mice.

In addition, this study employed the sera from un

"Unimmunized" mice are constantly being immunized by

their environment.

The different populations of antibodies

in each

strain's sera may have reflected the different antigenic histories of
the mice.

Hence, the use of sera from unimmunized mice also lends doubt

to the validity of these results.
Another study which employed only isoelectric focusing to disting
uish different V-regions was that of Cramer and Braun (32).

They

characterized the spectrotypes of various strains of mice hyperimmunized
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with Group A streptococcal polysaccharides (A-CHO).

After performing

the appropriate matings, the isoelectric focusing patterns were found
not to segregate with hair color, sex, H-2 type, or Ig-1 allotype.
The banding patterns however were very complicated and it is not clear
what the bases of the spectrotypic differences were.
Claflin (28,29,146) used the isoelectric focusing banding patterns
of the L chains of four Balb/c phosphorylcholine (PC) binding myeloma
proteins to analyze the isoelectric focusing patterns of the L chains
of PC binding antibodies from various strains of mice.

The anti-PC re

sponse is very amenable to such a study because this immune response
is very restricted in terms of the subclass of immunoglobulins induced
and the number of different V-regions present.

Each strain had a charac

teristic banding pattern that could be depicted in terms of overlapping
bands of the L chains of the PC-binding myeloma proteins.

Claflin and

colleagues, however, extended this analysis by looking at the fine speci
ficity, idiotypic determinants, and N-terminal amino acid sequences of
these naturally raised PC binding antibodies.
The Concept of Idiotypic Markers
The idiotypic markers of V-regions provide a very sensitive set of
determinants which in conjunction with fine specificity and the physical
properties of antibodies can be used to distinguish one immunoglobulin
from another.

The term "idiotype" was coined by Oudin (127)

in 1965 to

describe the set of characteristics, serological or otherwise, that were
thought to distinguish two antibodies with the same antigenic specificity
from each other.

By 1965 abundant evidence was produced that demonstrated

that antibodies to the same antigens were heterogeneous.

For example,

|
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Kunkel, Mannik, and Williams (100) had demonstrated that rabbit antiser i
directed against human antiserum to hog gastric A substance would only
recognize the human serum that was used to induce the rabbit antiserum.
These rabbit anti-human sera would not bind to any other individual's
serum or with the pre-immune serum from the same individual.

Thus the

rabbit antisera recognizes idiotypic determinants in the human serum.
With time, however, it was recognized that anti-idiotypic antibodies
could bind to subsets of antibodies with similar antigenic specificities.
Kunkel ^t al (101) demonstrated that rabbit anti-idiotypic sera to human
cryoglobulins (anti-y-globulin IgM) would bind to different human cryo
globulins, but not with other human IgM's.

Similarly Williams et al

(176) isolated a rabbit antiserum that could distinguish cold agglutinins
from other human IgM's.
Myeloma proteins were demonstrated to share idiotypic determinants
with naturally raised antibodies by the work of Cohn £t al (30).

They

isolated an A/J mouse antiserum to the Fab of S63, a Balb/c myeloma
protein which bound the pneumococcal C carbohydrate (C-CH0).

Only

one of 160 Balb/c myeloma proteins tested were bound by this antiserum.
Interestingly, this idiotype positive myeloma protein (S107) also bound
C-CHOl

Positive idiotypic determinants were also detected in six

of ten sera of individual Balb/c mice immunized with pneumococci.
high frequency of idiotype positive sera in the Balb/c mice implied
that inbred animals would probably be more amenable to the study of
the genetics and expression of immunoglobulins than outbred animals
like rabbits and human beings.

(125)

L
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The

Whether the source of the anti-idiotypic serum was derived from
another species (xeno- or hetero- anti-idiotypic serum), from another
strain of' the same species (alio- anti-idiotypic serum) or from the
same strain or animal (iso-anti-idiotypic serum),
the antisera are similar (62, 97, 161,

132a).

the properties of

For example, Cohn- et

al (30) demonstrated that a rabbit anti-idiotypic serum to the Fab
fragments of S63 recognized only four of 160 Balb/c myeloma proteins
surveyed.

One of the four proteins was the same as that recognized

by the A/J anti-idiotypic serum.

Undoubtedly,

the mouse and rabbit

anti-idiotypic sera were highly specific for the Fab fragments of S63,
but they recognized different determinants on S63.

Iverson (76) and

Sirisinha and Eisen (155) were the first to demonstrate that inbred
strains of mice could produce anti-idiotypic sera against myeloma
proteins derived from the same strain.

Rodkey (143) later demonstrated

that a rabbit was able to make anti-idiotypic sera' against its own anti
bodies.

For the purposes of this thesis,

the term "anti-idiotypic

sera" will be used to describe sera with anti-idiotypic properties
regardless of the

animal source of the sera (37).

Sirisinha and Eisen (155) and

Brient et. al^ (12) showed that hapten

could inhibit thebinding of some anti-idiotypic antibodies
reference myeloma

proteins.

to the

Since haptens are bound in the V-regions of

immunoglobulins, this inhibition of antibody anti-idiotypic serum binding
by hapten is suggestive that anti-idiotypic antibodies are directed to Vregion determinants.
(174) was
1

However the work of Cohn et al (30) and Wells et el

the first to physically localize the region of the immuno-

globulin to which the anti-idiotypic antibodies are directed.

if
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While Cohn

al^ (30) demonstrated that the idiotypic determinants

of the myeloma protein, S63, resided in the Fab portion of the immuno
globulin molecule, the investigation of Wells ej: al (174) was the first
to demonstrate that the specificity of an anti-idiotypic serum is
directed against the V-region of an antibody.

Wells et al determined

that all the idiotypic determinants on protein 315 were present on its
Fv fragment which contains only the V-region of the molecule.

The

binding of hapten by protein 315 and by its Fv prevented any interaction
of these proteins with the anti-idiotypic sera.

Thus the anti-idiotypic

sera used in this experiment were directed against the V-region of the
protein 315 and had an interaction which was suppressed by antigen
binding to the combining region of the antibody molecule.
The Structure of the V-Region as it Relates to Idiotypic
Determinants and to the Multispecific Binding of Antigens
by Immunoglobulins
In order to understand the molecular basis of the serological
interactions observed with anti-idiotypic sera, the structure of the
combining region and the V-region of immunoglobulins must first be
understood.

In the late 1960's after the amino acid sequences of many

myeloma proteins were established it became evident that certain amino
acid positions within the V-regions of the H and L chains were more
variable than others.

Wu and Kabat (87) decided to quantitate this

variability of amino acid composition as a function of sequence posi
tion in the V-regions of L chains.

They defined variability "as the

number of different amino acids at a given position divided by the
frequency of the most common amino acid at that position."

They found

that the variable region had statistically certain areas of "hyperi

variability" (Hv) in which many different amino acid residues can be

j^j
ft-'*'

te
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found among the various myeloma proteins.

Other parts of the variable

region had much less variability or none and were called "framework"
or non-Hv residues.

It should be emphasized that the distinction

between positions designated as hypervariable and as non-hypervariable
is statistical.

There are very few positions of the V-region of- the

different immunoglobulin chains that are completely invariant in amino
acid composition.

Capra and Kehoe also performed this type of analysis

with the V regions of H chains (14).

In the ensuing six years, more

sequences confirmed this hypothetical analysis of the structure of the
V-region of immunoglobulins (88), thus defining in humans and mice three
Hv regions in the light chain at amino acid residues 24 to 34, 50 to 56,
89 to 97 and four Hv-regions in the H chain at residues 31 to 35, 50
to 56, 81 to 84, and 95 to 102.

Haber ej^ jlL (68) performed a similar

analysis with the H and L chains of natural rabbit antibodies and found
different positions of hypervariability than that found in human and
mouse immunoglobulins.

Wu and Kabat argued that the amino acid side

chains found in the Hv regions composed a "complementarity" region some
how involved with antigen binding in the combining site of an antibody.
Not until x-ray crystnllographic studies of the Fab fragments of myeloma
proteins (140, 141,

150) revealed the tertiary structure of immunoglobu

lin V-regions could an explanation be advanced for the possible asso
ciation of Hv regions with antibody specificity and idiotype.
The tertiary structure of immunoglobulin molecules

is

composed of

a series of two polypeptide chains closely associated in a series of
polypeptide folds called "domains".
tically diagrammed in Figure 1.
chains make up a domain;

This basic structure is schema

The variable regions of the H and L

the constant region of the L chain and the

1
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FIGURE 1
A Hypothetical Model Of An Immunoglobulin Molecule

ri
jf
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This drawing is a hypothetical model of the domain groupings of the
chains of an immunoglobulin molecule. The bends and folds shown
are not descriptive of the actual tertiary folding except that it
shows that the domains of the immunoglobulin molecules consist of
the V-regions of the H and L chains (V and V ), the C-region of
the L Chain and the first 120 amino acid residues
of
the
H
C-region (C and C l ) , the second 120 amino acids of the H chain
(Cy3) and tne third 120 amino acids of the H chain (C^4). In actuality
these domains are folded into compact structures.
Figure from reference 48.
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first 110 amino acids of the constant region of the H chain provides
another domain; and two more domains are composed of the two H chains
being associated with one another.

Despite sequence differences,

every immunoglobulin studied to date has this basic domain structure.
(67)

At the end of the domain created by the association of the two

V-regions of the H and L chains, a cleft or cavity exists which provides
a solvent channel between these chains.

The walls of this cleft are

almost entirely composed of amino acid residues which compose the Hv
regions of Wu and Rabat and Capra and Kehoe.

While many of these Hv

residues are located at the surface of the immunoglobulin molecule at
the opening of the cleft, not all of the Hv regions are represented
about the cleft.

Insertions and deletions of amino acids in the Hv

regions can be demonstrated to modify the dimensions of the cavity, there
by, changing the amino acid side chains that are exposed to the interior
of the cleft.
Segal

O
For example in the 3.1 A model of the Fab of McPC 603,

al (150) demonstrated that five of the seven Hv regions are

located in this cavity.

One Hv region of the H chain is at a bend away

from the cavity and one light chain Hv region is also not part of this
region.

Compared to the tertiary structure of the Fab of the human

myeloma protein, NEW, a six amino acid insertion in one of the light
chain loops of McPC 603 results in a different structure of the cavity
from NEW's.
Crystallographic studies have demonstrated that hapten is bound by
the immunoglobulin in this cleft at the solvent exposed end of the Vregion domain.

Antigen is bound by multiple interactions with many

amino acid side chains which line the combining region cavity.

Thus

in the combining region of McPC 603, phosphorylcholine (PC) molecule
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has contact with more residues of the H than the L chain (150) and in
the Fab of NEW (140,141,1) the hapten Vitamin

makes contact with at

least twelve residues equally distributed in the L and H chain of the
combining region cleft.

It is therefore incorrect to refer to an

antibody's combining "site", but rather, antibodies have combining
regions whose architecture is determined by the folding of the Hv
regions at the fluid channel at the end of the V-region domain.
In the two examples known (NEW and McPc 603) not all Hv regions
affect the shape of the antigen binding cleft.

Thus it is possible that

immunoglobulins with some differences in primary sequence of their Vregion may bind the same hapten with identical affinity.

Similarly

differences in the architecture of the cavity and in the number of
contact residues may be the basis for different affinities and fine
specificities observed amongst different antibodies which bind the same
hapten (72).
If the combining region is able to bind more than one structurally
distinct antigen, the antibody is said to be multispecific.

Many pairs

of different antigens have been described in the literature as being
bound by the same antibodies (13, 149, 121, 83, 46).

For example, a

sub-population of antibodies to streptococcal cell walls has been demon
strated to bind to myocardial cells (142) and some DNP binding antibodies
can also bind vitamin K (menadione)

(121, 83).

demonstrated that three different rabbit M P
different sets of unrelated antigens.

Cameron and Erlanger (13)

binding antibodies bind

Rosenstein and Richards (144, 145,

120) by a variety of techniques demonstrated that a mouse myeloma protein
460, binds both DNP and vitamin
the antigen binding region.

in two non-overlapping locations in

Furthermore, they were able to selectively
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denature protein 460 so that it could bind one hapten and not the other.
The multispecificity of antibodies has been used in arguments that limit
the repertoire of antibody genes.

It is proposed that each antibody V-

region coded in the genome can bind overlapping sets of different anti
gens (162, 140).

Using the three dimensional models of the Fab frag

ments of the immunoglobulins, the ability of an antibody to bind more
than one antigen in different parts of the V-region now can be interpretted in terms of the antigens having different contact residues in the
cleft at the solvent exposed end of the V-region domain.
Based on the common tertiary structure of the myeloma proteins
determined to date, various groups have attempted to create models of
the combining regions of immunoglobulins that have not been examined by
x-ray crystallography.

These models were built in order to determine

which amino acid residues might be involved with antigen binding.
example of this approach is the work

of Padlan

An

et al. (128) for MOPC

315, a DNP and menadione binding mouse myeloma protein, based on the
O
3.1 A model of McPC 603.

The obvious difficulty with such analyses is

that verification of their conclusions can only be made by x-ray crystallographic studies.
Since the V-region domains appear to have similar folding patterns,
many investigators believe that the non-ELv residues determine the common
domain structure and the Hv residues

determine

combining region.

are born out with the recent work of

These assumptions

the fine structure ofthe

Capra and Nisonoff (17, 173) which show that two immunoglobulins which
bind the same antigen (jv-azophenylarsonate) may have very different nonHv residues in the V-region of the L chain, but identical Hv residues.
I
ft'
■

The sequences of the Hv-regions of the H chains of these two immunoglobu-

I'. .
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lins were identical.

Vrana

al. (173) have demonstrated a similar

situation with the sequences of two Balb/c myeloma proteins that bind
fructosans with B (l->2) linkages.
Since many Hv region residues are exposed to solvent at the surface
of the immunoglobulin and these residues represent the largest amount of
structural diversity amongst the immunoglobulins, it would not be sur
prising if these Hv differences were the molecular bases for antiidiotypic sera’s ability to distinguish one V-region from another.

If

the amino acid residues of the Hv region were the antigenic determinants
for anti-idiotypic sera, then the ability of antisera to bind to myeloma
proteins with the same antigenic specificity can be explained.
It must be emphasized that just as any antiserum is heterogeneous
in its composition, anti-idiotypic serum contains more than one antigenic
specificity.

Many studies (130, 148) have demonstrated the heterogeneity

of the population of antibodies which compose "highly" specific antiidiotypic serum.

Thus the complete binding of an anti-idiotypic serum

with an antibody may be a function of the different portions of the immuno
globulin molecule which each individual anti-idiotypic antibody of the
antiserum recognizes.

The complete binding of an antiserum to two anti

bodies is a very sensitive measure of the two antibodies similarity.
The identity of the two V-regions must however be demonstrated by sequence
since an antiserum may not have specificity for all the differences which
exist between two molecules.

Even in the case of TEPC 15 and H0PC8, two

Balb/c myeloma proteins that have identical interactions with antiidiotypic antibodies, identical isoelectric focusing patterns, and
identical antigen binding characteristics, there is one amino acid dif
ference in residue #99 of the H chain (in the third Hv region) (88, 109,
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23, 27).
Anti-idiotypic serum can be described in terms of the quality of
its interactions with immunoglobulins.

Anti-idiotypic sera can be classi

fied into those whose interactions with the V-regions of the antibody is
inhibitable by the reference antibody binding a hapten and those whose
interactions are not inhibitable by the antibody binding a hapten.
Brient et al. (12) and Sirisinha and Eisen (155) were the first investi
gators to demonstrate the hapten inhibitable nature of the antibody anti-idiotypic serum interaction.
the following reasons:

Inhibition by antigen can occur for

a) antigen binding in the combining region cleft

can mask (sterically hinder) certain amino acid residues that an antiidiotypic serum may recognize; or b) antigen binding may cause subtle
changes in the tertiary structure such that certain Hv-loops are no
longer exposed to the surface of the molecule.

For the purposes of this

thesis, the group of anti-idiotypic sera whose interaction with antibody
are hapten inhibitable will be labeled "combining region complementary"
anti-idiotypic antibodies in recognition of the fact that the binding of
antigen by the combining region affects the expression the idiotypic
determinants.

The term, "combining region complementary" anti-idiotypic

serum is therefore both a functional and a structural description of the
interaction between antibody and anti-idiotypic serum.
Claflin and Davie (25, 23) have used the ability of the hapten to
inhibit anti-idiotypic sera binding as a means to isolate combining region
complementary anti-idiotypic sera.

Antibodies to a reference myeloma

protein are passed through a column containing the reference antibody
bound to a solid support such as Sepharose.

After exhaustive washings,

antigen is passed through the column and a population of immunoglobulins
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are eluted which can be demonstrated to be combining region complementary
anti-idiotypic antibodies.
No study to date has correlated a specific idiotypic determinant
with specific amino acid residues in the V-region of an immunoglobulin.
This is probably because the population of antibodies and specificities
in an anti-idiotypic serum is heterogeneous (130, 148).
amino acid sequence is solely recognized by the serum.

Thus no one
Using a variety

of approaches, investigators have demonstrated that the anti-idiotypic
specificity of a serum can be directed against determinants of the Vregions of the H chain, the L chain, or a combination of both chains
(125, 173, 179, 37).
The Application of Anti-Idiotypic Antibodies To Identify V-Region
Determinants
Intensive investigations are currently underway to correlate amino
acid sequences to the presence of idiotypic determinants.

This is es

pecially true in those instances in which idiotypic markers of individual
mouse immunoglobulins have been demonstrated to be genetically linked to
C-region allotypic loci (173).

In such studies, a reference immuno

globulin is injected into an animal and an anti-idiotypic serum is iso
lated from the immune serum.

The anti-idiotypic serum is used to deter

mine whether an immune response of an organism contains antibodies both
which are bound by the anti-idiotypic serum and which bind the same
antigens that the reference immunoglobulin does.

At present, it is un

predictable whether a given anti-idiotypic serum will bind ?o antibodies
from just a few individuals, from a specific strain, or from a particular
species (37).
from A/J mice:

For example Eichman (35) isolated clones of immunoglobulins
A5A, a single clone which binds streptococcal group A
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carbohydrate (A-CHO); and A2C, a mixture of immunoglobulins which bind
pneumococcal C carbohydrate (C-CHO).

Guinea pig anti-idiotypic sera

specific for each clone were purified.

Eichman found that in the anti-A-

CHO response greater than 80% of A/J mice contain immunoglobulins that
were bound by the anti-idiotypic sera to A5A.

On the other hand, less

than 20% of the A/J anti-C-CHO responses contain immunoglobulins which
were bound by the anti-idiotypic sera to A2C.

Only mice with the Ig-1

0

allotypic locus produced anti-A-CHO antibodies which were A5A idiotype
positive.
Both myeloma proteins and naturally raised antibodies have been used
as reference proteins for idiotypic sera employed in investigating the
immune response to different antigens.

Tables 4 and 5 summarize the dif

ferent immune responses in mice studied by idiotypic analysis.

Occasion

ally an idiotypic determinant is found to have a strain distribution that
was linked to the Ig-1 allotypic locus.

The three most characterized

immune responses in the mouse are those to phosphorylcholine (or the
pneumococcal C-CHO), to

2

,-azophenylarsonate (ARS), and to ct(l->3) dextran.

Before discussing these immune responses, a few points about this
method of analyzing immune responses must be emphasized.

The method of

inducing and purifying the anti-idiotypic sera and the assay employed
to detect the presence of the idiotypic marker affects the specificity of
the serological marker.

While most assays quantitate the amount of immuno

globulin that is bound by an antiserum, only a radioimmunoassay (RIA)
gives both quantitative and qualitative information about the interaction
between the antibodies and the anti-idiotypic serum (22).

In a RIA, the

binding of a radioactive antigen to an antiserum is measured in the pres
ence of varying concentrations of inhibitor.

Each antiserum consists of
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TABLE A

Antigen

Marker
(ref)

Reference
Myeloma
Protein

Reference
Strain

R36 strain
of Pneumococci
(A-CHO)

V T15

TEPC 15

Balb/c

a+

HOPC 8

Balb/c

Ig-1
Link
age

Cross-Reaction
Source
of
With Other
Immunoglobulins AntiSera

Chain
Require
ment of
Sera

Binding
Region
Spec.

Distance
From
Ig-1
Locus

H8, MOPC 299,
S63, S107,
Y5170, Y5236

A/He

L & H

no

all
strains

T15, CBPC-2

rabbit

L 6 H

yes

n.a.

PC-KLH

VlrPC
HOPC 8
Balb/c
(27)
cross-react
ion with
MOPC 167

all
strains

T15, CBPC-2,
M511, M603

rabbit

H

yes

n.a.

PC-KLH

173
U10-173
Balb/c
(9, 173) cross-reac
tion with
U10

all
strains
but C3H,
PL/J.CBA

U10, ABE48,
Y5236
J5539, X24,
X44, T601,
CBPC-4
MOPC 406

rabbit

L & H

7

n.a.

8(2*1) Levan
(a.levdnicum)
8(1+6) D
galactan

(109)
II8q
(23)

<1

N-acetyl-Dmannosamine

MOEV 48, 173,
PC3
Dextran
a (1-3)

Strepto
coccal
A-CHO

Other Anti
gens That
Are Bound by
Induced Anti
body
PC-KLH

IdX
(136,
173)

J558

Balb/c

IdI
(60,
61)

J558
M104e
UPC10

Balb/c
C57BL,
Balb/c
Balb/c

S117

Balb/c

a+

S117

DBA/2

c

S117
(7)
S117cr

fT\

a+

MOPC 104G,
UPC 102,
HOPC-1

unknown
A/He
goat

X.L & H

yes

A/He
goat

A.L & H

7

Guinea
Pig,
A/He

0.41

E. coli,
B1355S
E. coli,
B13555S

3.84
4.16

N-acety
glucosamine
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Immune Responses Studied By Idiotypic Analysis Using Myeloma Proteins As References

"O
CD

TABLE 4

(Continued)

Antigen

DNPconjugated
proteins

Levan
3(2-1)

Marker
(ref)

Reference
Myeloma
Protein

Reference
Strain

(76)

5563

CBA

(155,
62,
157)

MOPC 315

Balb/c

(155)

MOPC 460

Balb/c

(132a)
(157)

XRPC 25

Balb/c

IduldX
(110,
173)

EPC109,
Balb/c
UPC61, A47,
A48, A4,
W3082, AMI,
T803, W3082 »

Idl

M702, ABP51 >
ABPC1, ABPC45

cn

Ig-1
Linkage

Cross-Reaction Source
With Other
of
Immunoglobulins AntiSera

Chain
Requirement of
Sera

Binding
Region
Spec.

Distance
Prom
Ig-1
Locus

Other Anti
gens That
Are Bound by
Induced Anti
body

CBA
PC22Aadj,
SI76, J504,
M292

M460
a,e,d,
c

all proteins
listed in
reference
proteins
no other
immunoglobulin

Balb/c,
A/J,
rabbit

yes &
no

Balb/c

yes

Balb/c,
rabbit

yes &
no

A/He

yes

one Iduldx
a.
marker Is
levanlcum
2.44 from
Ig-1
(ref. 173)

yes

(110)
Each Levan binding myeloma protein had a A/He anti-serum which could cross-react with most other levan
binding proteins (IduldX); however, idiotypic specificities were isolated that only bound to the
particular immunoglobulin to which the antiserum was made (Idl).
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TABLE 5

Antigen

Marker
(ref)

Reference
Antibodies

Azophenylarsonate
(ARS)

ARS
(99,
167)

Anti-ARS
A/He,A/J
with cross
reactive
idiotype

(56)

anti-ARS
with
no CRI

A5A
(35) ...
A5Acr
(35)

clone of A/J
anti-A-CHO

NP

NP
(77)

Heterocli- C57BL/6
tic sera for
NP from C57BL
mice

Staphylo
coccal
Nuclease

Nase-A
(45)
Nase-S
(45)

anti-nuc A/J
lease Anti
bodies
SJL

Val
(89)

Antibodies
to HbS

Strepto
coccal
A-CHO

Hemoglobin

of A/J
mice

Reference
Strain

Ig-1
Link
age

e

A/J

DBA

e

Cross-reactions
With Other
Immunoglobulins

Source
of
AntiSera

Binding
Region
Spec.

rabbit

yes

2 x (0 out of 181) rabbit
51 out of 181
3 out of 181
Above is Survey of 181
Neonatally-Suppressed
A/J Mice
guinea
Pig

yes

Distance Other Anti
gens That
From
Are Bound by
Ig-1
Locus
Induced Anti
body
<1

2.44

c

guinea
Pig

b

guinea
Pig

no

linked

a,e

rat

no

linked

a,b

rat

no

<0.4

sheep,
goats

N-acetylglucosamlne

1.38
NIP, NNP
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more than one antibody directed against the antigen.
a different affinity for the antigen.

Each antibody has

At lower concentrations of un

labeled inhibitor, only the antibodies with the greatest affinity for
the inhibitor will bind the cold competitive antigen.

At higher concen

trations of unlabeled inhibitor a greater proportion of labeled haptens
will no longer be bound because of competition for the combining
regions of the antibodies.

Thus the inhibition curve of the binding of

radioactive antigen generated by varying the concentration of unlabeled
inhibitor is a reflection of the aggregate affinities of the antibodies
for that inhibitor.

If two different inhibitors are bound with dif

ferent binding constants by the antibodies that compose an antiserum,
the concentration of inhibitor required to effectively compete with the
same radioactive antigen will differ with each inhibitor.

Thus the "shape"

of the inhibition curve produced by each inhibitor will differ.

A RIA,

therefore, measures both the extent of inhibition (the percentage of
radioactive antigen binding immunoglobulins that also bind the un
labeled competitor) and the nature of the inhibition.

It can only be

implied of two inhibitors that have identically shaped inhibition curves
that all antibodies in the antiserum bind the two inhibitors with the
same affinity.

That is, the two inhibitors are antigenically identical.

No conclusion can be made about these inhibitors structural identity
because antibodies in the antiserum may not be directed against all
structural features of the antigen.

On the other hand, two inhibitors

that produce differently shaped inhibition curves are definitely anti
genically dissimilar, even if the two inhibitors produce the same extent
of inhibition.

Thus the RIA provides information about both the ability

of an antiserum to bind an inhibitor and the nature of this binding.
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Berek et al. (7) used the shape of the inhibition curves produced
by mouse anti-A-CHO immune sera in a RIA with anti-idiotypic sera to
distinguish two sets of idiotypic markers.

The S117 and S117

cr

and the

A5A and A5Acr idiotypic markers were distinguished by both the extent of
inhibition and the shape of the inhibition curves in the RIAs.

Only

identical inhibition curves produced by mouse sera were used to imply that
the anitserum employed to identify the idiotype recognized the same deter
minants on the V-regions of the sera.
The RIA, per se, gives no information about sequence identity.

Any

other assay of idiotypic determinants provides less information about the
quality of the interaction between the anti-idiotypic sera and an anti
body.

Conclusions about the idiotypic identity of two V-regions based on

any assay but a RIA must be tempered by the lack of knowledge about the
nature of the interaction between the anti-idiotypic antibodies and the
two V-regions.
Another important aspect of many of the studies which employed idio
typic markers to analyze an immune response is that there is an under
lying assumption that the anti-idiotypic sera are directed against
"complementarity" determinants of the V-region.

In most instances, there

is no definitive demonstration that this is the case.
of these markers such as the Ig-1

In addition, some

locus linked TEPC 15 idiotype (109)

are not combining region complementary, i.e. hapten does not inhibit the
binding of the reference antibody by the anit-idiotypic serum.

In this

case, Claflin and Davie (27) demonstrated that while hapten would not
inhibit the binding of anti-idiotypic sera to TEPC 15, very large anti
gens would.

This is presumably so because of steric hindrance of the

bulky antigen near the V-region of TEPC 15.
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In many of these studies, the antisera were presumed to be antiidiotypic because the sera will bind to only one or two of a few myeloma
proteins which all bind the same antigen.

The authors often failed to

screen large numbers of myeloma proteins to rule out in the antisera the
presence of "spurious" specificities for immunoglobulins that bind dif
ferent antigens than the reference antibody does.

This point was empha

sized by the investigations of Bosma jet al. (9, 173) in which the binding
of

125

I-labeled U-10, a Balb/c myeloma protein, to a rabbit antiserum for

the Balb/c myeloma protein, MOPC 173, was measured in a RIA.

Of 58 Balb/c

myeloma proteins surveyed, thirteen antibodies had identical inhibition
curves to that of U-10.

Furthermore, these "idiotype positive" anti

bodies bound different haptens.

All of these antibodies had similar se

quences in the 27 N-terminal amino acids of the H chain.

By recombining

the H and L chains of different immunoglobulins to construct new 7S immuno
globulin molecules, the authors demonstrated that both H and L chains were
required for the full expression of this serological determinant.

Thus

Bosma et al have isolated a V-region serological marker that is unrelated
to antigenic specificity and may be related to "non-complementarity"
residues of the V-region.

This result may be analogous to the V-region

"a" allotypic marker of rabbits (160).

A major implication of this study

is that before an antiserum can be used as a probe for the entire V-region
of an immunoglobulin, it must first be demonstrated that the antiserum
recognizes only those immunoglobulins with the same specificity, or better
yet, it recognizes only those immunoglobulins with identical amino acid
sequences.

The latter of course is more difficult to demonstrate.

Another important point which must be kept in mind when studying the
phenotypic expression of immunoglobulin V-regions is that just because a
V

i;.
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particular V-region is not expressed in an immune response of a strain
does not mean that genes for that particular V-region are absent from the
genome.

Strosberg ^t a l . (159, 160) and Mudgett ^t al^. (123, 173) have

demonstrated that rabbits hyperimmunized with Micrococcus lysodeikticus
expressed V-region "a" locus allotypic determinants which breeding experi
ments had demonstrated did not exist in those particular rabbits studied.
The expression of these "forbidden" allotypes implied that the allelism
observed for the "a" locus was not real, but rather, a regulatory mechanism
for the expression of "a" allotypes was most likely operative.

In a

similar study, Bosma and Bosma (8) demonstrated the transient expression
of the Balb/c allotype in a congenically inbred mouse strain that had been
selected to contain only C57BL allotypes.
No substantiative conclusion can yet be made regarding whether the
difference in expression of one particular immunoglobulin gene product
among the various strains of mice is due to structural or regulatory genes.
This is especially pertinent because regulatory loci have been mapped that
modulate the maturation of an immune response (147) and that modulate the
amount of immunoglobulin produced depending on the carrier employed (169)
and depending on the adjuvant used (170).

Thus it should always be born

in mind that serological markers such as idiotypic and allotypic deter
minants are phenotypic, but not necessarily genotypic.
The R36 Pneumococcal Polysaccharide Idiotypic System
Probably the best understood immune response is that of the mouse
to the C-polysaccharide (C-CHO) of the strain R36A pneumococci.

The

initial work of Cohn et al. (30) was extended in a series of studies that
demonstrated:

1) of 70 Balb/c myeloma proteins assayed, only six could

bind C-CHO (134); 2) anti-idiotypic sera could distinguish a subset of
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C-CHO binding myeloma proteins (134); and 3) the C-CHO binding immuno
globulins also bind the simple hapten, phosphorylcholine (PC) (108).
Table 4 summarizes the sources and specificities of the different antiidiotypic sera made against the myeloma proteins which bind PC.

The

myeloma proteins, HOPC 8 (H8) and TEPC 15 (T15), are idiotypically
identical.

The anti-T15 idiotypic antibodies have varied specificities:

some anti-T15 (H8) idiotypic antibodies bind all PC binding myeloma
proteins and other anti-T15 (H8) idiotypic antibodies bind only to a
subset of the PC-binding myeloma proteins (27).

The idiotypic differences

seen between T15 and H8 and the other PC binding myeloma proteins are
reflected in other properties of these proteins.

For example, the fine

specificity of T15 and H8 for a variety of PC-related compounds, such as
phosphoglycerolcholine and choline, differed from that of other PC
binding myeloma proteins which do not have identical idiotypic profiles

( 21).
In an important paper Barstad et al. (6) compared the first 41 Nterminal amino acids of the H and L chains of five of these PC binding
proteins.

These sequences included the first Hv regions of both H and

L chains.

Three myeloma proteins (T15, H8, S107) were identical by fine

specificity antigenic preferences and by idiotypic interactions with anti
sera.

The light chains of these three immunoglobulins had identical se

quences.

These sequences were markedly different from the two other PC

binding myeloma proteins, McPC 603 and M167 (88).

Surprisingly, the amino

acid sequences of the H chains of all five proteins were identical except
;

for one residue in M167 (valine at position 4).

This result was the first

demonstration that antibodies isolated from different animals could have
|

similar antigen specificity, idiotypic determinants and amino acid sequences.
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Furthermore, the identity of the H chain sequences and the differences
of the L chain sequences of the five proteins were used to predict that
the residues of the H chain of PC binding antibodies were mostly involved
with the binding of PC.

O
The 3.1 A Fourier difference map of PC bound to

McPC 603 has confirmed this prediction (150).
In a related study, Claflin et al. (26, 31) characterized a PC binding
myeloma proteins, CBPC-2, derived from a congenic inbred strain which
possessed most of the genome of Balb/c but the Ig-1 locus of C57BL.
CBPC-2 contains the allotype for C57BL, but it is identical to H8 and
T15 by its fine specificity for PC-related antigens.

CBPC-2 also has

identical idiotypic interactions as T15 does with two different binding
region complementary anti-T15 idiotypic sera, but CBCP-2 lacked the idio
typic determinants specified by a non-binding region directed antiserum to
T15.

As with the Barstad study (6), the L chain sequence of CBPC-2 was

identical to that of T15, H8, and S107 to the thirty-fifth N-terminal
residue (which includes the first Hv region).

The first 36 N-terminal

amino acids of the H chain of CBPC-2 differ from the Balb/c PC binding
proteins by two amino acids (residues #14 and #16) that were both non-Hv
residues.

In this study a difference in the non-Hv region of the V-

region of the H chain was presaged by idiotypic differences.

Based on

fine specificity characteristics CBPC-2, T15, and H8 are identical.

This

study emphasizes that while fine specificity and the idiotypic deter
minants are extremely sensitive markers for the V-region, only the amino
acid sequence is the final arbiter as to the identity of two V-regions.
Even T15 and H8 differ by one amino acid iu the third Hv region (88).
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Armed with the various anti-idiotypic sera for the V-region of
T15-like myeloma proteins, many investigators have analyzed the immune
response to pneumococcal C-CHO in mice-

Claflin and Davie (21, 22, 23)

and Kluskens at al. (94) demonstrated that the immune response to C-CHO
in mice involves solely the IgM class of immunoglobulins.

Host strains

of mice produce PC binding antibodies that have the same fine specificity
to PC-related antigens as the reference PC-binding myeloma proteins.
While many anti-T15 (H8) sera binds to anti-PC antibodies from most
mouse strains, one serum, A/He anti-T15, a non-combining region complemen
tary anti-idiotypic serum, only binds to the PC binding antibodies from
strains of mice with the Ig-1

cL"t"

allotypic locus (109) .

Anti-PC sera from

animals other than mice did not contain immunoglobulins with the idio
typic or fine specificity properties of T15 (H8) (22) .
In a series of elegant studies, Claflin (28, 29), Rudikoff (146, 173)
and Kluskens and Kohler (94) demonstrated that the L chains of an anti-PC
response of each mouse strain could be analyzed in terms of the isoelectric
focusing spectrotypes of the L chains from the three PC binding Balb/c
myelomas, T15, M167, and McPc 603.

The L chain spectrotypes of each mouse

strain was characteristic for that strain.

Anti-idiotypic sera were

employed to isolate the anti-PC antibodies from the anti-C-CHO sera of
45 A/J mice.

The 36 N-terminal amino acid residues of the isolated H

chains yielded a single homogeneous sequence identical to that of the
Balb/c proteins T15, H8, and M511, except for a single amino acid dif
ference at a non-Hv residue (#22).

The N— terminal amino acid sequence of

the L chains gave evidence for the presence of three sequences.

This

composite sequence of the isolated L chains is identical to what would be
obtained if the L chains of the PC binding proteins, T15, M167, and McPC
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603, were pooled and sequenced.

Thus, based on isoelectric focusing

patterns, idiotypic analysis, and N-terminal sequences, the V-regions of
A/J mice are very similar to the V-regions of both the H and L regions of
myeloma proteins from Balb/c mice.

This is especially interesting since

A/J and Balb/c mice have different allotypic loci and the PC binding
antibodies of these two strains differ idiotypically using a non-binding
region complementary A/He anti-T15 sera which marks an allotypically
linked determinant of the V-region of T15.

The large amount of sequence,

isoelectric focusing, and idiotypic homologies observed among the different
strains of mice argues for a common origin of their V-region genes with

'

late evolutionary divergence of the non-binding region related idiotypic
sequences.

An analysis of the sequences of antibodies obtained from a

pool of 45 mice can only be valid, if it is kept in mind that the
sequences found were that of the majority of immunoglobulins present.
Antibodies present in small concentrations or in a few mice would not be
detected.
Recent work by a number of groups has demonstrated that the PC
binding antibodies induced by pneumococcal C-CHO are only a subset of the
repertoire of PC binding V-regions present in the genome and capable of
being elicited.

While mice only have an IgM class response to C-CHO

with little or no maturation of the response (21, 94), Gearhart et al.
(52, 51) have demonstrated that PC attached to a tripeptide spacer linked
to the carrier, Keyhole Limpet Hemocyanin (KLH), will also induce PC
binding antibodies of both the IgM and IgG classes.

Some of these PC

binding antibodies lack the T15 idiotypic determinants.

Furthermore,

Julius ^t a l . (31, 86, 173) demonstrated that neonatal Balb/c mice
treated with A/J anti-T15 idiotypic sera were rendered unable to produce
immunoglobulins with these T15 idiotypic determinants.

These "suppressed"
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mice produced PC binding antibodies which lack the T15 idiotypic but have
as great an avidity for PC as the T15 idiotype positive PC binding anti
bodies produced by non-suppressed mice.

Thus regulatory factors not yet

understood determine which set of PC binding V-regions are expressed in
an immune response.
The js-Azophenylarsonate Idiotypic System
Another well characterized immune response in mice is that of A/J
mice to j>-azophenylarsonate (ARS) which was characterized by Nisonoffand associates (99, 167, 16, 17, 15, 56, 18, 179, 118).

In the A/J mouse,

from 20% to 70% of its anti-ARS response is bound by a rabbit antiidiotypic serum made against A/J mouse anti-ARS sera (167).

Presumably

only common idiotypic determinants served to sensitize the immunized
rabbits.

The mouse immunoglobulins that are bound by this rabbit anti-

serum are termed to have the "cross-reactive idiotype" (CRI).
no myeloma protein has been isolated which binds ARS.
with the Ig-1
(99).

To date

Only mouse strains

allotypic locus produce CRI positive anti-ARS antibodies

Although the CRI marker is linked to the H chain allotype, both

H and L chains are required for the expression of this determinant(s)
(15).

While antibodies of every subclass can be found to have the cross-

reactive idiotype, two major bands of IgGl anti-ARS antibodies were iso
lated by isoelectric focusing and were found to constitute a major compo
nent of anti-ARS sera.

These two bands were isolated from pools of sera

of many immunized mice and from the ascites of a single immunized mouse
(167).

When these isolated immunoglobulins were sequenced, results

similar to those described above for the PC binding antibodies were found.
The H chain was sequenced to position 54 and yielded a unique amino acid

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

44

seqeunce for both anti-ARS fractions obtained from an individual mouse
and from pools of mouse sera (15, 16).

The H chain of anti-ARS anti

bodies which did not have the cross-reactive idiotype had a very hetero
geneous sequence, almost as varied as that of immunoglobulins from whole
serum.

Sequence data for the L chains implied that as few as two se

quences to as many as 20 different L chains could be found (18).

The

sequences of the L chains were found to differ not at the Hv region but
in the non-Hv (or "framework") residues.

It is interesting that the Hv

regions of the L chains of guinea pig anti-ARS antibodies have almost
identical sequences to those of the mice but almost completely different
non-Hv residues (18).

These results are very suggestive that a unique

H chain sequence and a unique sequence of the Hv regions of the L
chain are required for the cross-reactive idiotype.

The large array of

different L chains that have similar Hv regions apparently allows the
genetics of the cross-reactive idiotype to appear to be that of just the
H chain.

It should be remembered that these sequence studies were only

performed on immunoglobulins isolated from two major peaks on isoelectric
focusing of anti-ARS sera.

Nisonoff and colleagues did not sequence the

pool of all CRI positive antibody.

More than one immunoglobulin was

present in each peak and the sequence obtained was that of the majority
immunoglobulin present.
Nisonoff*s group demonstrated that the repertoire of anti-ARS Vregions is diverse despite the fact that the CRI positive antibodies
compose the major part of the anti-ARS response in mice that have the
g
Ig-1 heavy chain allotype (56).

By immunizing neonatal A/J mice with

rabbit anti-CRI sera, the anti-ARS response obtainable does not contain
antibodies with the cross-reactive idiotype.

Rabbit anti-idiotypic sera
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to the anti-ARS antibodies which lacked the CRI were used to survey the
anti-ARS response of these neonatally suppressed mice.

While some anti-

idiotypic' sera did not bind to any immunoglobulins of 181 A/J
anti-ARS sera from neonatally suppressed mice, one anti-idiotypic serum
bound to only three sera and another to 51 sera.

These results support

the concept that either there is a very large repertoire of V-regions of
anti-ARS antibodies or that each animal is capable of generating unique
antibodies for specific antigens.

As in the case of the anti-PC response,

the regulatory controls involved in the preferential expression of one
idiotype over another must be understood in the anti-ARS response.
The a(l->3) Dextran and 8(2->l) Levan Idiotypic Systems
A third well characterized mouse immune response is that to a(l->3)
dextrans.

This immune response has been analyzed in terms of the anti-

idiotypic sera to three Balb/c mouse myeloma proteins that bind ct(l->3)
dextrans, J558, M104e, and U102.

Anti-idiotypic antibodies have been

isolated from goat and A/He sera that are specific only for each indivi
dual myeloma protein.

These specific anti-idiotypic sera are called

"private" or "Idl" anti-idiotypic sera since the sequences which
they recognize appear to be unique for each of these anti-dextran anti
bodies.

One goat anti-idiotypic serum to J558 has been studied which also

binds M104e and U102.

This cross-reactive determinant has been labelled

a "public" or "IdX" marker by these investigators, since the idiotypic
determinants bound by this antiserum appear to be associated with a number
of different V-regions with the same antigenic specificity (173, 60, 61).
The difficulty in classifying determinant as Idl or IdX is that not
enough myeloma proteins have been studied to indicate whether many immuno
globulins will be found that possess Idl determinants.

As stated above,
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the myeloma proteins represent a skewed population of antibodies;
therefore, the relationship of Idl and IdX determinants to the reper
toire of all a(l->-3) dextran binding immunoglobulins is not known.
Using these sera, it was determined that all anti-dextran immuno
globulins in mice have L chains of the A„ type (173).

Mouse strains

3*"^

that have the Ig-1

allotypic locus can produce antibodies that are

bound by these anti-idiotypic sera (136).
binding antibodies from Ig-1

3,"4*

Furthermore, a(l->3) dextran

positive strains consist of three types:

a) those that do not interact with anti-idiotypic antibodies directed
against proteins J558, U102 and MIOAe; b) those which have only the IdX
determinant; and c) those that have both the IdX marker and one of the
three Idl determinants.

The dextran binding immunoglobulins which have

both the IdX and Idl determinants for M104e and J558 share the same fine
specificity for antigens as the reference immunoglobulins.

It is also

clear that the M104e and J558-lilce. immunoglobulins are composed of more
than one class of immunoglobulin (IgM and IgG).

While not all strains

make the X 0 L chain isotype (e.g. C57BL), the presence of this light
chain is not the sole requirement for the idiotypic determinants.

Even

though dextran binding immunoglobulins of NZB (Ig-1^) mice make the X Q
chain, these immunoglobilins have idiotype negative dextran binding
antibodies.
The immune response to 8(2->l) levans is similar to that of the
a (1+3) dextrans.

A whole series of IdX and Idl mouse anti-idiotypic

sera have been isolated and characterized (110).

The take home lesson

from this work with the C-CHO, ARS, a(l->3) dextran, and f3(2-KL) lexan
idiotypic systems is that very well defined anti-idiotypic sera are able
to bind to natural immunoglobulins which the same antigenic specifities
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as the reference proteins to which the anti-idiotypic antibodies were
made.
Table 4 summarizes the data concerning the immune responses that
have used myeloma proteins as reference immunoglobulins in performing
an idiotypic analysis of the immune response.

Table 5 summarizes the

data concerning the immune responses that were analyzed by using antiidiotypic sera directed to native antibodies found in immune sera.

In

general the work summarized in Table 5 is unsatisfactory because the
homogeneity of the isolated V-regions must be demonstrated before the
specificity of the anti-idiotypic sera is believable.
not been demonstrated.

Usually this has

For example, Jack at al. (77) isolated a non

binding region complementary anti-idiotypic serum for heteroclitic anti-NP
antibodies in the sera of C57BL mice.

While the idiotypic determinants

co-inherit with the heteroclitic anti-NP response, it is unclear how
specific the anti-idiotypic serum is, i.e., whether the antiserum is
directed against many different determinants found on many different
V-regions or the antiserum is directed against determinants found on
just one V-region.

This problem is now being approached by using the

cell fusion techniques developed by KShler and Milstein (96,107,175).
Normal spleen cells from immunized mice are fused to a myeloma cell
line which can be grown in culture.

The hybrid cells secrete immuno-

I
globulins, some of which bind the antigen for which the animal was
primed.

In this fashion, KShler and Milstein were able to establish

new cell lines that produce immunoglobulins with the antigen specifi
city that they desired and which can be carried in tissue culture.
Presently, a number of groups are creating stable cell lines in order
to obtain homogeneous antibodies of a given antigen specificity so that

,L
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idiotypic markers can be generated and used to analyze various immune
responses (107,175).

This approach is a satisfactory extension of the

anti-idiotypic analysis that used myeloma proteins as references.
The major advantage of the hybrid cell technique is that homogeneous
antibodies from any strain of mouse and to any antigen may now be iso
lated.
By employing the various V-region markers of the H chains of
different immune responses of inbred and congenic strains, a linkage
map of these determinants to loci for the Ig-1 allotypes and for a serum
protein called pre-albumin has been derived (164, 173, 137, 136, 37).
This linkage data is summarized in Tables 2, 4, and 5 and in Figure 2.
As emphasized earlier, it is still unclear whether the inheritance of
these markers represents the inheritance of regulatory or structural
genes and it is unclear whether many of the determinants represents one
V.,-region or families of V-regions.
n

It is also curious that all idio-

typic determinants of mouse immunoglobulins that have been serologically
defined are found on the H chain or require both the H and L chains for
expression.

Many of these idiotypic markers of mouse V-regions appear to

be genetically linked to H chain allotypic markers.

No idiotypic deter

minant has been found to be located solely on the L chain.

Very few

investigations to date (19, 70) have employed RIA's to determine the
effect of the L chain in modulating the expression of idiotypic deter
minants located on the H chain.

Until it is determined how the H and L

chains affect the expression of the idiotypic determinants which are
studied as markers for the presence of specific V-regions, the signi
ficance of these "inheritable" idiotypic determinants is unclear.
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FIGURE 2
Linkage Order of V

Ig-1

Region Markers That Have Been Demonstrated To Be
Linked To The Ig-1 Locus (173)

- NaseA - [T15, Dex, S117] - [InuldX, ARS] - A5A°r- [A5A, ABA-HOP, ESE]

i
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The Anti-DNP Response of Rabbits, Guinea Pigs and Mice
The immune response in mice to the simple hapten, 2,4-dinitrophenyl (DNP), is also one of the most studied immunological phenomena,
yet little work has been performed to develop idiotypic markers in this
system or to determine the genetics of DNP binding V-regions.

The

ability to easily synthesize chemically defined haptens, antigens, and
reagents for detecting DNP binding antibodies has made this immune
response a very popular one for those who study the cellular modulation
of B cells (50).

The immune response to DNP containing antigens in

volves antibodies of every immunoglobulin subclass.
Eisen and Siskind (38) and Steiner and Eisen (158) have demonstrated that
in rabbits the average affinity of DNP binding antibodies in an immune
response increases with time.

By sequentially immunizing rabbits with

DNP, followed by TNP (2,4,6-trinitrophenyl) or vice versa, different and
more homogeneous populations of DNP-binding antibodies are induced.
Little and Eisen (112) continued this analysis and demonstrated that the
population of antibodies induced by TNP immunization are different from
those raised to DNP.

In the early stages of an anti-DNP or anti-TNP

response, as little as 50% of the antibodies directed to one hapten will
bind the other.

With maturation of the response, the percentage of dual

specific immunoglobulins increases in the antisera.

Klinman and Press

(93) demonstrated that in the neonatal mouse non-overlapping populations
of spleen cells exist which produce immunoglobulins that bind either DNP
or TNP.

Each type of clone can only be stimulated by one antigen, but

not the other.

It should be emphasized that a DNP binding antibody that is

said not to bind TNP (or vice versa), actually represents an antibody
3 -1
whose affinity for TNP is low (in the order of 10 M
or less) and which

.L
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is many orders of magnitude less than the antibody’s affinity for DNP.
Pink and Askonas (133) estimated that the number of different V-regions
in the mouse that bind DNP is in the order of thousands.

This estimate

was based on the number of different isoelectric focusing patterns of
DNP binding antibodies induced by the sequential immunization with DNP
and TNP containing antigens.
Normally the immune response to DNP antigenic challenge is too
heterogeneous for an analysis of individual antibodies.

A number of

groups have demonstrated that the immune response to DNP conjugated to
certain carriers is greatly restricted in heterogeneity.

For example,

when Richards and Haber (138) injected rabbits with DNP conjugated with
the "L" peptide, a synthetic polypeptide, a relatively homogeneous
antibody response with very high affinity for DNP was induced.

This

response did not "mature", i.e., the average affinity and Sips hetero
geneity index did not change with time.

DNP-deca-lysine (179) elicits

a very homogeneous response in guinea pigs.

Each animal averages less

than two clonal products of DNP binding immunoglobulins based on iso
electric focusing patterns.

Of 53 guinea pigs surveyed, only 19 dif

ferent isoelectric focusing patterns were distinguishable and seven of
these patterns constituted the majority of the DNP binding antibodies
detected.

Similarly, Montgomery et al. (122) demonstrated that rabbits

after somewhat prolonged immunization with (DNP)^-gramicidin S will
produce a very restricted anti-DNP response that does not change for
the entire life of the animal.

Thirty five percent of the rabbits

will not respond to antigenic challenge at all, and about 20% of the
rabbits produce monoclonal antibodies.

While these techniques have

demonstrated means of inducing limited anti-DNP responses, no studies
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have correlated these restricted responses to an idiotypic analysis,
nor have these relatively homogeneous responses been employed to study
the inheritance of the V-regions of DNP-binding immunoglobulins.
Another method of studying a limited population of DNP binding
antibodies was developed by Varga £t al. (168).

As explained earlier,

immunoglobulins can be demonstrated to have multispecificity for
distinctly different chemical moieties (13, 149, 121, 83, 46).

Varga

et al. (168) screened rabbit anti-DNP sera for its ability to bind
144 other haptens and found that four sub-populations of DNP binding
antibodies also bound inosine, uridine, menadione (Vitamin K^) and
ribonuclease.

When rabbits were sequentially immunized with antigens

containing one of these haptens followed by DNP-BGG, the early phase of
the anti-DNP response had a preferential stimulation of those clones of
immunoglobulins that bind both haptens.

Later in the anti-DNP response,

the increase in concentration of "monospecific": antibodies for DNP
prevented the detection of these double binding immunoglobulins.

This

experiment not only showed that sequential immunization could limit
the diversity of a normally complicated response, but also it demonstra
ted that the multispecificity of immunoglobulins may play a physio
logical role in the induction of specific clones of antibodies.
The specificity of some DNP binding antibodies for menadione (or
vitamin Ks) had already been described by Jaffe at al (79) for two
Balb/c myeloma proteins, MOPC 460 (IgA2 » K) and MOPC 315 (IgA^, X^).
The relative affinity of protein 460 for DNP-lysine, menadione, and 2,4
dinitronaphthol differs from that of protein 315.

Michaelides and

Eisen (121, 40) showed that the naphthoquinone ring "resembles" the
structure of DNP and they argued that the multispecificity observed
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among the different DNP binding antibodies for menadione was due to
both haptens being bound to the same site of the combining region.
However, as described above, Rosenstein and Richards (144, 145, 120)
have subsequently presented evidence that DNP and menadione are bound
in different parts of the combining region of Protein 460.
Not all immunoglobulins bind both DNP and menadione in an immune
response to antigens containing either hapten.

Johnston and Eisen

(83) demonstrated that between 46 and 66% of the anti-DNP response in
rabbits also bind menadione.

These double binding antibodies have a

higher affinity for DNP than menadione.

Similarly, menadione conjuga

ted antigens induced menadione binding antibodies of which 33 to 49%
also bind DNP.

These menadione binding antibodies have a higher af

finity for menadione than for DNP.

Thus the population of antibodies

induced by each hapten contains a significant fraction of double binding
antibodies, but the double binding immunoglobulins are drawn from dif
ferent V-region gene pools.

This result is reminiscent of the proper

ties of the different populations of TNP and DNP binding antibodies
induced in rabbits (158, 112).
A few preliminary experiments with anti-idiotypic sera to DNP
binding myeloma proteins have been employed to analyze this complex
immune response.

Sigal (153) employed rabbit and mouse anti-T15

idiotypic sera to analyze the DNP binding antibodies produced in
spleen cultures.

Of 680 anti-DNP clones studied, only two clones

produced antibodies that bound both DNP and phosphorylcholine (PC).
Antibodies from one of these clones was bound by the rabbit anti-T15
serum, but not by the mouse anti-T15 serum.
clone failed to be bound by either sera.

The other double binding

A major criticism of this type
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of study is that the author failed to describe the shapes of the inhi
bition curves in the RIA used to detect the interaction between the
double binding antibody and the rabbit anti-idiotypic sera. It is
therefore unclear how the antigenicity of this DNP and PC double bind
ing immunoglobulin relates to that of protein T15.
Hunkapiller e_t al. (173) have studied the first 38 N-terminal
sequences of the L and H chains of six Balb/c myeloma proteins that
bind DNP.

The amino acid sequences of five of the six light chains

were distinctly different from each other. Only J604 and J688
had similar sequences. The heavy chain sequences, however, could be
divided into two groups (or families) consisting of MOPC 460, MOPC
315, and S23 in one family, and of XRPC25, J604, and J688 in the other.
The validity of this division of DNP binding myeloma proteins into two
groups awaits the elucidation of the entire amino acid sequence of these
and other DNP binding myeloma proteins.
A number of groups have succeeded in making anti-idiotypic sera to
these DNP-binding myeloma proteins.

Despite the sequence homologies

in the H chains of proteins 460 and 315, many studies have failed to
detect idiotypic antigenic identity between these two proteins (155,
163, 62).

In other studies, protein 46Q was used to absorb out the

allotypic similarities between proteins 315 and 460 from an anti-315
i

sera (12).

Thus any idiotypic cross-reactions that may have existed

in these antisera were lost.
While demonstrating that a strain could make anti-idiotypic anti
bodies against its own myeloma proteins, Eisen and Sirisinha (35) demon
strated that normal Balb/c sera was bound by Balb/c anti-idiotypic sera
to protein 460, but normal Balb/c sera does not interact with Balb/c

A
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antisera to protein 315.

These results suggested that 460-like deter

minants and not 315-like determinants may be found in Balb/c sera.
It also explained why Wells et aJL. (174) failed to detect an interaction
between protein 460 and a rabbit anti-315 idiotypic sera.

This antisera

had been absorbed against "normal" Balb/c immunoglobulins and this may
have removed the immunoglobulins with specificities directed to 460-like
determinants.

Thus while it is clear that proteins 315 and 460 have

distinct idiotypic determinants, it is unclear whether they share any.
Unlike the MOPC 460 tumor which is a Balb/c myeloma, the MOPC 315
plasmacytoma was derived from the seventh generation of a congenic inbred
strain derived from a mating of Balb/c and C57BL mice (39).

Although

protein 315 has Balb/c H-chain allotypic markers, it is not clear from
what strain the information for the L chain and the V-region of 315 was
derived.

Furthermore, the L chain of 315 has a sequence in its V-region

that is unique from any other X chain sequenced.

It is therefore inter

esting, but not surprising, that Sirisinha and Eisen (155) were unable
to detect 315-like determinants in the sera from fourteen different
strains including Balb/c and C57BL and in fifteen different Balb/c
myeloma proteins including protein 460.
These results are to be contrasted to those of Granata at al. (55)
who demonstrated that protein 315-immunized Balb/c mice produced a
binding region complementary anti-idiotypic serum which was specific for
protein 315 and which also bound to Balb/c anti-DNP sera.

Balb/c mice

immunized against protein 315 had a less heterogeneous anti-DNP response
than the untreated Balb/c mice.

These authors concluded that the pro

tein 315 Immunized mice produced anti-idiotypic antibodies that sup
pressed the production of DNP binding antibodies which have idiotypic
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j
;

determinants similar to protein 315.

Furthermore, by a hemagglutin

ation inhibition assay, Granata €it al. (55) demonstrated that a signif

ficant percentage of DNP binding antibodies of Balb/c mice contained
immunoglobulins that contained X chains.

The authors, however, failed

to consider that a non-specific suppression of the DNP response may have
occurred due to the prior immunization with protein 315 (i.e., anti
genic competition limited the anti-DNP response).
In a brief paper by Jorgenson and Hannestad (84), a Balb/c
anti-idiotypic response to protein 315 was weakly enhanced by priming
the mice with protein 460.

While this result appears to imply that

proteins 315 and 460 may share idiotypic determinants, the recent
i
papers of Helman e£ al. (62) and Tanykanak and Sirisinha (163) failed to
report any idiotypic antigenic identity between the two DNP binding
immunoglobulins.

Tanykanak and Sirisinha (163) found that A/J and Balb/c

anti-idiotypic sera made against protein 315 or its Fv fragment were
similar in terms of specificity and in terms of the amount of antiserum
:

which was hapten inhibitable.

The only difference between the four

sets of mouse antisera was that the A/J anti-315 serum had a higher
percentage of non-binding region complementary anti-idiotypic anti
bodies than the other anti-idiotypic sera,
In a similar paper, Helman edt al. (62) compared the properties

i

!

of anti-idiotypic sera from rabbits and Balb/c mice made against
proteins 315 and XRPC 25, another myeloma protein that binds DNP.
Even though the first 38 N-terminal amino acids of the H and L chain of
XRPC 25 and MOPC 460 differ (173), rabbit anti-XRPC 25 idiotypic serum
also bound protein 460.

Furthermore, mouse anti-XRPC 25 and rabbit

and mouse anti-idiotypic sera to protein 315 did not bind to protein

i

,L
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460.

Helman et^ al. observed that while 60 to 70% of the Balb/c anti

sera had their binding to the reference myeloma proteins inhibited by
hapten (i.e. they were combining region complementary), greater than
|

90% of the rabbit sera were non-combining region complementary.

Hence

the subpopulation of combining region complementary anti-idiotypic anti
bodies of rabbits directed to mouse myeloma proteins may represent a more
homogeneous population of anti-idiotypic antibodies.
Thus to date no study has developed a series of V-region markers
for DNP binding immunoglobulins that have been employed to study the
inheritance of DNP binding antibodies.
The Present Investigation: To Develop A Set of V-Region Markers
For DNP Binding Immunoglobulins Which May Be Used To Study The
Expression and Inheritance of V-region Gene Products
In this thesis, two approaches were taken to develop sets of Vregion markers which may be used to study the expression and inheritance
i

of DNP binding immunoglobulins.
In the first approach a series of serological markers were developed
to detect and characterize particular DNP binding V-regions.

;

The fol-

lowing questions were asked:
1.

Can rabbit combining region complementary anti-idiotypic anti

bodies be isolated to the DNP and menadione binding mouse myeloma pro
teins 315 and 460?
2.

Are these anti-idiotypic antibodies directed against a single

determinant or can these anti-idiotypic antibodies be separated into
two groups:

those that recognize common determinants (IdX) of many

different DNP binding immunoglobulins; and those that recognize unique
determinants (Idl) of individual immunoglobulins?

i
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i

3.

On what chains are the amino acid residues that comprise the

i

idiotypic determinants found?

Are specific L and H chain residues

|

required for the idiotype's expression?

Does one chain modulate the

expression of idiotypic determinants found on the other chain?
4. Using these anti-idiotypic sera in RIAs, can idiotype positive

b
I

mouse immunoglobulins be found?

Are the idiotype positive immuno

globulins found in the serum of a few mice, in the serum of all mem
bers of an inbred strain, in the serum of all mice, and/or in the
i-

•

serum of more than one species?

Are these idiotypic markers inheri

ted in a recessive or dominant fashion?
|

5.

What antigens are able to induce idiotype positive immuno

globulins in mice?
j

6.

What are the properties of the idiotype positive mouse immuno

globulins?
t

7.

May these anti-idiotypic reagents be employed to examine antigen

binding receptors on the surface of lymphocytes?
In the second approach, the anti-DNP response was analyzed using
j

the isoelectric focusing patterns of double binding immunoglobulins

i'

j

induced by the sequential immunization of pairs of antigens.

I
;
!

following questions were explored:
1.

The

After isoelectric focusing and cross-linkage in polyacrylamide

gels, is the antigen binding specificity of an immunoglobulin altered?
2.

Can the isoelectric focusing banding patterns of the double

binding immunoglobulins be detectable in analytical isoelectric focusing
gels by incubating the gels with radioactive hapten in the presence
and absence of a cold competitor?
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3.

In mice can the sequential immunization of DNP and menadione

preferentially induce DNP and menadione double binding immunoglobulins?
Are all menadione conjugated proteins antigenic for mice?
4.

In mice can the sequential immunization of RNase and DNP-

BGG preferentially induce DNP and RNase double binding antibodies in
the early immune response?
5.

Among individual mice of the same inbred strain, is there a

variability in the expression of specific clonal immunoglobulin products
of double binding antibodies?

What are the bases for the variation in

banding patterns observed among mice of the same inbred strain?
Below investigations based on these questions are discussed.

L
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MATERIALS AND METHODS
I.

Materials
A. Animals
All rabbits were New Zealand White males.

Balb/cN and C57B1/6 mice

were from a breeding colony maintained at Yale by Dr. M.Y.K. Armstrong.
All other strains were gifts of Dr. R. Riblet of the Institute for
Cancer Research, Philadelphia.
B.

Buffers

Phosphate Buffered Saline (PBS) was a 0.01 M phosphate buffered
solution of saline adjusted to pH 7.4.

Borate Buffered Saline (BBS) is

a 0.01 M solution of buffered borate in saline adjusted to pH 8.2. Tris
buffers were also employed.
C.

Haptens

DNP-glycine was a gift of Dr. R.W. Rosenstein.

e-DNP-lysine was

prepared as described by Rosenstein .and Richards (145) by the reaction
of flourodinitrobenzene (FDNB) in ethanol with the copper chelate of Llysine in 0.1 M NaHCO^.

3
H-DNP-lysine (New England Nuclear) was

purified by electrophoresis at pH 1.5 prior to use.

It was diluted to

a specific activity of 67 Ci/mole by the addition of DNP-lysine.
e-DNP-caproic acid was synthesized by a cognate synthesis of DNP_3
BGG of Eisen (41).

2 g of DNB-sulfonic acid (Eastman) (7.4 x 10
_3

moles) was added to 0.5 g of e-amino caproic acid (3.8 x 10
50 ml of 2% ^ C O j solution.
the dark for 4 hours.

moles) in

Reaction occurred at room temperature in

The reaction mixture was passed through a Dowex

1 column and washed with distilled water.
DNP-caproic acid was extracted with ether.

The Dowex containing the
The ether extract was

60
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dried under ^

and the yellow material was recrystallized 3 times with

ethanol and water.
^C-phosphory1-choline (specific activity 56.81 Ci/mole, New
England Nuclear, t-boc-glycine (Lot #7145, Pierce Chemicals), t-boctyrosine (Pierce Chemicals), menadione (2-methyl-l,4-napthoquinone,
Mann Research Laboratories), and menadione bisulfite (Lot #8746,
Nutritional Biochemical Corp.) were used without further treatment.
Vitamin Rs (menadione thiopropionic acid) was synthesized by the
procedure of Hanna (59).

The purity of the product was checked by m.p.

(161-162° C, uncorrected— literature value 161° C).
Bovine pancreatic ribonuclease-A (RNase, E.C.3.1.4.22, Worthington
Laboratories, 12 times recrystallized) was stored at 4° C until use.
a-N-tyrosyl-e-(2,4-dinitrophenyl)-lysine hydrocholoride (TLD) was
synthesized by the method of Dr. P. Jackson (unpublished).

e-DNP-lysyl

ethyl ester was reacted with t-boc-tyrosine by dicyclohexylcarbodiimide
(DCC, Eastman) and the ethyl- and t-boc-protecting groups were removed.
-3
In a typical synthesis, 10
moles of DNP-lysyl ethyl ester was synthesized
by dissolving DNP-lysine in a minimal volume of dry absolute ethanol
(USP grade).

While cooling the reaction vessel on ice, HC1 gas was

slowly bubbled through the solution.
vacuum.

The solution was dried under a

The dry product (DNP-lysl ethyl ester) was twice dissolved in

ether and dried under a vacuum with NaOH.

The product was checked

purity on polyamide TLC plates (Eastman) using 1-butanol:
water:

pyridine (15:3:

12:

10).

for

acetic acid:

No trace of DNP-lysine was found.

After recrystallizing in ethanol and ether, the product was dissolved
in 4 ml of redistilled acetonitrile (Eastman) and an equal molar amount
of triethylamine and a further aliquot of acetonitrile (about 4 ml) was
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f"
t-added.

Care was taken to avoid an excess of triethylamine.

0.181 g t-

-3
boc-tyrosine (10
moles, Cyclo) was dissolved in 2 ml of acetonitrile
and added to the DNP-lysy1-ethyl ester solution.

The coupling reaction

was performed in a glass stoppered reaction vessel.

0.206 g

(10

-3

moles) of dicyclohexylcarbodiimide (Eastman) was dissolved in 2 ml of
acetonitrile and added to the reaction vessel.

The reaction was

stirred at room temperature in the dark for 24 hours.
The solution was filtered and white-yellowish crystals were
collected.

The filtrate was dried under vacuum. 150 ml of 5% NaHCO^

solution was added and the reaction product suspension was extracted
times with ether.

To the ether layer was added an equal volume of

water and solid citric acid was added slowly with shaking.
frothing.

6

This caused

When the pH was lowered to 3.0, the ether layer was ex

tracted and then two times more with a saturated citric acid solution.
The product N-t-boc-tryosyl-e-DNP-lysyl-ethyl ester remained in the
ether layer which was washed 3 times with water to remove all citric
acid. The ether layer was dried with anhydrous Na 2 S0 ^, filtered and
dried under N^.
The yellow residue was dissolved in benzene with warming in as
small a volume as possible, and was placed on a Biosil A column (BioRad 100-200 mesh) 2 cm x 30 cm previously equilibrated with benzene.
The column was washed with benzene (2 liters).

The one yellow fraction

(DNP-OH) was eluted and one major yellow band remained at the top of
the column.

The column was eluted with methanol.

Most yellow material

was eluted at the solvent front, and two minor bands of yellow were
r

1

left on the column.

This eluted yellow material is t-boc-tyrosyl-e-DNP

i. ,

;

lysine ethylester which was chromatographed to check purity on silica
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TLC (Eastman) plates in benzene:
acetic acid:

acetic acid (9:1) or 1-butanol:

water: pyridine (15:3:12:10).

NaOH was used to remove the ethyl ester blocking group.

The

compound was dried in vacuo, and then suspended in 1 N NaOH (15 ml).
The suspension was stirred for one hour at room temperature and then
extracted three times with ether.

The aqueous layer was made acidic by

adding citric acid slowly to avoid frothing until the solution was satu
rated (pH 3).

The color of the reaction mixture became dirty brown and

cloudy and was extracted with water saturated ethyl acetate.

The ethyl

acetate extract was washed 4 times with water to remove the citric acid,
then anhydrous Na^SO^ was added to dehydrate the ethyl acetate.

In a

rotary evaporator the volume was reduced to almost dryness and the product,
N-t-boc-tyrosyl-e-DNP-lysine was washed out in ethanol and dried under N^.
To remove the t-boc-blocking group, the product was dissolved in
4 N HC1 in dioxane (10 m l ) .
1 hour with stirring.

The solution was kept at room temperature for

The HC1 was blown off with ^

dried overnight in vacuo.

and the solution was

A small quantity of ethanol was added to the

dried product and again dried in vacuo over NaOH pellets to remove any
excess HC1.

This was repeated 2 times for 24 hours.

Orange crystalline

powder was produced which chromatographed as a single species in two
solvents (described above).

The final product was dissolved in 0.1 M
_3

NaHCO^ adjusted to pH

6.8

and this saturated solution (about

was stored at 20°C in the dark.

2

x 10

M)

The final product was also stored as a

dry powder in a desiccator and rechromatographed before use.

The melting

point of the TLD was not sharp at 110°C.
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C.

Antigens

Bovine Serum Albumin Fr. V (BSA) and Bovine Gamma Globulin (BGG)
were obtained from Nutritional Biochemical Corp. and used without
further treatment.

Rabbit Gamma Globulin (RGG) was obtained by ammonium

chloride precipitation of rabbit serum from unimmunized New Zealand White
males.

Human Serum Albumin (HSA) was obtained from Miles Laboratories

without further treatment.
DNP-KLH was a gift of Dr. P. Askenase and had about 50 residues of
DNP per mole of KLH.
(75).

DNP-Ficoll was prepared by the method of Inman

DNP-BSA, DNP-RGG, and DNP-BGG were prepared by the method of

Eisen (41).

Assuming the E^j^ of BGG is 14.0 and the

of DNP is 17340,

the average number of DNP residues per mole of BGG was found to be 18 to
30, depending on the preparation.

Similarly, the number of residues per

mole of protein for residues per mole of protein for DNP-BSA was 23 and
for DNP-RGG was 20.
Men-RGG was prepared by the method of Rosenstein (unpublished).
2 g of BGG was dissolved in 50 ml of 0.2 M Tris pH 8.4.

350 mg of dithio-

threital (DTT, Sigma) was added and the reaction stirred at room tempera
ture for

2

hours.

2

g of menadione was added and the reaction was stirred

overnight at 4°C in the dark.
liters of PBS for
against

6

8

The suspension was dialyzed against

6

hours, then filtered, and dialyzed two more times

liters of PBS for 12 hours at 4°C in the dark.

O.D.2 gQ/O.D .3 3 5 ratio of 3.6 and an

335

Based on an

of 2200 for menadione, and a

negligible absorbance of BGG at 335 nm, the number of menadione moieties
per mole of BGG was about 50 to 60.

Men-RGG, Men-HSA, and Men-BSA were

similarly prepared.

L
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Menadione-acetyl homocysteine-BGG (Men-Spacer-BGG) and menadioneacetyl homocysteine HSA (Men-Spacer-HSA) were synthesized by the method
of Johnston and Eisen (82).

The number of menadione residues per mole

of protein for Men-Spacer-HSA was 20 and for Men-Spacer-BGG was 25.
This was determined by the dry weight of the protein which had been
dialyzed against water and by the optical density at 335 nm for the
concentration of menadione moieties.
D.

Protein Coated Sheep Red Blood Cells

Proteins were conjugated to Sheep Red Blood Cells (SRBCs) by the
method of Evans et al. (44).

Typically, SRBCs stored for two to eighteen

weeks in Alsever's solution at 4°C were washed 4 times with PBS.

0.4 ml

of packed SRBCs were added to 9 ml of PBS and 1 ml of 1 to 5 mg/ml
solution of protein.

Over a period of 15 minutes 1 ml of 2.5% glutar-

aldehyde (electron microscope grade) was added and the reaction was
stirred at room temperature for an additional 45 minutes.
then centrifuged and washed 3 times with PBS.
were used for up to one month.

The cells were

Protein conjugated SRBCs

Before each use the protein conjugated

SRBCs are washed once with PBS.
E.

Myeloma Tumors and Proteins

MOPC 315 and MOPC 460 tumor lines were the generous gift of Drs.
H.N. Eisen and E. Simms and were maintained by passage in Balb/cN mice.
Protein 460 and protein 315 were isolated from the serum and ascitic
fluid of tumor bearing mice by the DNP-affinity column procedure of

I:

Goetzl and Metzger (54).
alkylation step.

Some preparations omitted the reduction and

Evidence has been presented (145, 120) that the puri

fied proteins were indeed proteins 315 and 460 based on M.W., affinity
constants for

3
H-DNP-lysine and menadione, and N-terminal amino acid
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residues.

DNP-lysine is bound to protein 460 with an affinity constant

of 1 x 10"* M
1 x 10^M \

at room temperature and protein 315 yielded a constant of
Menadione (vitamin Ka) competes with DNP-lysine to be

bound by protein 460 with a

-4 -1
of 2 x 10
M
at 4 C.

of protein 315 for vitamin Ks was found to 3 x 10

3

Similarly, the
M

-1

by phage

inhibition assay at room temperature.
Serum from mice with the McPC 603 tumor was the gift of Dr. W.
Konigsberg.

Protein 603 was purified from the serum by a modification

of the method of Jaffe et al. (78).

McPC 603 serum was treated with 50-%

saturated (NH^^SO^ at room temperature.

The protein precipitate was

centrifuged, redissolved in distilled water, and applied to a 2.4 x 30 cm
DEAE-Sephadex A25 column, equilibrated with PBS.

Elution of the column

with PBS yielded a single peak, which upon Ouchterlony double diffusion
analysis versus rabbit anti-mouse H-chain subclass sera was found to
contain immunoglobulins of the y^, Y 2a > Y 2 b s Y 3 *
tested).
pH

8,

a ^P

63

^ was not

The column was then eluted with 0.1 M phosphate-0.3 M NaCl,

yielding a single protein fraction.

This fraction upon testing

by Ouchterlony analysis was found to contain only a heavy chains.

This

fraction was concentrated, dialyzed into 0.2 M Tris pH 8.0 containing
0.075 M NaCl, and reduced with 0.01 M DTT (1 hour) and alkylated with
0.025 M iodoacetamide.

The reaction mixture was dialyzed against PBS

and chromatographed on Sephadex G-200 to separate monomeric IgA (7S)
from unreduced multimers and albumen.
and tested for

14

The 7S fraction was concentrated

C-phosphory1-choline binding by equilibrium dialysis.

The 7S IgA fraction so obtained bound ^^C-phosphory1-choline with a Ka 1.2 x 10"* M \

saturation being achieved at 1.85 moles of hapten bound

per mole 7S IgA, close to the theoretical 2.0.

N-terminal analysis of

this 7S IgA revealed glutamic acid on the H chain and aspartic acid on
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the L chain, exactly as previously described for McPC 603 (6 ).
Purified myeloma proteins MOPC 104, UPC 10, MOPC 195, RPC 5, MOPC
41, and FLOPC 21 were obtained from Litton Bionettics.
protein T15 was a gift of Dr. S. Pierce (Univ. of Penn.)

Purified myeloma
Myeloma proteins

XRPC-25, J604, and S194 were gifts of Dr. M.W. Hunkapiller (Cal. Inst.
Tech.)

Protein S23 were a gift of Dr. W. Geckler (Salk Institute).

These proteins were used as supplied, as 7S monomers (prepared as described
for Protein 603), or as Fab fragments.

Fab fragments were prepared by

the papain digest ion as previously described (49).
F.

Affinity Labeled Proteins 460 and 315

Various affinity labeled protein 315 and protein 460 molecules were
gifts of Dr. R.W. Rosenstein.

These are summarized in Table 7 of the

RESULTS with the different amino acid residues to which these DNPaffinity labeling reagents were attached.

Table 2 of reference 139

summarizes the techniques employed to prepare these affinity labeled
myeloma proteins.

By difference spectroscopy at 360 nm, by fluorescence

quenching, and by site titration by equilibrium dialysis using

3
H-DNP-

lysine the extent of reaction of the different affinity labeled reagents
with the proteins was determined (analyses were kindly performed by Dr.
R.W. Rosenstein).

All reagents but MNBDF abolish the ability of the

protein to bind hapten.

MNBDF only lowers the affinity of protein 315

for DNP-lysine by fifty fold (182).
3
3
H-DNP-azide labeled protein 460 and H-DNP-azide labeled mouse
immunoglobulins were prepared by a cognate synthesis of Yoshioka et al.
(184), using 1.0 mCi of 2, 4-dinitroflourobenzene [3,5-^H (N)] (New England
Nuclear, lot #929-123).

0.25 ml of dimethylformamide (DMF, sequanol

grade, Pierce Chemicals) was added to the

3
H-FDNB which had been dried
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under N£.

14.7 mg of cold FDNB (7.86 x 10 ^ moles, Eastman) was added.

10 mg of NaN^ was added to the reaction mixture.

After two hours of

stirring in the dark at room temperature, the reaction was terminated by
drying in vacuo at room temperature.

DNP-azide (DNP-N^) was separated

from this reaction mixture by chromatography on polyamide thin layers
(Chen-Chin Trading Company), pre-run in chloroform.

The sample was

exposed to NH^ gas for 5 seconds before chromatography in chloroform,
in order to change the unreacted FDNB to nitroaniline.
moved with the solvent front.
dried under

The DNP-azide

The material was eluted with chloroform,

and redissolved in 1 ml of absolute ethanol (USP grade)

and stored in the dark at -20°C.

The UV absorption spectrum for the

purified DNP-N^ was as previously described (184).
specific activity of the

The approximate

3
13
H-DNP-azide was 10
cpm/mole and the concen

tration was 7.86 x 10 ^M.
Protein 460 and mouse immunoglobulins were photoaffinity labeled
by adding 0.01 to 0.001 ml of the DNP-N^ ethanol solution to a 1 ml
solution of a 2 mg/ml solution of protein in PBS.
-3
-4
10
to 10 M solution of the affinity label.

This results in a

The reaction mixture

was stirred on ice for 15 minutes in the dark and then irradiated for
60 minutes under UV lamps, as previously described (184).
was terminated by dialyzing against PBS.

5 x 10

The reaction

solution of DNP-

glycine was demonstrated to reduce the labeling of the affinity labeled
protein by 3-fold if the DNP-glycine was added before irradiation.
G.

Enzymatic Digestion Fragments of Immunoglobulins

Pepsin digestion of rabbit immunoglobulins from antisera was per
formed by the method of Nisonoff et al. (124).

The (Fab) 2 was converted

to Fab^ by mild reduction in 0.005 M DTT followed by alkylation with
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0.015 M iodoacetamide.

Papain digestion of mouse myeloma proteins were

prepared as previously described (49).
H.

Hapten Affinity Columns

Sepharose 4B (Pharmacia) was activated with cyanogen bromide according
to the procedure of Axen, et al.

(5).

The activated Sepharose was

washed with ice cold water, followed by 0.1 M NaHCL^.
with either DNP-lysine (1 x 10

It was then stirred

_3
M); protein 315 (4 mg/ml); protein 460

(4.8 mg/ml); or immunoglobulin from rabbit antisera (1 mg/ml) at 4°C for
12 hours, before washing with PBS and using.

Menadione affinity columns

were a gift of Dr. R.W. Rosenstein and were synthesized as previously
described (145).
I.

Antisera

Rabbit anti-mouse Fab sera (gift of S. Pierce), goat anti-rabbit
Fc sera (GAR, gift of Dr. B.N. Manjula), sheep anti-rabbit immunoglobulin
(SAR, gift of Dr. P. Askenase), rabbit ant-mouse immunoglobulin (RAM,
Behring Diagnostics), rabbit anti-H chain subclass sera specific for the
a > Vi Y-^

Y 2 a > Y 2 b > Y^ isotypes (Litton Bionettics) were used without

modification or as the Fab^ fragments obtained by papain digestion (49).
Rabbit antisera to myeloma proteins were obtained by immunizing New
Zealand White male rabbits with 1.0 mg of protein 315 or protein 460
(7S monomers) in complete Freunds adjuvant (Difco) by foot pad injection.
Two weeks later the rabbits were immunized s.c. with 1.0 mg of the myeloma
protein in complete Freund adjuvant, and bled by cardiac puncture.

Sub

sequently the rabbits were bled at two week intervals and boosted intra
venously with 0.1 mg of the reference protein in PBS.
Rabbit antibodies directed against the combining region of proteins
315 and 460 were purified by a modification of the procedure of Claflin
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and Davie (23).

In a typical experiment, 5.0 ml of rabbit anti-315

serum or anti-460 serum was filtered through a 10 ml column of protein
315-Sepharose or protein 460-Sepharose, previously equilibriated with
PBS.

The column excluded volume was collected and tested for the dis

appearance of precipitating antibody to proteins 315 and 460.

The

columns were washed with five column volumes of PBS or until the O.D.~on
ZoU

of the eluate was less than 0.015.
of 0.05 M DNP-glycine in PBS.

Elution was performed with 5.0 ml

The DNP-glycine fraction was dialyzed

exhaustively with PBS to remove DNP-glycine.

Yields of purified anti-

315 or anti-460 antibody, as judged by O.D.^gg measurements usually fell
between 100 and 200 ugm per ml.

The purified anti-315 and anti-460

antibodies were stored at 4°C in the presence of 0.01% NaN^.
Mouse anti-hapten sera were induced by the subcutaneous injection
of 0.1 ml of antigen in complete Freunds adjuvant containing 1 mg of
protein, except for DNP-Ficoll.

DNP-Ficoll immunizations were performed

as described (129) and consisted of intraperitoneal injections of 1 mg/ml
solution in PBS.

Mice were bled from the sub-orbital fossa or were

exsanguinated by cutting the aorta.
quired a second injection,

0.1

If the immunization protocol re

ml (containing

1

mg of antigen) was

administered subcutaneously in complete Freunds adjuvant.
J.

Iodinated Compounds and Proteins

All iodinations were performed by the Chloramine T procedure (69).
Typically, 50 ugm of protein or 2 x 10~^ moles of TLD was dissolved in a
pH

6.8

free

0.1 M phosphate buffer and incubated with 0.5 to 1.0 mCi carrier

125

I (New England Nuclear) to make up a total volume of 0.150 ml.

0.020 ml of 1.7 mg/ml solution of Chloramine T (freshly prepared) was
added.

A

The reaction was quenched with 0.050 ml of a 5 mg/ml solution of

.
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sodium metabisulfite after 5 minutes for the iodination of TLD and after
one minute for the iodination of proteins.

The reaction mixture was

immediately chromatographed on a 1 x 10 cm Sephadex G-25 column to separate unbound K

125

I from iodinated compounds.

eluted with the void volume of the column.

The

The
125

125

I-labeled proteins

125
I-labeled TLD (
I-

TLD) had slight affinity for Sephadex G-25 and eluted after 2.5 to 3
column volumes of PBS filtered through the column.
elute with the yellow colored material.
was about 5 x 10

18

cpm/mole.

The

125

The

125

I-TLD did not

The specific activity of the TLD

I-labeled protein had a specific

9
activity of 4 x
II.

10

cpm/mg.

Equipment
Liquid scintillation counting of

3
14
H and
C samples was performed

in aquasol (New England Nuclear) using a Packard Scintillation Spectrometer (model 3375).
y-counter (AW 1450).

125

I counting was performed in a Scientific Products

All optical density measurements were made on a

Beckman 24 Spectrophotometer.
model 15 Spectrophotometer.

Recording UV spectra were taken on a Cary
Fluorescence quenching was performed on a

Farrand Mark I Spectrofluorometer.

All pH measurements were made with a

single calomel electrode or flat plate electrode on a Radiometer PHM62
Standard pH meter.

All intensity measurements of the darkening of film

after autoradiography were made with a Joyce, Loeble Double Beam Recording
Microdensitometer (Mark III CS).
III.

Methods
A.

Ouchterlony Double Immunodiffusion with Autoradiography

Immunodiffusions was performed with Immuno-plates (Hyland, list no.
085-074).

Typically antiserum and antigen were placed in opposite wells

and incubated at 37°C.

After precipitin lines were observed, the agar

1
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3

gels were washed in PBS containing 0.001 M Nan
Washing was repeated three times.

for 12 hours at 4° C.

If the precipitin pattern only was

to be analyzed, the gel was dried on a glass microscope slide and stained
with Coomassie Brilliant Blue (Accurate Chemical and Scientific Corp.)
as described (57).

If the precipitin lines were to be tested for anti-

gen binding ability (e.g.

125

I-TLD binding) or for the presence of deter

minants (e.g. idiotypic determinants), the washed gel was overlayed with
3 to

6

x 10^ cpm of iodinated hapten or iodinated Fab 1 of the rabbit

antiserum.

The gel was incubated for 3 hours at room temperature and

then washed three times with PBS for 12 hours each at 4° C for

125

I-labeled

antisera and washed three times with PBS for one hour each at room temperature for

125

I-labeled TLD.

The gel was then dried on a glass micro

scope slide and incubated with x-ray film (Kodak, Royal X-omat film
RP/R-54).

After autoradiography, the slides were stained with Coomassie

Brilliant Blue to detect the precipitin lines.

The film was developed

by a Kodak X-omat.
B.

Hemagglutination Titers and Hemagglutination Inhibition Assays

Hemagglutination assays were performed in microtiter plates (Cooke
Engineering Company).

Each well contained 25 ul of PBS containing 0.1%

BSA, 25 ul of serial two-fold dilutions of antiserum, 25 ul of a 3%
suspension of antigen coated SRBCs in PBS-0.1% BSA.

For hemagglutination

inhibition, four times the limiting dilution of antiserum was used.

In

place of the 25 ul of PBS-0.1 % BSA, 25 ul of serial two-fold dilutions
of inhibitors were used.

The endpoint was taken as the highest dilution

giving no visable agglutination.
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C.

Radio-Immuno Assay (RXA)

A modification of the solid phase tube assay of Askenase and Leonard
(3) was used.

Antisera were diluted in PBS to an O.D.^qq3 0.1.

12 x 75 mm Falcon plastic tubes were coated with 50 ul of the antiserum
by incubation at 4°C for 18 hours.

The tubes were then washed with PBS

and re-coated with 0.5 ml of 1% BSA in PBS again for 18 hours at 4°C.
For the assay, the tubes were washed 3 times with 1 ml PBS, drained and
then a 50 ul reaction mixture was added, consisting of 10 ul (100,000 cpm)
125

I-labeled FAB of the reference protein (4 x 10

of inhibitor in PBS.

9

cpm/mole) and 40 ul

The tubes were incubated at room temperature for

two hours, washed 4 times with 1 ml PBS and counted.

Non-specific

binding to tubes incubated with 1% BSA was never more than 1% of the
total radioactivity.

Specific binding in the absence of inhibitors was

usually 30 to 50% of total added radioactivity.
A later modification of this method was also employed which greatly
increased the ease in performing the assay.

25 ul of the antiserum

solution was incubated at 4°C for 24 hours in flexible vinyl microtiter
plates (Cooke Engineering Co.).

The diluted antiserum was removed and

0.1 ml of 0.1% BSA in PBS was added.
for 24 hours.

The plates were again incubated

The assay consisted of incubating the wells with 25 ul

of inhibitor at 4°C for 24 hours, then adding 5 ul of

125
I-labeled Fab

of reference protein and incubating for another 24 hours at 4°C.

The

plates were then washed, dried, and individual wells were cut out and
the

125

I cpm bound determined.

A modification of this RIA was used to determine the concentration
of DNP binding antibodies present in serum.
by Klinman and Aschinazi (92).

This method was developed

25 ul of 1 mg/ml solution of DNP-BSA in
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PBS was incubated at 4°C in microtiter plates.

After 24 hours, the DNP-

BSA solution was replaced with 0.1 ml of 1% BSA in PBS.

After 24 hours

at 4°C, 25 ul of various dilutions of anti-DNP sera were added to the
wells.

The wells were incubated for 24 hours at 4°C, washed 3 times with

1% BSA in PBS, then 25 ul (1-10 ngm) of

125

I-labeled Fab' of rabbit antig

mouse Fab serum was added (specific activity 4 x 10

cpm/mg).

The plates

were incubated for an additional 24 hours at 4°C, then washed, dried, and
counted.

Protein 460 served as the reference DNP binding protein used to

standardize the calculation of the concentration of DNP binding anti
bodies present in serum.
D.

SDS Polyacrylamide Gel Electrophoresis

SDS-polyacrylamide gel electrophoresis was performed by the method
of Shapiro et al. (151) to estimate the molecular weight of various
proteins.
E.

Equilibrium Dialysis and Fluorescence Quenching

Equilibrium dialysis was performed by the method of Eisen (42).
100 ul plexiglass chambers (Gateway Immunosera) were employed for the
dialysis measurements.
Fluorescence quenching was performed by the method of Eisen (43)
as described by Rosenstein and Richards (145).
F.

Chain Recombination

The light and heavy chain recombinants of proteins 315 and 460 and
proteins 315 and 603 were a gift of Dr. R.W. Rosenstein.

Table 11 of

the RESULTS summarized the binding properties of the protein 315-460
recombinants as determined by fluorescence quenching and equilibrium
dialysis (kindly performed by Dr. R.W. Rosenstein).
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The recombinant proteins were prepared by reducing the proteins
with 0.01 M DTT in 0.2 M Tris, pH
alkylating the proteins with a

2.2

8

for 1 hour at room temperature and
fold molar excess of iodoacetamide.

After dialyzing the reduced and alkylated proteins against several changes
of PBS and then against

6

M urea- 1 M propionic acid at room temperature,

the proteins were chromatographed on Sephadex G-100 columns (2.5 x 95 cm)
equilibrated and eluted with

6

M urea -

1

M propionic acid to separate

the light and heavy chains.
Chains were recombined at a heavy to light O.D.oor, ratio of 3/1
ZoU
by dialysis against several changes of water, followed by several changes
of PBS.

The chain recombinant proteins were concentrated and again

chromatographed on Sephadex G-200 and eluted with PBS.

The 7S fraction,

as judged by marker positions, was collected and concentrated.

The

yield of 7S material was about 50% of the total recombinant protein
placed on the column.
G.

Analytical Isoelectric Focusing With Autoradiography

Isoelectric focusing and autoradiography were performed as previ
ously described (90, 177, 4, 98).
gel consisted of:

12.5 ml of

8

A typical flat plate polyacrylamide

M deionized urea; 7.5 ml of 30% (w/v)

acrylamide with 0.96% bis-acrylamide (Bio-Rad Laboratories); 3 ml of 40%
ampholine solutions (LKB or Bio-Rad Laboratories) such that 1.2 ml is
narrow ranged ampholine solutions (e.g. pH 3 to 5, 5 to

8,

or 4 to

6)

and 1.8 ml is broad ranged ampholine solutions (e.g., pH 3 to 10); 1 ml
of riboflavin
water.

(10

mg / 1 0 0 ml saturate solution); and 26 ml distilled

The gel was poured between two pieces of glass, one of which

was siliconized (177) with a 1/16' inch tygon tubing serving as a gasket.
The dimension of the width of the gel varied depending on the number of
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samples to be isoelectric focused.

The length of the gel was 9 inches.

The gels were polymerized under a fluorescent lamp for 12 hours at room
temperature.

The glass sheets were then separated and the gel usually

attached to the siliconized glass.
Myeloma proteins (7S) and serum samples were subjected to isoelectric
focusing by placing a piece of Whatman 3 MM filter paper about 2 inches
from one end of the gel.

After the samples were blotted into the filter

paper, the gel was placed face side down onto two carbon electrodes,
already moistened at the anode with 5 x 10
with 0.05 N phosphoric acid.

-4 N NaOH and at the cathode

The electrodes were

8

inches apart and

the gel was suspended in the closed apparatus above a moisten sponge.
The isoelectric focusing was performed at 4°C.

Care was taken to clean

the electrodes before applying the gel to avoid areas of non-conductance
which cause "warping" of the isoelectric focusing patterns.
The current was clamped at 10 mamps until the voltage exceeded
500 V.

Then the voltage was clamped at 500 V and the electrophoresis

continued until the change in current was less than 0.5 mamp/hr (usually
about 9 hours).
The pH gradient was measured by cutting a 1 cm wide strip along the
length of the gel.

The strip was cut into 1 cm squares and each square

was placed in 1 ml of water for 1 hour.

The pH of each section was

measured with a single calomel electrode.
Autoradiography of immunoglobulins after isoelectric focusing was
performed by cross-linking the immunoglobulins in the gel and then by
exposing them to iodinated haptens.
To cross-link the immunoglobulins in the gel, the antibodies were
first precipitated with two changes of 18% Na^SO^ and then cross-

1

.
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linked for 1 hour with a 0.5% solution of glutaraldehyde in 18% Na 2 S0 ^,
at room temperature.

The gel was washed 3 times with distilled water

and soaked for 10 minutes with Borate Buffered Saline, pH 8.2, then soaked
1

hour in one liter of a

20

mg/liter solution of sodium borohydride in

Borate Buffered Saline at room temperature.

The gel was then washed

three times with PBS.
To label the gel with

125

I-labeled haptens, the gels were placed

in plexiglass chambers so constructed that a minimal volume of labeled
hapten (60 ml) would submerge the gel.
to 50 to 100 x 10

6

cpm

Typically the gel was exposed

of labeled hapten.

The

125

I-TLD solution had a

-10
-3
concentration of 2 x 10
M and it was dissolved in PBS or a 1 x 10 M
solution of vitamin Ks

in PBS pH 7.4.

The

125

I-labeled RNase solution

-7
9
was about 1 x 10 M with a specific activity of 4 x 10 cpm/mg.

The

gels were incubated at 4°C and after 24 hours, they were washed 3 times
with PBS.

After placing the washed gels on Whatman 3MM filter paper, the

gels were dried by a Slab Gel Dryer (Hoefer Scientific Instruments Model
SE 540).

Autoradiography was then performed for two, seven and thirty

day film exposures with RP/R-54 X-omat film (Kodak).
developed by a Kodak X-omat processor.

The films were

The band intensities were

measured by a Joyce Loeble Microdensitometer.
H.

Preparative Isoelectric Focusing In Sephadex G-75

Preparative isoelectric focusing in Sephadex G-75 was performed as
described (113) with the exception that the G-75 slurry was connected
to the carbon electrodes with wicks of Whatman 3MM filter paper soaked
with 0.25% ampholine solutions.

The isoelectric focusing pattern of

immunoglobulins in the presence or absence of 2 M urea was unchanged.
After isoelectric focusing, the immunoglobulins were eluted from the
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Sephadex slurry in PBS.
I.

DNP-Phage Inhibition Assay

All DNP-phage inhibition assays were kindly performed by Dr. H.
Kalasz.

The DNP-conjugated phage T4 was a gift of Dr. 0. Makela (Univ.

of Helsinki).

The phage inhibition assay was performed as described by

Makela et al. (115).
Briefly, DNP-coated phage and various dilutions of immunoglobulins
were incubated for 30 minutes, then IS. coli in exponential growth was
added.

The mixture added to soft nutrient agar was overlayed on a

nutrient agar plate.
number of T4 plagues.

After 12 hours, the plate was scored for the
By plotting the immunoglobulin dilution against

the number of T4 plaques, an estimate of the antibody titer can be
made.
To determine the inhibition constants of various haptens for the
antibody, the DNP-phage was incubated with two times the concentration
of immunoglobulin needed to cause 50% inhibition of plaquing.

This

concentration is usually sufficient to inhibit all phage plaquing.
After 10 minutes, dilutions of inhibitors (DNP-lysine or vitamin Ks)
were added.

After 3 hrs. incubation at room temperature, IS. coli in

exponential growth were added and the mixture in soft nutrient agar
was plated on nutrient agar in Petri Dishes.
at 37°C, the number of plaques were scored.

After a 12 hour incubation
By plotting the concentration

of inhibitor versus the number of plaques, the concentration of inhibitor
which causes 50% inhibition of the antibody-phage interaction can be
determined.

In this way the inhibition constant (K^.) of the antibody

can be determined.
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RESULTS
The present investigation was an attempt to develop a series of
markers which may be used to follow the expression and inheritance of Vregion gene products in mice.

The V-Regions of DNP binding antibodies

were selected for the purposes of this study.

In the first series of

investigations, a description will be presented of the generation and
characterization of anti-idiotypic antibodies that are directed against
combining region determinants of the reference DNP binding myeloma
proteins 315 and 460.

After the elucidation of the determinants to

which these anti-idiotypic reagents were directed, these antisera were
used in radioimmunoassays to survey mouse sera for the presence of
"idiotype positive" immunoglobulins.

Below are described the studies to

characterize the properties and inheritance of these "idiotype positive"
immunoglobulins.

Finally a series of investigations will be presented

that attempted to identify the isoelectric focusing banding patterns of
immunoglobulins which bind more than one antigen.

This was done in an

effort to establish a set of criteria for immunoglobulins that would
distinguish a small number of antibodies within a large complex response.
The isoelectric focusing patterns of double binding immunoglobulins were
used in an attempt to study the expression and inheritance of particular
V-region products in mice.
I.

The Generation and Characterization of Antibodies Directed Against
Combining Region Idiotypic Determinants of Protein 315 and
Protein 460.
Anti-combining region antibodies were purified from rabbit anti-315

or anti-460 sera by the hapten elution method of Claflin and Davie (23).
Antisera from rabbits immunized with one of these myeloma proteins are
absorbed onto a Sepharose column to which the reference protein was
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coupled.

Those antibodies with specificity towards the myeloma protein

are retained.

The combining region complementary anti-idiotypic anti

bodies are eluted from the column by DNP-glycine.

Below the eluted

antibodies to protein 315 ("anti-315") and to protein 460 ("anti-460")
are shown to be combining region complementary anti-idiotypic antibodies
which are heterogeneous in their specificity for the V-regions of immuno
globulins.

The antiserum to protein 460 purified from 460-Sepharose

columns is composed of two populations of antibodies:

those with speci

ficity for protein 460 ("private anti-460” or "anti-IdI-460"); and those
antibodies that bind only mouse myeloma proteins 460, 315, and S23,
a subset of the DNP binding mouse myeloma
anti-460" or "IdX").

proteins tested ("public

Similarly, antiserum to protein 315 is composed

of private (IdI-315) and public (IdX) idiotypic specificities.

These

three sets of anti-idiotypic antibodies (directed to IdI-460, IdI-315,
and IdX) were found to bind determinants on the H chain of their respec
tive reference myeloma proteins; however, the L chains of each immunoglo
bulin modulates the quality of the interaction between the reference
antibody and the private 460 and private 315 antisera.
A.

DNP Eluted Anti-315 and Anti-460 antibodies are Specific
Only for Idiotypic Determinants of Proteins 315, 460,
S23.

The elution of anti-460 and anti-315 antibodies by DNP-glycine is
due to the binding of the hapten by the combining regions of the reference
protein 315 and 460.

The binding of hapten somehow displaces the

combining region complementary anti-idiotypic antibodies off the reference
protein-Sepharose column.

The hapten elution of antibodies was shown

not to be a salt effect by substituting t-boc-glycine for DNP-glycine.
The t-boc-glycine eluted anti-315 antibodies had only 2% of the hemagglu-
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tination titer of the DNP-glycine eluted antibodies anti-315 in an assay
that measured the agglutination of 315-coated SRBCs.

A similar result

was obtained when the 460-coated SRBC agglutination titers of anti-460
antibodies eluted by t-boc-glycine were compared to anti-460 antibodies
eluted by an equimolar concentration of DNP-glycine.
Only anti-460 and anti-315 antibodies whose binding to the
reference myeloma protein is inhibited by hapten should be eluted from
the columns.

Thus the hapten elution method should rid an antiserum of

non-binding region directed antibodies.

Figure 3 illustrates the immuno

diffusion precipitation patterns obtained by three Balb/c proteins:

315

(ct,l), 460 (a,K), and S194 (cx,k ) produced by rabbit ati-315 and anti-460
sera before and after these antisera had been purified by hapten elution.
The "crude" anti-315 and anti-460 precipitated all three proteins;
however, the anti-315 and anti-460 antibodies prepared by hapten elution
precipitated both proteins 315 and 460, but not protein S194.

Like

S194, two other DNP binding Balb/c myeloma proteins, XRPC 25 (a,K) and
J604 (cx,k ), also were only precipitated by the original antisera before
hapten elution purification.

These results show that the unpurified

antisera have specificities for determinants common to XRPC 25, J604,
S194, 315, 460, and S23.

The antibodies that were purified by hapten

elution are no longer directed to determinants found on XRPC 25, J604,
and S194.

The results of these immunodiffusions also suggest that

proteins 315, 460, and S23 share common determinants, not present on the
constant regions of the H and L chains.
To put the above observations on a more quantitative basis, hemag
glutination inhibition assays and solid phase RIAs were also employed.
Figure 4 shows a typical solid phase RIA that measured the binding of
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FIGURE 3
The Immunodiffusion Patterns Of Three Balb/c Myeloma Proteins
With Rabbit Anti-460 and Anti-315 Sera.
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Ouchterlony double immunodiffusions performed as described in
MATERIALS AND METHODS.
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FIGURE 4
The Binding of DNP-glycine Eluted Anti-315 Antibodies To Various Mouse
Myeloma Proteins
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RIA was performed as described in the MATERIALS AND METHODS with
'i-Fab 315 and DNP-glycine eluted anti-315 antibodies. The serum
from which the antibodies were purified was obtained from a rabbit
2 weeks after protein 315 immunization.
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FIGURE 5
The Binding Specificities Of The DNP-glycine Eluted Rabbit
Anti-315 and Anti-460 Antibodies For
Proteins 315, 460, and S23.
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FIGURE 5 (cont.)
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RIAs performed as described in the MATERIALS AND METHODS with anti-315
and anti-460 obtained from rabbits 2 months after immunization.
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the ^ I - l a b e l e d Fab fragment of 315

I-Fab 315) to anti-315 serum

in the presence of varying concentrations of six different mouse myeloma
proteins.

While a 1 x 10

-9

M solution of proteins 315 and 460 both in-

hibited over 80% of the binding of

125

I-Fab 315 to anti-315 serum, the

other myeloma proteins produced only incomplete inhibition in concentra—

tions exceeding 1 x 10

8

M.

(7

These other myeloma proteins produced 50%

inhibition only with concentrations exceeding 1 x 10

—6
M.

Both pooled

serum from unimmunized Balb/c mice and serum from a Balb/c mouse which
contained greater than 1 mg/ml (10 ^M) of myeloma proteins 603 (a,<)
caused significant inhibition in the RIA.
serum samples were identical.

The inhibition curves of both

This suggests that the large amount of

protein 603 present in one serum did not contribute to the inhibition
of the binding of

125

I-Fab 315 in the solid phase RIA, thus Balb/c serum

must contain antibodies which are bound by the anti-315 serum.

In a

similar experiment, shown in Figure 5a, the DNP binding myeloma protein
S194 (a,<) and the phosphory 1-choline (PC) binding protein T15 (a,<) were
also found not to be bound by anti-315 antibodies.

Thus under the condi

tions in which these assays were performed, myeloma proteins representing
the major classes of H and L chain (including a,K, and X chains) are not
bound by anti-315 antibodies purified by DNP-glycine from a 315-Sepharose
column.

This suggests that anti-315 antibodies have anti-idiotypic

specificity for both proteins315 and 460.
Similarly, anti-460 antibodies have idiotypic specificities for
proteins 460 and 315.

Figure 5c illustrates the results of a solid

phase RIA that measured the binding of

125

I-Fab 460 to anti-460 serum

in the presence of various concentrations of four Balb/c IgA myeloma
proteins:

T15, S194, 460, and 315.

Only protein 460 completely competes

J
t
f
c
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with

I-Fab 460 for binding by the anti-460 antibodies.

is able to inhibit about 40% of the binding of the

125

Protein 315

I-Fab 460.

A portion

of the inhibition curve produced by protein 315 overlaps that of protein
460.

This suggests that some, but not all, of the anti-460 antibodies

are also directed against determinants on protein 315.

In a hemagglutination

inhibition assay, protein 603 (a,<) would not inhibit the agglutination
of 460-coated SRBCs by anti-460 antibodies in the concentration range
that protein 460 did.

Thus anti-460 antibody purified by the hapten

elution method are highly specific for non-a and non-K chain related
determinants.
Three additional lines of evidence indicate that both anti-315 and
anti-460 sera are anti-idiotypic, i.e., they do not bind to C-region
determinants:
a.
125

Neither anti-460 nor anti-315 antibodies inhibit the binding of

I-Fab 460 to rabbit anti-a serum.

Hapten eluted antisera therefore do

not compete for a chain determinants found on the first domain of the
constant region.
b*

The univalent Fab' fragments of anti-460 antibodies inhibit

the agglutination of 460-coated SRBCs by anti-460 serum.

These same

univalent Fab’ fragments do not inhibit the agglutination of 460-coated
SRBCs by rabbit anti-a serum.

The lack of Inhibition by this serum by

the univalent fragments of anti-460 suggests that the anti-460 antibodies
do not have specificity for a chain determinants.
c.

A 2 x 10

solution of the Fab' fragment of rabbit anti-a serum

was unable to inhibit the hemagglutination of 460-coated SRBCs by a
2 x 10

solution anti-315 serum.

If the class specific determinants

on protein 460 had been recognized by anti-315 serum, the univalent Fab*
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fragment of anti-a serum should have inhibited this agglutination.
In conclusion it has been demonstrated that from rabbit anti-315
and from rabbit anti-460 serum a population of antibodies can be purified
by DNP-glycine elution from protein 315-Sepharose and protein 460Sepharose columns.

These purified antibodies are not directed to deter

minants found on the constant regions of immunoglobulins but rather both
the anti-460 and anti-315 antibodies bind to three DNP-binding myeloma
proteind 315, 460, and S23 exclusively.

These hapten eluted antibodies

are therefore anti-idiotypic antibodies.
B.

The Hapten Eluted Anti-315 and Anti-460 Antibodies Are Each Composed
of Two Populations of Anti-Idiotypic Antibodies: One Specific
Only For its Reference Protein (Idl); and One Specific For Proteins
315, 460, and S23 (IdX).

Before the hapten eluted anti-idiotypic antibodies may be used as
probes for V-region determinants present in mouse serum, it should first
be determined whether all antibodies are directed to the same determinant(s).
Below experiments are described which demonstrated that each set of antiidiotypic antibodies could be separated into a public (IdX) and a private
(Idl) anti-idiotypic fraction.
In a number of experiments (e.g. Figure 3), both proteins 315 and
460 produced identical inhibition curves with anti-135 serum.

This anti

serum was obtained from a rabbit only two weeks after it was first immunized
with protein 315.

With serum obtained from the same rabbit at 2 months or

later, quantity of anti-315 antibodies in the hapten eluted fractions which
would also bind protein 460 declined with time.

Figure

three solid phase RIAs that measured the binding of

125

6

is a summary of

I-Fab 315 to anti-

315 sera in the presence of varying concentrations of proteins 315 and
460.

The anti-315 serum used in each assay was obtained from the same
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FIGURE 6
The Decrease With Time Of The Fraction of Antibodies That
Bind Both Proteins 315 and 460 In Anti-315 Serum.
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RIA was performed as described in MATERIALS AND METHODS with
I-Fab
315 and anti-315 sera obtained from rabbits 2 weeks, 6 weeks, and •
4 months after first immunization.
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rabbit two weeks, six weeks, and 4 months after primary immunization.
The percentage of antibodies that bind both proteins 460 and 315 declined
from approximately 95% to less than 15% of the total anti-315 antibodies
purified by hapten elution.

This implies that each anti-315 serum can be

characterized in terms of two anti-idiotypic specificities:

those anti

bodies that recognize determinants common to both 315 and 460 ("public315" IdX).
The binding behavior of the public anti-315 idiotypic antibodies may
be detected by performing a solid phase RIA using the binding of

125

I-Fab

460 to anti-316 antibodies in the presence of varying concentrations of
competing myeloma proteins as demonstrated in Figure 5b.

While only 15%

of hapten purified anti-315 antibodies also bind protein 460 (Figure 5a),
this sub-population binds both protein 315 and 460 with an identical
inhibition curve.

Another DNP binding Balb/c myeloma protein, S23

(oi,k ) also has an identical inhibition curve with the public anti-315

antibodies to that produced by protein 315 (Figure 5b).

This suggests

that the puhlic anti-315 antibodies are recognizing common determinants
on proteins S23, 460 and 315.
Similarly, the inhibition curves in Figures 5c and 5d show that
anti-460 serum is also composed of a population of antibodies that bind
only to protein 460 ("private 460" or IdI-460) and another set that binds
to S23, 315, and 460 ("public 460" or IdX).

As with the protein 315

immunized rabbit, serum obtained 2, 8, and 12 weeks after the initial
protein 460 immunization contained a declining amount of public antiidiotypic antibodies in the population of hapten eluted anti-460 idiotypic
antibodies.
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The sub-populations of antibodies with specificities for public (IdX)
and private (Idl) determinants can be separated.
Figure 7 shows that by preparative isoelectric focusing in Sephadex
G-75, the antibodies with private anti-460 specificities can be separated
from those with public anti-idiotypic activity.

At some regions of the

pH gradient (e.g. pH 5.0 to 5.4), both proteins 315 and 460 coated
SRBCs were agglutinated.

At other parts of the gradient (e.g., pH 5.8

to 6.2) only protein 460 coated SRBCs were agglutinated.
To isolate the public anti-idiotypic antibodies, rabbit antiserum
is absorbed onto the heterologous myeloma protein-Sepharose column and
then eluted with DNP-glycine.

Only antibodies which bind both the reference

and heterologous myeloma proteins will be obtained.

Those antibodies

that are not directed to "public" idiotypic determinant will not be
absorbed into the heterologous myeloma protein column.

By absorbing the

breakthrough material from the heterologous column onto a homologous
myeloma protein-Sepharose column, the DNP-glycine eluted antibodies should
be specific for "private" (Idl) determinants of the reference protein.
After one such purification, the hemagglutination of protein 460-SRBCs
by the "private" anti-460 antibodies was inhibited by a concentration of
protein 460 only one ten thousandth that needed by protein 315 to inhibit
the same agglutination.
The amount of "private' and "public" anti-idiotypic antibodies purified
from columns approximates the fraction of each specificity determined by
RIA (Figure 5).

For example, in Table 6 equal amounts of anti-315 serum

was absorbed onto protein 460 and protein 315-Sepharose columns.

The

anti-315 serum was found on RIA to have 60% of its anti-315 activity also
directed to protein 460.

As, predicted by RIA, the titer of anti-315

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

92

FIGORE 7
The Separation Of Public And Private 460 Anti-idiotypic Antibodies
By Preparative Isoelectric Focusing
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Preparative isoelectric focusing of hapten eluted anti-460 antibodies
was performed as described in MATERIALS AND METHODS. A strip of this
preparation was blotted onto Whatman 3MM filter paper and stained with
Coomassie Blue to detect the focused protein bands. Hemagglutination
titers with 460-coated and 315-coated SRBCs were determined as described
in MATERIALS AND METHODS.
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TABLE 6

Comparison of Yields of Rabbit Anti-460 and Anti-315 Antibodies
Eluted by DNP-glycine from Protein 315- and Protein 460-Sepharose Columns

Yield(mg)

I5

Hemagglutination Endpoint

c

(log2>
460-Coated
SRBCs

315-Coated
SRBCs

g

460-Sepharose Column
anti-315

0.16

5

5

anti-460

0.25

7

6

anti-315

0.24

7

6

anti-460

0.28

7

6

315-Sepharose Column3

Each column consisted of 5 ml of protein-Sepharose; 2 ml of antiserum
were applied to each column; after exhaustive washing (>10 column
volumes) with PBS, the column was eluted with 2 ml of 0.1 M DNP-glycine.

An

k

Yield of immunoglobulin based on optical density at 280 nm after
dialysis 3X with PBS.

c

Titer is expressed as log2 value of lowest dilution that causes
hemagglutination (performed as described in MATERIALS AND METHODS).

.
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activity (agglutination endpoint) of 315-coated SRBCs of antibodies
purified from the protein 460-Sepharose column was half that of the
anti-315 activity of the antibodies eluted from the protein 315Sepharose column.

The yield of immunoglobulin (0.16 mg) from the protein

315-column (0.24 mg).

The antibodies eluted from the protein 460 column

produced the inhibition curves of Figure 5b which show that this serum
binds equally well to proteins 315 and 460.
Similar results were obtained when this experiment was repeated
with anti-460 serum that had been shown by RIA to be highly cross
reactive (>90%) with protein 315.

In this case, the yields and hemag

glutination endpoint titers of the eluted immunoglobulins from both the
315- and 460- columns were approximately equal.

Thus hapten elution of

antiserum absorbed onto a heterologous column is able to purify a sub
population of antibodies with public idiotypic specificity.
In conclusion, antibodies purified by hapten elution can be divided
into two populations of antibodies with "public" or "private" antiidiotypic specificities.

In RIAs by substituting

125

I-labeled Fab fragments

of the heterologous protein for that of the reference myeloma protein
(e.g. Figure 5b and 5d), the "public" antibodies' binding specificity
may be measured.

The "public" and "private" anti-idiotypic antibodies

can be separated by preparative isoelectric focusing or by hapten elution
from the appropriate myeloma protein Sepharose columns.
C.

The Hapten Eluted Antibodies To Proteins 315 and 460 Are Combining
Region Complementary Anti-Idiotypic Antibodies

Below it is shown that the anti-idiotypic antibodies that were
purified by hapten elution will inhibit antigen binding to the reference
myeloma protein and, conversely, that antigen will inhibit the reference
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myeloma protein from being bound by these anti-idiotypic antibodies.
Thus these anti-idiotypic antibodies are complementary to combining
region determinants.
DNP-BSA is able to agglutinate protein 460-coated SRBCs.

The uni

valent Fab' fragments of anti-315 and anti-460 antibodies were found to
inhibit this agglutination.
diluted to a 4 x 10

The Fab' of anti-315 antibodies could be

-9
M solution and still inhibit the agglutination of

460-coated SRBCs by DNP-BSA.

Similarly the Fab’ fragments of anti-460

antibodies could be diluted by 2 x 10

—8
M and inhibit this agglutination.

This suggests that the antibodies compete with determinants in the
combining region of protein 460 with DNP-BSA.
The anti-315 antibodies (IdX) were also demonstrated to be comple
mentary to the combining region determinants of proteins 315 and 460 in
an experiment whose results are illustrated in Figure 8.
RIA was used to measure the binding of

125

I-Fab 315 or

125

A solid phase
I-Fab 460 to

public anti-315 antibodies in the presence of varying concentrations of
DNP-lysine.

As explained in Appendix 1, if the inhibition of the binding

of the public anti-315 antibodies to the myeloma proteins is due to the
binding of DNP-lysine to each protein's combining region, then the ratio
^ 3 1 5 ^ a460 sk°u -^ b e e<3ual to the ratio [DNP]^^/[DITP]^^^, where Xa^ is
the binding constant of myeloma protein x for DNP, and [DNP]x is the
concentration of DNP-lysine that inhibits 50% of the binding of the Fab
fragment of protein x to the antiserum.
[DNPJ.C [DNP]«1C is 114.
4011
Jib
(79, 145).

In this experiment, the ratio

The ratio of Ka's of 315 to 460 is about 100

This demonstrates that the binding of the public anti-315

antibodies to both proteins 315 and 460 is inhibitable by the binding of
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F IG U R E 8

125
125
The Inhibition Of the Binding Of
I-Fab 315 and
I-Fab 460 To
Anti-IdX-315 Antibodies By DNP-lysine

100

- 80

-60

8x10 M
-40

1-20

-5

-4

-3

•• LOG-m (concentration of DNP-lysine) •

RIA was performed as described in MATERIALS AND METHODS.

.L
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DNP-lysine by these myeloma proteins.

Thus the public anti-315 anti

bodies are complementary to combining region determinants.
The complementarity of the public anti-idiotypic antibodies for
combining region determinants was also determined by studying these anti
bodies ability to bind to proteins 315 and 460 whose combining regions
had been chemically modified.

Both proteins 315 and 460 were reacted

with the DNP-affinity labeling reagents:
azide (Table 7).

EfilBDF, BADL, BADE, and DNP-

The different DNP-affinity reagents bind to specific

residues of the V-region of either the E or L chain as listed in Table
7.

Except MNBDF, for every mole of the DKP-affinity labeling reagent

covalently bound to the combining regions o£ proteind 315 and 460, there
is a concomitant molar decrease in antigen binding; MNBDF reduces the
affinity of protein 315 for DNP-lysine.

A s shown in Table 7, the percentage

of binding regions blocked by these affinity reagents were approximately
equal to the percentage of inhibition of binding of the anti-idiotypic
antibodies to each preparation of DNP-affinity labeled myeloma proteins.
This result suggests that the affinity labeling reagents (including
MNBDF) modify the myeloma proteins so that t h e binding of the public
anti-idiotypic antibodies to the myeloma proteins are sterically inhibited.
The affinity labeled proteins 315 and 460 were also used as competitors
in RIAs, measuring the binding of

123

I-Fab 315 or

123

I-Fab 460 to private

anti-315 or private anti-460 antibodies, respectively.

The shape of the

inhibition curves of the affinity labeled proteins were identical to
that of the unlabeled myeloma protein controls; but the inflection points
were decreased to lower concentrations.

The difference in the concentra

tions calculated from the RIA of the native and modified myeloma proteins
was equal to the number of moles of these proteins modified by the DNP
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TABLE 7

Effect of Affinity Labeled 460 and 315 on the Binding of Public Anti-Idiotypic
Antibodies to 460 and 315 Coated SRBC s Respectively
315 affinity labels

Hemagglutin inhibition
endpoints'3

Z inhibition of
idiotype binding

sites Residue labeled
(139)
blocked0
H chain L chain

MNBDF

3.200

75

88

12,800

0

0

BADL2

3.200

83

83

BADE3

6,400

65

70

18,100

0

0

2.560

75

65

10.240

0

0

tyr-88

2.560

75

70

tyr-33

10.240

0

0

MNBDF control

"BAD" - control

tyr-34

lys-54
tyr-34

460 affinity labels

DnpN34
DnpNj control
BADE
BADE control

tyr-33

unknown
residue

lys-54
cys ?

a) All solutions were adjusted to about 1.0 mg/ml of protein based on optical density except
for the BADL and BADE labeled protein 315.
1 MNBDF is m-nitrobenzenediazonium fluoroborate
2 BADL is a-N-bromoacetyl-£-2,4-dinitrophenyl-L-lysine
3 BADE is N-bromoacetyl-N'2,4-dinitrophenyl-L-ethylenediamine
4 DNP-N3 is DNP-azide or 2,4-dinitrophenyl-l-azide
b) Hemagglutination inhibition assay was performed with public anti-idiotypic antibodies puri
fied from a one month bleed of a rabbit anti-315 serum; the assay was performed as described
in MATERIALS AND METHODS. The % inhibition of idiotype binding is the ratio of the hemag
glutination inhibition endpoints of the affinity labeled preparation to that of its unlabeled
control.
c) Z sites blocked was determined by fluorescence quenching and equilibrium dialysis except for
the MNBDF preparation which was determined by optical density.

1

J
L
^
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affinity labeling reagents.

This implies that only the unlabeled V-

regions in each preparation of modified proteins were being bound by
the public anti-idiotypic antibodies.

In another experiment, the Fab

315 was affinity labeled with DNP-azide and then passed through a DNPSepharose column to remove any unlabeled Fab.

The labeled Fab 315 would

be expected not to adhere to the column as unmodified Fab 315 does.
Spectrotypically it was determined that one mole of DNP-azide was bound
to one mole of Fab 315.

The private anti-315 antibodies did not bind

the DNP-azide labeled Fab-315; therefore, DNP-azide sterically hinders
the binding of the private anti-315 idiotypic antibodies to determinants
related to the combining region of protein 315.

Thus the ability of DNP-

affinity labeling reagents to block the antigen binding capacity of the
reference protein and render it unable to be bound by both the public
and private anti-idiotypic antibodies implies that the hapten eluted
antibodies are complementary to combining region determinants.
Both proteins 315 and 460 bind DNP and menadione (vitamin Ks)
competitively.

Manjula, Rosenstein and Richards (144, 145, 120) have

demonstrated that these two haptens are bound in spatially separated
parts of the combining region of protein 460.

It is therefore possible

that different poupluations of anti-idiotypic antibodies may be eluted
with DNP-glycine and vitamin Ks.

Table 8 summarizes the data from an

experiment that compares the populations of anti-315 antibodies eluted
by DNP-glycine versus those eluted by vitamin Ks.

Equal quantities of

rabbit anti-315 serum were absorbed onto two identical protein 315Sepharose columns.

After each column was eluted with one hapten, the

other hapten was then passed through the column.

In this way any anti-

idiotypic antibody that is complementary to combining region of protein

JL
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TABLE 8
Specific Hapten Elution of Anti-315 Antibodies
Bound to 315-Sepharose Columns

315-Sepharose eluted with:

a

Yield (mg)

Hemagglutination titer

(A) .1 M DNP-glycine

0.33

640

(B) .08 M Vitamin K

0.14

320

s

Vitamin Ks eluate of (A)

0

DNP-glycine eluate of (B)

0.22

0
320

a)

Each column (A and B) consisted of 5 ml of 315-Sepharose to which
2 ml of rabbit anti-315 serum had been passed; the column was
washed with 10 column volumes of PBS, then eluted with 2 ml
of hapten solution

b)

Yield is measured from optical density at 280 mm after dialysis
3X against PBS

c)

Hemagglutination titer is measured as explained in MATERIALS
AND METHODS with 315-coated SRBCs
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315 which is not eluted by the first hapten might then he eluted by the
other hapten;

DNP-glycine eluted 0.33 mg of antibodies from the column.

Vitamin Ks did not elute any immunoglobulin from a column already treated
with DNP-glycine.

On the other hand, the yield of immunoglobulin eluted

first with vitamin Ks (0.14 mgs) was less than that obtained from the same
column by subsequently eluting with DNP-glycine (0.22 mg).

The total

yield of antibody from that column (0.36 mg) was essentially equal to
the yield of immunoglobulin (0.33 mg) from the column first treated with
DNP-glycine.

Thus no population of antibodies could be eluted that was

specific for determinants of the combining region that were involved in
the binding of vitamin Ks, exclusive of those determinants that were
involved with the binding of DNP-glycine.
From the above experiment, three fractions of hapten eluted antiidiotypic antibodies were obtained from protein 315-Sepharose columns:
1) those antibodies eluted by DNP-glycine; b) those antibodies eluted by

*

vitamin Ks; and c) those antibodies eluted by DNP-glycine from a column
previously treated with vitamin Ks.
In a solid phase RIA, the binding of the

125

I-Fab 315 to each anti

body fraction was inhibited by both DNP-glycine and vitamin Ks (Table 9).
Thus the anti-315 serum cannot be divided into subsets of anti-idiotypic
antibodies that are inhibitable by menadione and not by DNP and into sub
sets that are inhibitable by DNP and not menadione.
In conclusion, the public and private anti-idiotypic antibodies to
proteins 315 and 460 were demonstrated to be complementary for combining
region determinants of their reference myeloma proteins.

This was shown:

a) by the ability of the anti-460 (Idl + IdX) and anti-315 (IdX) anti
bodies to inhibit the binding of antigen by protein 460; b) by the ability
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TABLE 9
Both Vitamin Kg and DNP-lysine Inhibit the Binding
of 125i-Fab 315 to Anti-315 Antibodies

315-Sepharose Eluted with:a

% Binding^
0.1 M DNP-lysine
0.04 M Vitamin Ks

(A) 0.1 M DNP-glycine

40

33

(B) 0.08 M Vitamin Kg

33

30

24

29

DNP-glycine eluate of (B)

a)

Each anti-315 fraction was the same as purified in Table 8;
see Table 8 for details

b)

The concentration of each anti-315 fraction was adjusted to
0.100 0.0280 units; 0.1 ml of the antibody fraction was placed
in a 6 x 72 mm Falcon polystyrene tube at 4° C for 24 hrs; the
antibody fractions were removed and 0.2 ml of 0.1% BSA in PBS
was added and incubated at 4° C for 24 hrs; the BSA was then
removed; tube washed one time with PBS; then 25 yl of 125i-Fab 315
(containing V50 ng of protein; spec. act. is 4 x 10^ cpm/mg)
and 25 yl of PBS or hapten solution was added; the tubes
incubated 24 hrs at 4° C; washed 3X with PBS. The % binding
is the ratio of the cpm of the hapten inhibited tubes to the
non-inhibited tubes (with PBS) times 100%.

L
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of DNP-lysine to inhibit the binding of the public anti-315 antibodies
(IdX) to proteins 315 and 460; and c) by the inability of the private
and public anti-idiotypic antibodies to protein 315 and 460 to bind to
these reference proteins that had been modified by the DNP-affinity
reagents MNBDF, BADE, BADL, and DNP-azide.

Vitamin Ks elutes from a

protein 315-Sepharose column only a subset of the anti-idiotypic anti
bodies that DNP-glycine elutes.

Both vitamin Ks and DNP-glycine are

able to inhibit the binding of the anti-315 idiotypic antibodies eluted
by either hapten to the reference protein 315.
D.

The Anti-Idiotypic Antibodies For Proteins 315 and 460 Are
Directed Against H Chain Determinants Whose Expression is
Modified by the L Chain.

Before the anti-idiotypic antibodies may be used as probes for the
expression of V-region markers in mouse serum, it should first be ascer
tained to which determinants these anti-idiotypic antibodies are directed.
This was partially accomplished by testing a series of 7S light (L) and
heavy (H) chain recombinants for the ability to be bound by the various
anti-idiotypic antibodies.
To determine whether the L and H chains of protein 315 contribute
structurally to both the public (IdX) and private (Idl) idiotypic deter
minants, .a chain recombination experiment was performed between protein
315 and the idiotype negative protein 603 (a,<).

After reduction and

alkylation, the chains of each protein were separated and mixtures of the
separate chains were allowed to recombine ucnder renaturing conditions.
The recombinant 7S molecules were tested for the presence of both the
private (IdI-315) and public (IdX) idiotypes by hemagglutination inhibition
(Table 10).

Both public and private 315 idiotypic determinants were
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TABLE 1 0

The Ability Of Chain Recombinant Myeloma Proteins To Inhibit The Binding
Of Protein 315 And Protein 460 To Anti-315 Antibodies
Molecules

Hemagglutination Inhibition Titer

early anti-315
460-coated SRBCs

(log,,)

late anti-315
460-coated
SRBCs

315-coated
SRBCs

native 315 (7S)

7

315„-315 recombinant
a
L

5

5

5

315„-603 recombinant
a
L

7

6

5

603„-315T recombinant
H
L

no activity

no activity

315h chain

2

315 chain
L

no activity

no activity

(a)

Hemagglutination inhibition titers were determined as described
in the MATERIALS AND METHODS with either 460-coated SRBCs
or 315-coated SRBCs.

(b)

The early anti-315 antibodies were isolated from 9era of a rabbit
bled two weeks after protein 315 immunization and had greater
than 90% of its activity against public idiotypic determinants.
The late anti-315 antibodies were isolated from sera of a rabbit
bled 10 weeks after initial protein 315 immunization and had
greater than 90% of its activity directed against private 460
idiotypic determinants.
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detectable only on those molecules that contained the H chain of 315.
The hemagglutination inhibition titers of native 7S protein 315, of
the homologous recombinant of 315, and of the 3 1 5-603 recombinant were
h
1j
within one order of magnitude of each other.

Isolated L chains of 315

are not bound by the public anti-idiotypic serum.
315 are bound with a lower titer.

Isolated H chains of

This suggests that while the L chain

does not bear the determinants for the public idiotype, the conformation
of the V-region of the H chain of 315 in the presence of a L chain has
its residues exposed so they may be recognized by the public anti-idiotypic
antibodies.
The phosphorylcholine (PC) and DNP binding activities of the 603 and
315 chain recmobinants were not detected by equilibrium dialysis.

Since

the 315 -603 recombinant is bound by the public (IdX) and private (Idl)
H
L
anti-315 idiotypic antibodies, the complete functional integrity of the
antibody combining region does not seem to be necessary for the expres
sion of these idiotypic determinants.

It should be emphasized, however,

that the hemagglutination inhibition assay is only able to detect the
ability of the chain recombinant molecules to be bound by anti-idiotypic
antibodies.

No conclusion may be made about the antigenic identity of

these chain recombinant molecules to the native myeloma proteins.
A series of protein 315 and protein 460 recombinant molecules were
also prepared to test the chain specificity of the antisera directed
against the private (Idl) idiotypes of proteins 315 and 460.

Each anti

serum was purified by first absorbing the serum with the heterologous
myeloma protein attached to Sepharose to remove public anti-idiotypic
antibodies.

A series of 7S recombinant molecules between proteins 315

and 460 were prepared (gift of Dr. R.W. Rosenstein) and for each re-

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

106

combinant the binding constant (Ka) and number of binding regions per
7S molecule were determined.

Table 11 shows that the homologous re

combinant molecules have the same Ka as the native protein, but the
heterologous recombinants (460 -315 , 315 — 46QT ) have a lower Ka than the
ti

native proteins.

Li

L

cl

The number of binding sites per mole of all the re

combinant molecules was found to be the same as in the native proteins.
These recombinants were then tested for the presence of the private 460
and private 315 idiotypic determinants.

All recombinant molecules were

adjusted to the same concentration.
All of the 315-460 recombinant molecules have identical public (IdX)
idiotypic determinants.
Figure 9a illustrates the results of an R.IA designed to detect the
private idiotypic determinants of protein 315 (IdI-315).
that contained the H chain of 460 had this idiotype.

No molecule

The shape of the

inhibition curves produced by protein 315 and the 315 -315 homologous
n
L
recombinant were identical.

While the 315-460.
n.

L

recombinant did express

the private 315 idiotypic marker, it does so with a reduced affinity of
interaction with the anti-idiotypic serum.
of the inhibition curve of 315 -460
ci

L

homologous recombinant, 315-315, .
Q.

This can be seen in the shape

recombinant compared to that of the
For 50% inhibition of

L

125

I-Fab 315

binding, it takes 15 times more of the 315„-460, chain recombinant than
H
JLi
the homologous 315-315, chain recombinant.
ri

Thus, the private anti-315

L

antibodies recognize determinants in all molecules that contain the H
chain of protein 315.

Both the 315„-460, and 315-315, chain recombinant

inhibit the binding of the

n

125

L*

ri

L

I-Fab 315 to the same extent, only the shapes

of the inhibition curves differ.

This suggests that the heterologous

recombinant, 315-460,, interacts with the entire population of private
ii
L
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TABLE 11

-1
Binding Constant (M ) Determined By:

Recombinant Molecule

3

Fluor. Quen.

native 460

not done

native 315

5xl06

3150315l

460^460^

5x 106

not done

b

3

Eq. Dial.

1.8x10

S

3

# of Binding Sites/
7S Molecule

1.5

3xl06

1.5

3x 106

0.7C

2.0x10^

1.7

460h 315l

0d

3.0xl04

1.5

315h 460l

0

2.5xl04

1.5

Recombinant molecules were a gift of Dr. R.W. Rosenstein and all
assays were kindly performed by Dr. R.W. Rosenstein.
b_
Protein 460 fluorescence is only slightly quenched by e-Dnp lysine.
The Q max has been determined to be only 15-20 as opposed to a Q
max for protein 315 of 70.
c
The number of binding sites was calculated to be 0.7 by both
equilibrium dialysis and fluorescence quenching. Q max for this
recombinant was 30 as compared to 65 for native protein 315.
dft
0 means that e-Dnp lysine did not quench the fluorescence of that
particular recombinant molecule.
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FIGURE 9
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(a) The binding of
the protein 315-460
recombinant molecules
to anti-IdI-315.
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(b) The binding of the
protein 315-460 recombinant
molecules to anti-IdI-460.
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(c) The binding of the
protein S23-460 recombinant
molecules to anti-IdI-460.
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RIAs were performed as
described in the MATERIALS
METHODS.
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anti-315 idiotypic antibodies but the nature of the interaction is
changed compared to that of the homologous recombinant and native protein
315.

Thus the private 315 idiotype is present on the H chain of protein

315, but its expression is modified by the L chain.
A similar result was obtained when this set of recombinant molecules
was tested for the private 460 idiotype (IdI-460) (Figure 9b).

The private

idiotype of 460 was only detected in those molecules which contained the
H chain of 460.

Although the heterologous 460 -315T recombinant inhibits
11
i-i
125
the binding of
I-Fab 460 to the same extent as the homologous 460^-

460t recombinant, the shape of the inhibition curves of the heterologous
Li

recombinant differs from that of the homologous recombinant and native
protein 460.

As in the previous case, it takes 3 times more 460^-315^

to reach 50% inhibition of
recombinant.

125

I-Fab 460 than it takes of the 460^-460^

Thus the antibodies directed to the private 460 idiotype

recognize determinants on the H chain of protein 460, but the expression
of these determinants is also modulated by the L chain.
A more extreme modification of the expression of the private 460
idiotype is illustrated in Figure 9c.

A series of S23-460 7S recombinant

molecules were prepared (gift of Dr. R.W. Rosenstein).

All recombinant

molecules were shown to have identical public idiotypic (IdX) determinants.
The expression of the private 460 idiotypic determinants, however, only
was found in those recombinant molecules that contain the L chain of pro
tein 460, regardless of the H chain of the molecule.

Native protein 460,

the 460-460 homologous recombinant, and the S23 -460 heterologous reh
L
n
L
125
combinant completely inhibited the binding of
I-Fab 460 to anti-460
antibodies, while the 460 -S23T heterologous recombinant produce a
fci
L
completely different inhibition curve.

The S23jj-S23^ homologous chain
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recombinant the private and native protein S23 were not bound by anti460 antibodies.

The shape of the inhibition curves of the S23 -460
Li
L

recombinant was identical to that of the homologous 460 chain recombinant
and native protein 460.

Furthermore, by hemagglutination inhibition

the amount of private 460 idiotype in the 460 -S23
H

L

chain recombinant

was determined to be only 6% that of an equimolar concentration of the
homologous 460 chain recombinant.
On the surface, these results seem to be in conflict with those
obtained for the set of 315-460 chain recombinant molecules.
these results are consistent with two possibilities:

However,

a) the L chain

possesses the structures which are detected as the private 460 idiotypic
determinants; or b) the L chain modulates the expression of the private
460 idiotypic markers of the H chain, even to the extent of completely
preventing these determinants’ detection in protein S23.

The experiments

described above with the 315-460 recombinants clearly show that the
private idiotypic determinants are associated with the H chain.

There

fore, the H chain of S23 must contain the private idiotypic determinants
of protein 460, but the L chain of protein S23 prevents its antigenic
expression.

The L chain of protein 460 in the S23 -460
H.

L

chain recombinant

"permits" the expression of this H chain associated idiotypic determinant.
It is significant that the inhibition curve of the S23„-460 chain reH
Li
combinant is identical to that of native protein 460.

This implies that

with the appropriate L chain the surface residues of H chain of protein
S23 are antigenically identical to those of protein 460 for these private
460 idiotypic determinants.
In the next section, the private idiotypic marker of protein 460 is
demonstrated to coinherit with the allotypic markers of the H chain of
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immunoglobulins.

This is also indirect evidence that the private 460

idiotypic determinants are found on the H chain.
In conclusion by chain recombination experiments it has been found
that the residues for the private 315, private 460, and public idiotypic
determinants are found on the H chain of the reference proteins.

The

L chain associated with the "idiotype determining residues" modulates the
expression of the private 315 and private 460 idiotypes.

The fact that

proteins 460 (oi,k),315 (a, A), and S23 (a,<) have identical inhibition
curves with the public anti-idiotypic antibodies implies that the L chain
does not produlate the public idiotypes expression.
In the next section, experiments will be described that employed
the private 315, private 460, and public anti-idiotypic antibodies as
reagents to detect the expression and inheritance of immunoglobulins
bearing these V-region markers.
II.

The Characterization and Inheritance of Idiotype Positive Immuno
globulins in Mice.
A.

The Strain Distribution of the Idiotypic Determinants

Inbred strains of mice are homogeneous for the genetic loci that
control the level of the immune response (H-2 region) and the structural
genes for the constant region of the H chain of immunoglobulins (Ig-1
loci).

Below are described investigations that surveyed the sera of

various inbred strains of mice for the presence of immunoglobulins which
were bound by the private anti-315, public, and private anti-460 idiotypic
antibodies.

This was performed to determine if immunoglobulins with these

V-region markers are expressed in mice and if the strain distribution of
mice with idiotype positive immunoglobulins appears to be linked to the
presence of any other genetic loci.

,L

Rabbit and guinea pig sera were not
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bound by these anti-idiotypic antibodies.
1.

The Private 315 Idiotypic Determinants (IdI-315)

No strain of mouse was found to have immunoglobulins that were bound
by the private 315 anti-idiotypic antibodies.

Sera from eighteen mouse

strains including recombinant strains between Balb/c and C57BL that
resembled the strain from which the MOPC 315 plasmacytoma was induced were
surveyed for the private 315 idiotype by both RIAs and hemagglutination
inhibition assays.

Table 12 lists the H-2 and Ig-1 haplotypes of some

of the strains surveyed.

As illustrated in the RIA in Figure 10, as

little at 300 ng/ml (2 x 10

-9

M) of immunoglobulins with private 315-like

idiotypic determinants would have been detected.

The mouse sera employed

were pools of anti-DNP sera obtained 10 and 40 days after a single immuni
zation with DNP-BGG.

These sera were found to have an increased titer of

anti-DNP and anti-BGG antibodies compared to the titer of the serum of
the same mice obtained the day of immunization.

Table 12 also lists the

concentration of DNP binding antibodies in the 0 and 10 day sera.

While

each strain of mice is capable of responding to DNP-BGG, no strain produces
immunoglobulins that have the private 315 idiotype.
2.

The public 460 and 315 Idiotypic Determinants (IdX)

The anti-DNP serum of every mouse strain analyzed was found to contain
immunoglobulins with the public 460 and 315 (IdX) idiotypic determinants.
In the RIA employed to detect the public idiotypic determinants, the idio
type positive immunoglobulins from each strain produced identical inhibi
tion curves.

These results are summarized in Table 12.

some of the results of this RIA.

Figure 11 depicts

The shape of the inhibition curves of

the 10 day serum of DNP-immunized Balb/c (Ig-la+), BAB 14 (Ig-1*3)* and
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TABLE 12

Strain Distribution of 460-like Idiotypic Determinants in Mice

0 day3

Strain^

(IdX +
Idl)
(ug/ml)

IdX (pg/ml)

Idl (ug/ml)

Ig-1
locus

10 day** 40 day0 10 day** 40 day^

anti-DNP1
H-2
antibody
locus (ug/ml)
0 daye 10 ds

Balb/cN '

52

85

• 350

75 (B)

38 (B)

a+

d

24

556

SJA/9

72

65

300

105 (B)

37 (B)

a+

a

24

3700

C58/J

68

56

300

84 (B)

22 (B)

a+

k

20

1778

B-C/9

55

30

350

140 (B)

32 (B)

a+

b

b

2668

C57BL/6

n.d.

20

n.d.

4 (C)

b

b

n.d.

n.d.

SJL

8

26

50

4 (C)

4 (C)

b

s

7

667

C*B 17

7

11

50

6 (C)

0 (C)

b

d

24

890

BAB 14

22

28

240

567 (B)

14 (B)

b

d

29

2440

AL/N

13

0

240

14 (C)

0 (C)

d

a

17

556

C'AL/9

20

6

240

14 (C)

14 (C)

d

d

24

711

A/He

15

0

240

12 (C)

0 (C)

e

a

20

200

NZB

25

24

240

18 (C)

0 (C)

e

d

289

4000

DBA

(C)

c

d

CBA

(C)

a

k

C3H

<C)

a

k

AKR

(C)

d

k

a) The majority of the idiotype positive immunoglobulins in the unimmunized sera possessed
only the public idiotypic determinant(s). All concentrations in thistable were calcu
lated based on the serum dilution required to inhibit 50% of the binding of‘-3I-Fab
460 to an anti-idiotypic serum. The "ug/ml" units is calculated from the concentration
of protein 460 needed to cause the same amount of inhibition.
b) The anti-460 idiotypic serum employed had both public (IdX) and private (IdI-460)
specificities such chat 60% was anti-IdX. The IdX concentration was calculated by sub
tracting the value of the concentration of IdI-460 like determinants in the 10 day bleed
from the concentration of total 460-like idiotype in the 10 day bleed. The value obtained
for the public (IdX) idiotypic determinants are therefore only estimates but it is valid
in demonstrating that the concentration of immunoglobulins bearing the public idiotype
in a day 10 bleed is less than that in a 40 day bleed.
c) Determined from a solid phase RIA with public anti-idiotypic antibodies and *25I-Fab
315 as described in the MATERIALS AND METHODS.
d) Determined from a solid phase RIA with the private 460 anti-idiotypic antibodies and
125I-Fab as described in the MATERIALS AND METHODS.
e) Determined by solid phase RIA described in MATERIALS AND METHODS.
f) All mice were immunized s.c. at 6 to 12 weeks of age with 0.5 mg ofDNP-BGG in Complete
Freunds Adjuvant and Bled at 0, 10, and 40 days after immunization.
n.d. -- not done
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F IG U R E 1 0

The Binding Of Private 315 Anti-Idiotypic Antibodies To
Mouse Sera And Protein 315 and 460

•protein 460

r100

-80

mouse
serum

-6 0

-4 0
protein 315

-20
protein(ng/ml) 400
y0serum

4,000

40,000

1.0

100

Mouse sera tested includes those 0, 10, and 40 day bleeds summarized in
Table 12. RIA was performed as described in the MATERIALS AND METHODS
with -^I-Fab 315 and DNP-glycine eluted anti-315 antibodies that had
been pre-absorbed with 460-Sepharose.
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F IG U R E 1 1

The Binding Of Public 460 Anti-Idiotypic Antibodies To
Mouse Sera From Balb/cN, C57BL/6, and BAB 14 Mice

r-100
X-

-80
4-protein 460
\
or
'
protein 315

-60

40

C57BL/6

-20

BAB/14

1.0

100

•/•serum
RIA was performed as described in the MATERIALS AND METHODS with
315 and DNP-glycine eluted anti-460 Antibodies.

125
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I-Fab

C56LB (Ig-1^) resembles the lower half of the inhibition curves of prote ns
460 and 315.

The mouse sera were not diluted enough in this assay to

obtain a complete curve.

Both the mouse sera and the myeloma proteins have

the same extent of inhibition.

Thus the public anti-idiotypic antiserum

is recognizing antigenically identical determinants on the immunoglobulins
from the three strains which may be antigenically identical to proteins
315 and 460.
The concentration of immunoglobulins bearing the public idiotype is
only slightly increased in the serum obtained 10 days after DNP-BGG
1
i
I

immunization compared to the serum from the day of immunization (day 0).

i

The concentration of immunoglobulins bearing this idiotype is much greater
in the 40 day serum.

Mouse strains can be divided into three groups based

on the concentration of public idiotype positive immunoglobulins as sum|

marized in Table 12:

a) those strains whose pre-immune sera have a

significantly elevated level of public idiotype positive immunoglobulins
|

(>50 ug/ml) and whose immune titers of idiotype is higher than other

l

strains (>300 ug/ml);

'

public idiotype positive immunoglobulin in the pre-immune serum and which

b) those strains which have a much lower level of

!

I

produce a low concentration (<100 ug/ml) of idiotype positive immuno
globulin in their 40 day anti-DNP response; and c) those strains whose
initial concentration of idiotype positive immunoglobulin is low, but
which produce a large quantity (^200-300 ug/ml) in the fortieth day of
their anti-DNP response.
are in the first group.

Only strains with the Ig-1

allotypic locus

Strains with the Ig-1^ allotypic locus except

*

fbr BAB 14

are in the second group and all other strains including BAB

* BAB 14 is a recombinant inbred strain between C56BL and Balb/c mice which
has the allotype of C56BL and apparently a cross-over in the region of the
loci that code for the Vy genes, thus producing immunoglobulins with both
C56BL and Balb/c V-region determinants (36).

.L
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14 are in the third group.

Assuming that all public idiotype positive

immunoglobulins bind DNP, it is to be noted that the public idiotype is
found at most on 5 to 25% of the DNP-binding antibodies in the serum of
each strain (Table 12).

Thus this marker which is common to myeloma

proteins 315, 460 and S23 is represented on only a fraction of the DNP
binding antibodies present in an anti-DNP serum.
The public idiotype was found on immunoglobulins of the a,
y

and p subclasses of each strain.

As illustrated in Figure 12, each

pool of mouse anti-DNP serum was precipitated in an Ouchterlony double
immunodiffusion assay with rabbit anti-mouse subclass sera.
with PBS, the gel was overlayed with
public anti-idiotypic antibodies.

125

After washin

I-labeled Fab' fragments of the

Autoradiography of the washed gel

revealed intensely radioactive bands over each precipitin line, thus
demonstrating that each H chain subclass of mouse immunoglobulin of every
strain tested had the public idiotype.

Balb/c, DBA, C3H,

SJL, C56BL, and

AKR mice were tested by this technique.
Thus the public idiotypic determinants of protein 460 and 315 are
inducible by DNP immunization in every strain of mouse tested and these
V-region markers are found on immunoglobulins of every C-region H chain
subclass tested.
3.

The Private 460 Idiotypic Determinants (IdI-460)

Anti-DNP serum from every strain contains immunoglobulins that
are bound by the private 460 anti-idiotypic antibodies, however, the
nature of this interaction differs in quality from

strain to strain.

depicted in Figure 13, the shape of the inhibition

curves of the various

mouse strains in a solid phase RIA can be divided into two groups:

As

a)

those strains whose sera's inhibition curves almost completely inhibits

!A
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FIGURE 12
The Heavy Chain Isotypes Of The Public And Private 460
Idiotype Positive Mouse Sera

AUTORADIOGRAPHY

STAIN

125,
l-Ffth "Qnti-ldX

12^l-Fab-anti-•Id!

Mouse Sera

%

2b o

2b© — \ 0rl

n

\°

v 0

o

or 2a

r2a

(2 day)

*

oy 2a

(2 day)
/g

2b<j •—

jN'or2a
(30 day)

C°”tr 0 l315
O

603
O

315

603

°

315o

603

0
o<

(3 0 day)

C<

(30 da^

U> yl, y2a, y2b, a are rabbit anti-Heavy chain isotypic sera that were
employed in Ouchterlonly immunodiffusion against various mouse sera
as described in MATERIALS AND METHODS. DNP-BGG immune sera from
DBA, C3H, SJL, Balb/cN, C57BL/6, and AKR mice gave same patterns.
Proteins. 603 and 315 are two IgA mouse myeloma proteins.
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FIGURE 13
The Binding Of Mouse Sera To Private 460 Anti-Idiotypic Antibodies

O

•100

315
strains

- 80
-60
-40
lg-1

**+" strains

-20
460
1.0
°/o SERUM

10.0

The 10 and 40 day anti-DNP sera described in Table 12 was employed in a
RIA which was performed as described in the MATERIALS AND METHODS with
I-Fab 460 and anti-IdI-460 antibodies.
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the binding of

125

I-Fab 460 to the private 460 anti-idiotypic antibodies,

but the shape of the inhibition curve is not identical to protein 460’s
inhibition curve in the same assay; and b) those strains whose antisera
have a different inhibition curve with a less steep slope.

Since no

inhibition curve of any strain is identical to that of protein 460, the
concentration of 460-like determinants calculated from the Inhibition
curves can only be estimates.

Even though the immunoglobulins of the

anti-DNP sera of group (a) interact with most, if not all, of the private
anti-460 antibodies, it can not be determined from this assay how anti
genically similar the "idiotype positive" determinants of immunoglobulins
in these sera are to the private idiotypic determinants of protein 460.
As long as two sera produce the same shaped inhibition curves in a RIA,
the relative concentration of antigenic determinants can be reliably
calculated.

The mouse sera, however, do not have identical inhibition

curves compared to protein 460.

The concentration of "460-like" deter

minants was estimated based on the dilution of serum required to prevent
the binding of 50% of
RIA.

125

I-Fab 460 to anti-460 serum in the solid phase

The concentration of 460-like determinants will be expressed in

terms of "ug/ml of protein 460 equivalents" even though the "actual"
concentration of the antigen positive immunoglobulins is not known.
The units are calculated based on the concentration of protein 460
which would cause 50% Inhibition in this assay.

These units are only

valid in the context of the comparison of sera with the same shaped
inhibition curves within the same RIA.
As summarized in Table 12, anti-DNP sera from strains that have
the Ig-1
(a).

allotypic locus have the Inhibition curves described in group

The only other strain to have this shaped inhibition curve is BAB
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14, the C56BL x Balb/c recombinant strain.

Sera from strains with the

Ig-l*3, Ig-lC , Ig-l**, and Ig-l6 loci were found to be in the second group.
Thus the 460-like private idiotype appears to be associated with the
Ig-l

allotype.
This association was also tested by mating C57BL (Ig-l*3) and Balb/c

(Ig-l

3"^
) mice.

As illustrated in Figure 14a, the anti-DNP sera from six

FI mice yielded inhibition curves identical to that of the parental
Balb/c mouse.

The assay presented in Figure 14b shows the offspring of

the back-cross mating of FI x C57BL.

These offspring had anti-DNP sera

with inhibition curves that resembled either the C57BL or Balb/c curves.
The appearance of either inhibition curve is independent of sex.

Thus

the inheritance of the Balb/c 460-like idiotypic determinants appears
to be autosomal dominant.

The allotypic composition of these recombinant

mice are currently being determined.

Unitl further matings are performed

and assayed for the private 460-like idiotype, these conclusions must be
viewed as preliminary.
Ouchterlony immunodiffusion was employed to determine the subclass
distribution of the 460-like determinants of each strain.

Each serum

was precipitated with anti-subclass serum and overlayed with
labeled Fab fragments of private anti-460 antibodies.

125

I-

As shown in Figure

12, after a two day incubation, intense autoradiographic bands were noted
over the precipitin lines of the mouse anti-DNP serum with rabbit antisera
for the y, a and

subclasses.

After 30 day film exposure to auto

radiography, faint lines were detected over the precipitin bands for the
Y 2 a > and the
this method.

subclasses.

Every strain yielded the same results by

This assay does not reveal anything about the nature of

interactions between the mouse immunoglobulins and the private anti-460
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FIGURE 14
.a+
The Inheritance Of The Ig-laT Linked Private 460-like Idiotype
In A C57BL/6£ x Balb/c tff Hating
(a)

FI Generation.

100

80
rrtxise

O'

S£S 460-:ike id

(ucnrvrnl)

C573L/6 2
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F1W
(3
(3)

Ml

-3

120

or*
9

tf
9

120
240
170
130

CH 20

RIA was performed as described in ^ ^ERIALS AND METHODS with private
460 anti-idiotypic antibodies and
I-Fab 460. The sera used were
from mice bled 10 days after DNP-BGG immunization.

(b)

F2 Backcross To C57BL/6

•100

-80

mouse sex 460-!ikeid
(uq/ml)
C57BL/6
F,(1)

$
120

-6

50

—20
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antibodies.

From this experiment it can only be concluded that anti

bodies from every subclass tested are bound by the private anti-460 anti
bodies.

This experiment does not reveal whether antigenically identical

V-regions are found on immunoglobulin with more than one subclass.
Table 12 summarizes the concentration of private idiotypic markers
in the sera of mice bled 0, 10, and 40 days after DNP-BGG immunization.
No serum from unimmunized mice of any strain contains more than a back
ground oncentration (1 to 10 ug/ml) of the private 460-like idiotypic
markers.

Unlike the public (IdX) idiotype, the concentration of immuno

globulins that are bound by the private 460 anti-idiotypic antibodies
reached a peak concentration 10 days after immunization and then declined
by day 40.

Only a minority of the DNP binding antibodies of each strain

have the private 460-like idiotypic determinants.

While the public (IdX)

and private (IdI-460) idiotypic markers are both found on protein 460,
the different kinetics of induction of immunoglobulins bearing these two
determinants suggests that in mice, clones of DNP-binding antibodies are
induced that have one idiotypic marker and not the other.

This is con

firmed in later sections.
In conclusion, it has been shown that:
a) no mouse serum tested has a detectable quantity (>300 ug/ml) of
immunoglobulins that are bound by the private 315 anti-idiotypic antibodies;
b) all strains of mice contain immunoglobulins that have the public
idiotype.

The shape of the inhibition curves of mouse immunoglobulins

are identical to the inhibition curves of proteins 315, 460, and S23.
Each strain of mice produces a concentration of public idiotype positive
immunoglobulins in its pre-immune and anti-DNP sera that is characteristic
of that strain.

Immunoglobulins representing every H chain isotype contain
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V-regions with the public idiotypic markers;
c) all strains of mice contain immunoglobulins that are bound by
the private 460 anti-idiotypic antibodies; however, some immunoglobulins
from anti-DNP sera of mice that have the Ig-l

H chain allotypic locus

have a characteristic inhibition on RIA which distinguishes it from the
"idiotype positive" immunoglobulins from other strains.

No strain of

mice tested produces immunoglobulins that have an identical inhibition
curve to protein 460.

The inheritance of the Ig-l

allotype associated

private 460-like idiotype appears to be inherited as an autosomal dominant
trait.

The immunoglobulins that are bound by the private 460 anti-idio

typic antibodies are mostly of the a, u, and y^ H chain isotypes in the
serum of the mouse strains tested; and
d) the kinetics of induction of immunoglobulins that are bound by
the private 460 and public anti-idiotypic antibodies differ thus implying
that V-regions are present in the sera which have one set of idiotypic
determinants and not the other.
Below some of the factors involved in the induction of these 460-like
idiotype immunoglobulins of Balb/c mice will be discussed, as well as the
properties of the idiotype positive immunoglobulins of Balb/c mice will
be described.
B.

The Influence of Carrier and Hapten On the Induction of 460-like
Determinants In Balb/c Mice.

Balb/c mice were chosen for this study for two reasons:

a) the

plasmacytoma, MOPC 460, was induced in a Balb/c mouse; therefore, the
V-region of protein 460 may resemble the V-region of a DNP binding anti
body coded in the genome of Balb/c mice; and b) Balb/c mice were found to
produce 460-like idiotypic determinants whose inhibition curves were
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characteristic of mice with the Ig-l
1.

allotypic locus.

All Balb/c Mice Produce Immunoglobulins That Have 460-like
Idiotypic Determinants

The results of the previous section were derived from pools of sera
of mice from the same strain.

Table 13 presents data which show that

individual mice produce significant levels of 46Q-llke determinants in
its anti-DNP response.

In an assay that measured the binding of

125

I-

Fab 460 to anti-460 antibodies specific for both public and private idio
typic determinants, each mouse serum had an identical inhibition curve.
With the exception of one mouse (6 LII

1), the concentration of 460-like

idiotype in each serum spanned a range of 35 to 95 ug/ml with an average
of 54 ± 17 S.D. ug/ml (n=23) in mice immunized by DNP-BGG in "Protocol I".
A pool of 90 mice immunized by the same protocol produced an identical
inhibition curve with a concentration of 460-like determinants of 48 ug/ml.
Similarly, DNP-BGG immunization of mice by another protocol (#11)
induced immunoglobulins whose inhibition curves in the same RIA were
identical to each other and identical to the Balb/c sera of mice immunized
by Protocol I.

The concentration of 460-like determinants of eight indivi

dual mice immunized by Protocol II ranged from 109 to 268 ug/ml with a
mean of 181 ± 63 S.D. ug/ml, while that of a pool of sera of 200 mice
immunized the same way was 160 ug/ml.

Thus the range of the 460-like

idiotype seen in individual mice includes the values seen in pooled serum.
Pooled sera may be used to reflect the antibody response of individual
mice to different immunological stimuli.
2.

Sequential Immunization of DNP and Menadione Containing Antigens
Preferentially Induces Immunoglobulins With the 460-like Idio
typic Determinants

Protein 460 binds both DNP and menadione (vitamin Ks).

The binding of
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TABLE 13

ToCal Concentration of 460-Like Idiotypic Determinants (IdX + Idl) In
Individual Balb/c Mice Immunized With DNP-BGG

Mouse

6B^
6 B*
6 L II t 1
6 X3
6 -? 4
8 B o*>
8B£
8 LI £ 2
8 -? 1

Protocol la
Concentration (uK/ml)

11 B«f»

65
40
250
60
65
50
50
40
56
75

HB *
12 B *
12 B tf*

95
50
40

Mouse

Concentration
(ug/m)

15
15
3
3
10
1
2

B^
BJF»
b£
B o*
Bf
B*»
Bf
2 B<*
13 Bf

35
43
50
75
50
35
40
50
43

13 Btf*

45

Protocal 11^
Mouse
Concentration
(ug/ml)
9**
9?
15 o'
15*
14*9
14 *

240
172
150
172
109
268

6*

100

66 ?

240
average * 181 ±63 (n=8)
ug/ml
pool of 200 mice
Immunized by = 160 ug/ml
Protocol II

average'” 62 ± 44 S.D. (n=23) ug/ml
average (excluding 6L II -t 1) = 54 ± 17 (n-22) ug/ml
pool of 90 mice immunized by protocol I = 48 ug/ml
a) Protocol I is s.c. injection of 0.5 mg DNP-BGG into 6 week old Balb/c mice in Complete
Freunds ADjuvant on day 0; 0.5 mg of Men-BGG in Complete Freunds Adjuvant on day 30;
bleed day 40.
b) Protocol II is s.c. injection of 0.5 mg of RNase into 6 week old Balb/c mice in Complete
Freunds Adjuvant on day 0; 0.5 mg of DNP-BGG in Complete Freunds Adjuvant on day 30;
bleed on day 40.
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the menadione moiety by protein 460 has been shown by Rosenstein and
Richards (145) to be deep in the combining region cleft of the VO-

region.

Menadione attached to a solid support with less than a 22 A

spacer will not be bound by protein 460.

Table 14 is a summary of the

results of an experiment that tested the ability of two different'
menadione conjugated proteins, Men-BGG and Men-Spacer-BGG, to induce
460-like idiotypic determinants.

The distance of the naphthoquinone

O
ring to the protein carrier in Men-BGG is on the order of 10 A and in
0
Men-Spacer-BGG is greater than 22 A.

The primary and secondary responses

of mice immunized with Men-BGG had little or no stimulation of an anti-DNP
response and induced very little of immunoglobulins that were bound by the
anti-460 idiotypic antibodies (IdX and Idl).

On the other hand, the con

centration of DNP binding antibodies and of immunoglobulins with 460like idiotypic markers in response to Men-Spacer-BGG immunization was very
similar to the response to DNP-BGG immunizations.

DNP-BSA, DNP-RGG, and

DNP-KLH also induced DNP binding antibodies and immunoglobulins with the
460-like idiotypic determinants.

Thus antigens that can be bound by

protein 460 are able to induce immunoglobulins bearing 460-like idiotypic
determinants.

Work is in progress to determine the concentrations of

immunoglobulins which have the public (IdX) and private (IdI-460) idiotypes induced by each antigen.

Below the properties of the Balb/c immuno

globulins that are bound by the anti-idiotypic antibodies are described.
C.

Properties of the 460-like Idiotype Positive Immunoglobulins
From Balb/c Mice.

1.

Idiotype Positive Immunoglobulins Bind DNP and Menadione

Four lines of evidence have demonstrated that immunoglobulins with
the 460-like idiotypic determinants bind DNP and menadione:
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TABLE 14

The Concentration of DNP Binding Antibodies and Immunoglobulins With
The 460-Like Idiotypic Determinants
Antigen
Day 0

SL

b
460-Like Idiotype
(ug/ml)

e
DNP-binding
antibodies
(ug/ml)

Protbcol
Day 30

Day 40

saline

bleed

60

20

saline

bleed

60

20

DNP-BGG

bleed

139

700

DNP-BGG

bleed

281

Men-BGG

bleed

75

Men-BGG

bleed

75

Men-Spacer-BGG

bleed

140

Men-Spacer-BGG

Men-Spacer BGG

bleed

180

DNP-BGG

Men-BGG

bleed

1000

DNP-BGG

Men-Spacer-BGG

bleed

2000

Men-Spacer-BGG

DNP-BGG

bleed

saline

DNP-BGG

Men-BGG

150

40

1100

600

a) All immunizations were performed as described in MATERIALS AND METHODS with 6
week old BALB/c mice.
b) Solid phase RIA was performed as described in MATERIALS AND METHODS. Quantitation
done at serum concentration giving 50% inhibition of binding of 125I Fab 460 to
anti-460 idiotypic antibodies that have both public and private specificities.
c) Solid phase RIA was performed as described in MATERIALS AND METHODS.
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a) Both DNP and menadione inhibited the binding of an immunoglobulin
fraction from Balb/c anti-DNP serum to public anti-idiotypic
antibodies.
b) The passage of anti-DNP serum through a hapten-Sepharose column
removed the majority of the public and private 460-like idio
type positive material.
c) DNP-glycine was able to elute immunoglobulins from a protein 460
anti-idiotypic antibody Sepharose column onto which Balb/c DNP
binding antibodies were absorbed; and
d) Isolated 460-like idiotype positives immunoglobulin were demon
strated to bind both DNP and vitamin Ks in a DNP-phage inhibition
assay.
In the first experiment, a fraction of immunoglobulins from DNPimmunized mice was isolated from a Men-Spacer-Sepharose column* by DNPglycine elution.
menadione.

This should elute antibodies that bind both DNP and

The eluted immunoglobulins were attached to a solid support

and used in a RIA.

This assay measured the binding of

125
I-labeled Fab'

fragment of public anti-idiotypic antibodies to the solid support.
summarized in Table 15, 1 x 10

DNP-glycine and 1 x 10

both inhibit greater than 40% of the binding of the

125

As

vitamin Ks

I-labeled Fab'

fragments to the purified double binding immunoglobulins.

Thus immuno

globulins from DNP immunized mice that have the public idiotype bind
both DNP and menadione.
Additional evidence that immunoglobulins with 460-like idiotypic
determinants bind DNP and menadione is summarized in Table 16.

Sera

* The Spacer consists of N-acetyl homocysteine ornithine which is at
least 22 A long.
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TABLE 1 5

The Hapten Inhibition of Binding of Public Anti-Idiotypic
Antibodies to Mouse Immunoglobulins

Hapten solution

% Binding
100

PBS
0.1 M DNP-glycine in PBS

33

0.01 M DNP-glycine in PBS

40

0.02 M Vitamin K g in PBS

20

0.001 M Vitamin K

56

a)

s

in PBS

Solid phase RIA performed as described in MATERIALS AND
METHOD. A fraction of mouse immunoglobulins were attached
to the polystyrene tubes. This fraction was purified by passing
BALB/c anti-DNP serum through a Menadione-Spacer-Column.
After washing with 10 column volumes, the column was eluted
with DNP-glycine. The DNP-glycine was removed by extensively
dialyzing the sample against PBS and by checking the optical
density at 280 nm and 360 nm. The assay measured the binding
of
Fab' fragments of public anti-idiotypic antibodies
to this fraction of DNP and menadione double binding antibodies
attached to this polystyrene tubes.
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TABLE 1 6

Adsorption of 460-Like Idiotypic Positive
Immunoglobulins to Hapten Sepharose Columns

460-like Idiotype(ug/ml)a

1) Balb/c serum
2)

#1 after DNP-column

3) Concentrated Breakthrough of #2

% bound by columns^

50
27

46%

60

4)

//3 after DNP-column

35

42%

5)

//I after menadionehomocysteine-ethylene
diamine-Sepharose
column (19 A spacer)

47

6%

6)

//I after menadionehomocys teine-o rnitheneSepharose column
(23 A spacer)

35

30%

a)

Solid phase RIA was performed as described in MATERIALS AND
METHODS. Quantification was done at concentration giving
50% inhibition of binding of - ^ I-Fab 460 to anti-460 idiotype
antibodies that have both public and private specificities

b)

% bound is ratio of idiotype of starting serum to amount of
idiotype bound to column.
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from DNP-immunized mice were passed through Sepharose columns to which
various DNP and menadione haptens were attached.

While 30% of the idio-

O
type positive immunoglobulins were bound to a column with a 25 A spacer
between the menadione moiety and Sor'harose, only 6% was bound to a
P
column with a 19 A spacer.

This r- ^.lt shows that of the antibodies

capable of binding to such a column, many of the idiotype positive immuno0
globulins are like protein 460 in requiring at least a 22 A spacer for
menadione to be bound.
Only 46% of the idiotype positive immunoglobulins are bound to a DNPcolumn.

To test whether the 54% which did not bind to the DNP-column

actually binds DNP, the breakthrough from the DNP-column was concentrated
to the original concentration, then passed through another DNP-column.
this concentrated immunoglobulin, 44% was bound.

Of

This suggests that both

affinity and antibody concentration had an effect on the percentage of
idiotype positive immunoglobulins bound to the DNP-column.

The lower

percentage of immunoglobulins bound by the menadione columns could also
reflect the concentration of immunoglobulin used in this experiment and/
or reflect the affinity of the immunoglobulins for menadione.

This point

was not investigated.
The third line of evidence that idiotype positive immunoglobulins
bind DNP is based on the finding that DNP-glycine can elute an antibody
fraction from a protein 460 anti-idiotypic antibody-Sepharose column
to which anti-DNP serum had been absorbed.

The anti-460 antibodies attached

to the Sepharose column were directed against both public and private 460
idiotypic markers.

After the eluted immunoglobulins were extensively

dialyzed to remove the DNP-glycine hapten, it was demonstrated by
Ouchterlony double immunodiffusion that the immunoglobulins bound

JL
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125

labeled DNP (.

I-TLD).

These eluted immunoglobulins were mainly

composed of the IgGl, IgA, and IgM subclasses.
also IgG2a and IgG2b.
demonstrated that

125

A minor component was

As demonstrated in Figure 15, autoradiography
I-TLD was bound in a pattern that overlay the pre

cipitin lines caused by anti-subclass serum and the eluted immunoglobulins.
Thus Balb/c immunoglobulins with the 460-like determinants bind DNP.
When this experiment was repeated with a private 460 anti-idiotypic
antibody-Sepharose column, the class distribution of the DNP-glycine
eluted material was different from the above experiment.

The most intense

radioactive bands were found over the precipitin lines for the IgGl,
IgM, and IgG2b subclasses.

The radioactivity over the IgA precipitate

was faint and no radioactivity was detectable over the IgG2a line.

This

result suggests that the two idiotypes may exist on at least two different
populations of antibodies.
In conclusion, the Balb/c immunoglobulins that are bound by the
public and private 460 anti-idiotypic antibodies were demonstrated to
bind both DNP and menadione in the following manner:
a) both haptens inhibit the binding of the public anti-idiotypic
antibodies to these immunoglobulins;
b) either hapten attached to Sepharose will absorb idiotype positive
O
material from sera. A 25 A spacer between the menadione ring and Sepharose
O
will absorb more idiotype positive immunoglobulines than a 19 A spacer;
c) DNP-glycine can elute the idiotype positive immunoglobulins which
had been absorbed onto a Sepharose column to which both public and private
460 anti-idiotypic antibodies had been attached.

The H chain subclass

distribution of the eluted immunoglobulins differs when a column with
only the private 460 anti-idiotypic antibodies attached is used instead
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F IG U R E 1 5

Balb/c Public and Private 460-like Idiotype Positive Antibodies
Bind 125l-TLD

Antibodies
with:

IdX ♦ IdI

STAIN

125I-TLD

r or o \or2a
o o r 2b .

& ^ 2 b

oc

r"1
o

Id I

uoj— .or 2a
? / oj

f o ? — of 2a

oN o^2b
,

ov/or2b

_

A

Idiotypes
Ouchterlony double immunodiffusions were performed as described in
the MATERIAL AND METHODS with Balb/c immunoglobulins that had been
eluted from anti-460 (IdX and IdI)-Sepharose and anti-IdI-460-Sepharose
columns by DNP-glycine and had been dialyzed to remove the DNP-glycine.
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of one with both the public and private anti-idiotypic antibodies.

This

suggests that some Balb/c immunoglobulins may contain the determinants
for one marker and not the other.
Below the 460-like idiotype positive immunoglobulins were isolated by
preparative isoelectric focusing and characterized.
2.

The Isolation and Characterization of Balb/c Immunoglobulins
Which Have the 460-like Idiotypic Determinants

Sephadex G-75 preparative isoelectric focusing was employed to
separate and isolate the immunoglobulins that had different 460-like
idiotypic determinants.

As illustrated in Figure 16, the isoelectric

points (pi) of idiotype positive immunoglobulins from pools of mice
immunized with DNP-BGG were identical to that of a single mouse immunized
with DNP-BGG.

Although small quantities of idiotype positive immuno

globulins were detected throughout the pH gradient, two major peaks of
idiotype positive immunoglobulins were detected at pH 4.5 to 5.0 and at
pH 6.7 to 7.0.

Ouchterlony immunodiffusion of the immunoglobulins from

these bands with anti-subclass sera revealed that the immunoglobulins
from the first peak were of the IgA iso type and the material from the pH
6.7 to 7.0 area was of the IgGl subclass.
The immunoglobulins from these peaks were demonstrated to bind DNP
by three methods:

a) the immunoglobulin’s ability to bind DNP in a phage

inhibition assay as illustrated in Figure 17; b) the binding of

125

I-TLD

by the precipitated immunoglobulins in agarose; and c) the ability of the
immunoglobulins to bind to DNP-columns as summarized in Table 17.
The DNP-coated phage are able to form plaques unless antibody binds
to the DNP-coated tail fibers of the phage.

Based on the ability of DNP-

lysine and of vitamin Ks to inhibit the binding of pH 6.7 to 7.0 peak

k
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F IG U R E 1 6

The Preparative Isoelectric Focusing of Balb/c Immunoglobulins To Isolate
460 Idiotype Positive Antibodies
(a) Pooled "DM" Sera

-7

-6.

-4.

Xo.
-3.

-'

2-

2.

d is t a n c e

(b)

Ccny

Sera From A "DM" Immunized Balb/c Mouse (6LII

23

1, Table 13)

-4

4-

DlSTANCE (err)
After three salt precipitations with 18% Na 2 S0 4 , the sera were subjected to
preparative isoelectric focusing as described in the MATERIALS AND METHODS.
One half cm. wide strips were pooled and the antibodies were eluted and
adjusted to 1 ml after dialysis against PBS. The hemagglutination inhibition
assay was performed as described in the MATERIALS AND METHODS with anti-460
antibodies with both public and private 460 specificities and 460-coated
SRBCs.
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FIG U R E 17

DNP-Phage Inhibition Assay Of 460 Idiotype Positive
Immunoglobulins Eluted From pH 6.7 To 7.0 Region
Of The Preparative Isoelectric Focusing pH Gradient

400*E>"
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3 0 0to
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-7
q
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Phage inhibition assay was performed as described in MATERIALS AND
METHODS.

J
L
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TABLE 17

The Binding of the Preparative Isoelectric Focusing Purified
460-Like Idiotype Positive Balb/c Immunoglobulins to
DNP-Sepharose Columns

Peak

460-like Idiotype (ngm/ml)*

pH 4.5-5.0
immunoglobulins
a) before column
b) after column

380
200

pH 6.7-7.0
immunoglobulins
a) before column
b) after column

115
^
20 and 70

(therefore % bound to column was 48%)

(therefore % bound to column was
between 40% to 83%b)

a)

Solid phase RIA was performed as described in MATERIALS AND
METHODS. Quantitation was done at concentration giving 50%
inhibition of binding of 125i-Fab 460 to anti-460 idiotype
antibodies with both public and private specificities.

b)

Experiment performed twice

t

L
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immunoglobulins to the DNP-coated phage, an average avidity constant of
these immunoglobulins for DNP-lysine and vitamin Ks was calculated to be
5-1
3-1
1 x 10 M
and 3 x 10 M
at room temperature, respectively.

This is

shown in Figure 17.
The immunoglobulins from the pH 4.5 to 5.0 region of the pH gradient
were bound by both public and private 460 anti-idiotypic antibodies and
produced inhibition curves in RIAs identical in shape to those produced by
Balb/c serum.

On the other hand, the pH 6.7 to 7.0 peak material was only

bound by the private 460 anti-idiotypic antibodies and not by the public
anti-idiotypic antibodies.
Immunoglobulins eluted from the pH 4.5 to 5.0 range of the preparative
isoelectric focusing gradient, not only have the same Idiotype, isotype,
and DNP-apecificity as protein 460, but the immunoglobulins also have
the same isoelectric point as protein 460, but the immunoglobulins also
have the same isoelectric point as protein 460.

Figure 18a shows the

results of Sephadex G-75 preparative isoelectric focusing of protein
460.

The pi of protein 460 lies between pH 4.5 and 5.0.

The isoelectric

point of protein 460 was determined by the position of 460-like idiotypic
determinants measured by a hamagglutination inhibition assay and by the
position of

3
H-DNP-azide labeled protein 460.

Both the affinity labeled

protein 460 and the 460-like idiotype positive material have the same pi.
Thus

3
H-DNP-azide labeled 460 can be used as a means for following a trace

quantitiy of protein 460.
The following experiments were performed to determine if the 460-like
idiotype positive immunoglobulins of Balb/c sera could be affinity labeled
by DNP-azide.

Anti-DNP serum absorbed onto a public and private anti-idio

typic antibody-Sepharose column was eluted with DNP-glycine.
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FIG U R E 1 8

(a)

Preparative isoelectric focusing of protein 460 and
r" labeled protein 460.
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(b)

Preparative isoelectric focusing of H-DNP azide labeled 460
idiotype positive Balb/c immunoglobulins.

-1200

- 800

6-600
5400
4-

200
3-

0ISTANCE (cm)

R eproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(cprrVO.mil)

7-

'h counts

r-1000

(—©— )

8-

W }U 2

The eluted immunoglobulins were found to be mostly IgGl, IgA, and IgM,
although immunoglobulins with the IgG2a and IgG2b subclasses could be
detected.

The eluted immunoglobulins were dialyzed to remove DNP-gly-

cine, reduced and alkylated, and photoaffinity labeled with

3
H-DNP-azide.

Using SDS polyacrylamide gel electrophoresis, the eluted material' was
found to consist of four bands with the molecular weights approximately
25K, 50IC, 60K, and 72IC.

This corresponds to the molecular weights of the

L, y> « and P chains, respectively.

The a chain of protein 460 has

a molecular weight of 5QK (Dr. R.W. Rosenstein, pers. comm.).
the 25K and 50K peaks contained tritium label.

Only

This implies that the

L and y chains (and possibly a chains) of the 460-like idiotype posi
tive immunoglobulins are able to be affinity labeled.

When this affi

nity labeled antibody preparation was subjected to isoelectric focusing,

3
the pH distribution of the

H-label was found only between pH 4.5 and 5.0,

exactly as determined for protein 460 (Figure 18b).

Interestingly, no

3
H-label was detected at the pH 6.7 to 7.0 region of the gradient where
the 460-like idiotype positive IgGl is found.
Thus, Balb/c mice contain two immunoglobulins in its anti-DNP serum
that make up the majority of the immunoglobulins positive for the 460like idiotypes:

a) an IgGl DNP and menadione binding antibody with a

pi between pH 6.7 and 7.0 that has only the private 460-like idiotypic
marker of Balb/c mice; and b) an IgA DNP and menadione binding antibody
that is bound by both public and private 460 anti-idiotypic antibodies
and that has a similar pi to protein 460, the same H chain subclass to
460, and a similar ability to be photoaffinity labeled by DNP-azide like
protein 460.

.L
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D.

Lymphocytes From Balb/c Mice Have 460-like Idiotypic Deter
minants on Their Surface.

The induction of 460-like idiotype positive immunoglobulins in a
humoral response implies that the clones of lymphocytes that produce
the idiotype positive immunoglobulins have been stimulated.
possibly T cells have immunoglobulin on their surfaces.

B cells and

It would there

fore be expected that some lymphocytes from mice that produce idiotype
positive immunoglobulins would have on their surfaces material that is
bound by the anti-idiotypic antibodies to the V-region of protein 460.
Below is presented evidence that some Balb/c splenic lymphocytes have
public 460 idiotypic determinants on their surface and the percentage
of such lymphocytes increases after immunization with DNP-BGG.
Lymphocytes from the spleen cells of

6

Balb/c mice immunized with

DNP-BGG were eluted through nylon wool columns (85) to obtain an enriched
T cell fraction and an enriched B cell fraction.

The cells were incu

bated either with rabbit public 315 anti-idiotypic antibodies or with
rabbit anti-mouse immunoglobulin serum.

The cells were then "stained"

with fluorescein-conjugated goat anti-rabbit serum.

As summarized in Table

18, about half of the lymphocytes from the spleen cells were labeled
by the anti-mouse immunoglobulin reagent.

This is to be expected since

about half of the splenic lymphocytes are B cells with immunoglobulin
on their surface.

While 1.5% of splenic lymphocytes from the unimmuni

zed mice stained positive for the public idiotype, 17% of all the lympho
cytes were positive for the public idiotype.

No fluorescence could

be detected on the non-adherent (T cell) fraction, while the adherent
lymphocytes (B cell enriched) had an increase in the percentage of
lymphocytes with mouse immunoglobulin on their surface and an increase
in the percentage of the public idiotype positive lymphocytes.
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TABLE 1 8

The Presence of Public Idiotypic Determinants On The Surface Of Splenic
Lymphocytes Of Balb/c Mice
Percentage of Fluorescent Labeled Cells
Normal Rabbit
Immunoglobulin

"Staining Reagent":

Source Of Splenic
Lymphocytes:

Rabbit
Rabbit Public 315
Anti-Mouse
Anti-Idiotypic
Immunoglobulin Antibodies
Serum

g

Unimmunized Mice

I
DNP-BGG Immunized Mice
Nylon Wool Adherent
Fraction (B cell
enriched fraction)
Nylon Wool Non-Adherent
Fraction (T cell c
enriched fraction)

JL

0%

not done

0%

48%

17%

0%

71%

32%

2%

1%

1%

1.5%

(a)

The lymphocytes from six mice were pooled. After harvesting the
lymphocytes from teased spleens by low speed centrifugation,
1 x 1()6 cells were incubate with 0.1 mg/ml solution of one
of the reagents in Eagles Minimal Medium for 1 hr. at 0° C.
The cells were washed once with Eagles Minimal Medium; then
incubated with 0.5 mg/ml of fluorescein-labeled goat anti
rabbit Fc antibodies for 1 hr. at 0° C. The cells were then
washed 3x with PBS; then the percentage of fluorescent cells
in 200 lymphocytes was determined under a fluorescent
microscrope.

(b)

The DNP-BGG immunized mice were injected with 0.5 mg of DNP-BGG
in Complete Freunds Adjuvant 10 days prior to sacrifice.

(c)

The spleen cells from the DNP-BGG immunized mice were separated
by the Nylon Wool Technique of Julius et al (85). 1 x 10^
cells of each fraction were treated as above.
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rabbit serum substituted for rabbit anti-mouse immunoglobulin did not
enable the lymphocytes to be fluorescently labeled, thus demonstrating
that "Fc-receptors" on lymphocyte surfaces did not influence the scoring
of lymphocytes as positive for a surface marker in this experiment.

This

work is now being repeated with the private 315 and private 460 antiidiotypic antibodies.
In conclusion, in this section the rabbit public, private 315, and
private 460 anti-idiotypic antibodies were employed as reagents to detect
mouse immunoglobulins that have the V-region antigenic determinants to
which these rabbits antibodies were directed.

Of 18 strains surveyed,

no serum was found to contain immunoglobulins that are bound by the
private 315 anti-idiotypic antibodies.

All strains of mice produce

immunoglobulins with the public idiotype.

All strains of mice produce

immunoglobulins that are bound by private 460 anti-idiotypic antibodies.
Based on the shape of the various inhibition curves in RIAs, the mouse
immunoglobulins which are bound by the private 460 anti-idiotypic anti
bodies are antigenically dissimilar to protein 460.

The private 460-like
3.“f"

idiotype positive immunoglobulins from mice that have the Ig-1

allo

typic locus differ antigenically with the immunoglobulins of other
strains of mice that are bound by the private 460 anti-idiotypic anti
bodies.
the Ig-1

The 460-like idiotype positive V-region marker associated with
ei't"

locus appears to be inherited in an autosomal dominant pattern.

In Balb/c mice both DNP containing antigens and menadione containing
O
antigens with a 22 A spacer between the carrier and the naphthoquinone
ring are able to induce immunoglobulins with the public and private
460-like idiotypes.

These same antigens are bound by these idiotype

positive Balb/c immunoglobulins.

L

The majority of 460-like idiotype
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positive immunoglobulins in Balb/c anti-DNP sera consists of two DNP
and menadione binding immunoglobulins:

a)

an immunoglobulin that is

bound by both the private 460 and public anti-idiotypic antibodies and
whose isoelectric point, subclass, and ability to be labeled by DNPazide is identical to protein 460; and b)

an immunoglobulin that is

bound only by the private 460 anti-idiotypic antibodies and which has a
different isoelectric point and subclass than protein 460.

Some Balb/c

splenic lymphocytes have surface determinants that are bound by the
public anti-idiotypic antibodies.

The percentage of such lymphocytes in

the spleen increases after DNP-BGG immunization.
In the next section attempts to develop other sets of V-region
markers for DNP binding immunoglobulins will be discussed.

The iso

electric focusing patterns of double binding immunoglobulins were used
to distinguish one antibody from another.
III. Attempts at Employing the Isoelectric Focusing Patterns of Double
Binding Antibodies of Immune Serum as V-Region Markers
In the previous two sections, rabbit antibodies to reference
mouse myeloma proteins were employed to characterize a minor set of
V-region determinants in mouse anti-DNP sera.

A limitation of this

approach is that the only V-region determinants studied are those
that are bound by the anti-idiotypic antibodies.

The antigen specifi

city of most mouse myeloma proteins are unknown or are directed against
a few antigens (Table 1, INTRODUCTION).

Furthermore, among mice only

the Balb/c and NZB strains produce plasmacytomas with high frequency.
Only recently have techniques been developed to isolate homogeneous
antibodies from any mouse strain by performing cell fusion between
splenic lymphocytes and stable myeloma cell lines (107, 96, 175).
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Thus

until recently the majority of V-regions of most mouse strains could
not be studied by the idiotypic approach.
Another approach to characterize the combining regions of immuno
globulins has been to identify them by their specificity for a defined
set of antigens.

This work includes that of MSkela's group (71, 116)

who studied the inheritance of immunoglobulins with similar binding
preferences for related antigens (fine specificity).

Recently various

investigators have attempted to correlate the fine specificity pre
ferences to isoelectric focusing pattern (114) and idiotypic determinants
(77).

The assumption behind these studies has been that very few immuno

globulins possess both identical isoelectric points (pi) and antigen
binding properties or both identical pi and idiotypic determinants.
Eisen ert a]L. (40) were the first to demonstrate that myeloma pro
teins may bind many chemically dissimilar moieties.

For example, protein

460 has been shown to bind DNP and menadione in two spatially separated
regions of its combining region (144, 145, 120).

Johnston and Eisen

(83) have demonstrated that rabbits immunized with either DNP or mena
dione conjugated proteins will have an immune response of which 25 to
75% of the antibodies bind both antigens.

Varga

al. (168) have

shown that by sequentially immunizing rabbits with both antigens,
the early response to the second injection contains an increased amount
of antibodies directed against both antigens.

This preferential stimu

lation of multispecific antibodies was not only restricted to DNP and
menadione binding antibodies.

Double binding immunoglobulins were

induced by the sequential Immunization of DNP and inosine, uridine, or
bovine pancreatic RNase.

In a subsequent paper, Czaja et al. (20)

found that the sequential immunization of mice with RNase and DNP-BGG
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caused a concomitant increase of the cell surface receptors of splenic
lymphocytes that bind both antigens.
Concurrent with the idiotypic work described in the preceding two
sections of the RESULTS, an attempt was made to identify sets of Vregions for possible genetic study by analyzing the isoelectric focusing
patterns of multispecific antibodies in mouse sera.
the method of Varga et ^1.

In this approach,

(168) was followed, i.e., mice were sequen

tially immunized with two antigens and the "early" serum was assayed
for the presence of antibodies which bind both antigens.

For example,

mice were injected with RNase, then with DNP-BGG 30 days later and bled
10 days after the second immunization.

This "early" serum had a higher

proportion of RNase and DNP double binding immunoglobulins in its antiDNP response compared to serum from mice immunized with DNP-BGG alone.
The serum from the sequentially immunized mice were subjected to iso
electric focusing in flat plate polyacrylamide gels.

The gels were

preferentially precipitated with sodium sulfate and cross-linked in the
gel with glutaraldehyde.
tion of
titor.

125

Thus, prepared, the gels were exposed to a solu-

I-labeled hapten in the presence and absence of cold compe

In this way, a comparison of the radioactive banding pattern

(spectrotype) of the gels developed with or without competitor allowed
detection of double binding immunoglobulins.

Those bands which contained

immunoglobulins that bind both competitor and radioactive hapten were
less intense in the gels exposed to cold competitor.

The analytical

method therefore allowed a quick identification of both the isoelectric
points and the binding specificities of a large number of immunoglobu
lins present in small quantities of mouse serum.
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Below are descrihed attempts by this method of analytical iso
electric focusing to characterize the V-regions of multispecific
antibodies that also bind DNP.
A.

Antibodies Retain Their Antigen Binding Specificity While
Cross-Linked in Polyacrylamide Gels After Isoelectric
Focusing.

The method of isoelectric focusing and cross-linking of immuno
globulins in polyacrylamide gels was shown not to affect the binding
properties of immunoglobulins in the experiment illustrated in Figure
19.

Autoradiography of monomeric protein 315 exposed to

125

I-TLD in

a polyacrylamide gel after isoelectric focusing revealed a series of
five bands.

Three of these were prominent.

Although the monomeric pro

tein 315 that was subjected to isoelectric focusing has a homogeneous
amino acid sequence, the multiple banding pattern may be due to slight
changes in the pi caused by differences in carbohydrate content,
deamination or allomorphism (178).
vitamin Ks.

Protein 315 binds both DNP and

By incubating the polyacrylamide gels containing the cross-

linked protein 315 with various concentrations of vitamin Ks, the amount
of the radioactivity in these bands was affected.

A plot of the

intensity of each autoradiographic band versus the logarithm of the
concentration of vitamin Ks allows an estimation of the inhibition
constant (K^.) of vitamin Ks for the protein 315 bound in a polyacryla
mide gel after isoelectric focusing.

As shown in Figure 19b, the inhi

bition constant for vitamin Ks was calculated to be between 0.3 to
1 x 10

4

M

-1

based on the decrease in band intensity which increasing

vitamin Ks concentration.

Figure 19 also shows that all three bands

have within experimental limits the same Kj. for vitamin Ks, thus
further strengthening the argument that isoelectric focusing does not
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FIGURE 19

Densitometer tracing of a 7 day film exposure of the iso e l e c t r i c ^

(a)

focusing pattern of monomeric 315 that was incubated with 10
I-TLD in the presence of varying concentrations of
.v
Vitamin Ks. (Hoi *U p e^k s
)

concentration
Vi tam in K<;

PH2.5
(b)

PH4.5

A plot of peak intensity versus Vitamin Ks concentration. The
concentrations noted are those of Vitamin Ks that produce
50% inhibition of the peak’s intensity.
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1

L.

M

affect antigen binding.

The inhibition constant of vitamin Ks for

monomeric 315 in solution was found to be 3 x 10

3

M

-1

inhibition assay (kindly performed by Dr. K. Kalasz).

by a DNP-phage
Thus protein

315 was unaffected by isoelectric focusing and cross-linkage in a poly
acrylamide gel.
To show that TLD binding to antibodies fixed in gels is due to
their specificity for the DNP moiety of
used as a competitor for
graphic pattern of
absence of 10

-4

I-TLD.

I-TLD, DNP-caproic acid was

Figure 20 illustrates the autoradio-

I-TLD binding antibodies in the presence and

M DNP-caproic acid.

electric focusing.
are albumin.

125

125

125

Whole serum was subjected to iso

The prominant bands in the pH 4.9 to 5.2 region

While the intensity of the albumin bands are little

affected by the presence of DNP-caproic acid, most of the immunoglobu
lin bands have been "washed" out by the cold hapten.
DNP-lysine with a Ka about 5 x 10
a concentration of 2 to 5 mg/ml.

4

M

-1

Albumin binds

and it is present m

serum at

Undoubtedly the small change of

intensity of the ablumin band in the presence of the cold competitor
is not detectable because the large amount of radioactivity present.
This is due to the high concentration of albumin in the band.

As

explained in Appendix 2, by selecting a concentration of radioactive
hapten and of cold inhibitor to be used in developing the analytical
isoelectric focusing gels, a sub-population of double binding immuno
globulins can be detected after autoradiography.

Below the attempts

to employ two sets of antigens to characterize multispecific antibodies
in mouse serum will be presented.
The presence of multispecific antibodies were detected by autoradiography of antibodies that had bound

125

I-labeled haptens.
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FIGURE 20
The Inhibition of

125

I-TLD Binding Of Mouse Immunoglobulins By
1 x 10“^ M DNP-caproic Acid

DNP-caproic acid
PH

125 I-TLD

pH

125, •TLD
•

PH
“ 8.4
-

8.0

-7 .6

t

-7 .5
-7.1
-7 .0
-6 .7
-6 .5
-6 3
6.2
6.1
-5 .9
—5 6
-5 3
-5.1
-4 .9

serum
sample no.

5 1 2 34

5 12 34

Analytical isoelectric focusing, gel processing, and autoradiography
were performed as described in the MATERIALS AND METHODS.

L
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intensity of a band is a function of the number of molecules undergoing
radioactive decay, and is dependent upon the exposure time of the x-ray
film to the radioactive gel.

Figure 21 shows the results of an experi

ment designed to test these variables.

Strips of filter paper ( 1 x 6

mm) were impregnated with different quantities of
125

(

I-TLD).

125

I-labeled TLD

The film that was incubated to 180 cpm could be detected

after 7 days; film which was exposed to 18 cpm was barely detectable
after 30 days.

Thus at least 180 to 1800 cpm per 1 x 6 mm band is

required for detection after a two to seven day film exposure to

125

I-

autoradiography.
The amount of radioactivity present in a particular band is also a
function of the amount if immunoglobulin present, the affinity of the
immunoglobulin for the hapten, and the specific activity of the hapten.
As explained in Appendix 2, the amount of immunoglobulin present in a
given band can be estimated by the band's intensity after autoradiography
if an assumption is made regarding the antibodies affinity for the hap
ten.

In most instances, this information is not known, so this estimate

cannot be made accurately.

Thus a range of concentrations and affinities

spanning three or four orders of magnitude can yield the same amount
of film darkening in each band under the conditions in which the gels
were processed.
It is possible that autoradiography will not reveal all antibodies
that have binding specificity for the radioactive hapten, either
because the amount of immunoglobulin present in the band is too low
or the affinity for the hapten is not high enough.

In many instances,

mouse anti-DNP sera were found to agglutinate DNP-coated SRBCs and to
contain 460-like idiotype, yet these same sera failed to have

125
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FIGURE 21
125
Film Darkening Observed With
I Containing Bands After
2, 7, and 30 Days Autoradiography

film
exposure

2 day

7 day

30 day

cPm/strip
18,000
^800

-:’rn

180

Details for this experiment are described in the RESULTS.
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binding bands on autoradiography after isoelectric focusing.

Some of

these sera when precipitated by specific anti-subclass sera in an
Ouchterlony immunodiffusion were demonstrated to bind
radiography.

125

I-TLD by auto

The separation of the different immunoglobulins by iso

electric focusing may have resulted in the amount of immunoglobulin
in any band to be sufficiently low so that not enough radioactivity was
present to be detected under the conditions in which the autoradiography
was performed.
In conclusion, analytical isoelectric focusing gels may be used to
detect antibodies that bind more than one

ah+if*.r\

.

Many factors

affect the detection of immunoglobulins cross-linked inside the gel
including the concentration of immunoglobulin present, the affinity of
the immunoglobulin for the hapten, the specific activity of the labeled
hapten, and the exposure time of the film to the labeled gel.
Below experiments will be described that employed this analytical
technique to detect the isoelectric focusing patterns of double binding
antibodies induced by the sequential immunization of antigens.

This

was done in an effort to identify different V-region gene products of
mice.
B.

The Study of DNP and Menadione Multispecific Antibodies by
Isoelectric Focusing Patterns Analysis

The characterization of DNP and menadione binding antibodies by
isoelectric focusing pattern analysis was wrought with many difficulties.
Most of the studies which attempted to induce DNP and menadione multi
specific immunoglobulins were performed by sequentially immunizing mice
with DNP-BGG and Men-BGG.

It was only later that work was produced

that demonstrated that Men-BGG is not antigenic for most menadione

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

156

binding antibodies.

As shown in section II.B.2. (Table 14), Men-BGG

was barely antigenic for an anti-DNP response or for a response of
immunoglobulins bearing the 460-like determinants in Balh/c mice.
Spacer-BGG* is more antigenic for both types of responses.

Men-

This may

be so because Balb/c immunoglobulins like proteins 460 and 315 bind the
0
menadione moiety "deep" in the combining region cleft. A 22 A spacer
must exist between the naphthoquinone ring and the protein for the
menadione moiety to be bound by these immunoglobulins.

This was shown

in section II. C.l. (Table 16). Furthermore, Men-Spacer-BSA with a 23
0
0
A spacer and not Men-RGG with a 10 A spacer is precipitated by proteins
315 and 460 and Balb/c anti-DNP serum in an Ouchterlony immunodiffusion.
Thus Men-BGG did not serve as an antigen for the induction of DNP and
menadione binding multispecific immunoglobulins.

Any DNP and menadione

multispecific immunoglobulin induced by a protocol of the sequential
immunization with DNP-BGG and Men-BGG was solely due to the injection of
DNP-BGG.
The immunization protocol employed in these studies, called the
"DM protocol", consisted of a DNP-BGG injection followed by a Men-BGG
injection 30 days later.
injection.

The mice were bled 10 days after the second

Since the Men-BGG is not antigenic, the sera obtained by

this protbdol are equivalent to sera obtained from mice bled 40 days
after a DNP-BGG immunization with a second boost of BGG.

As noted in

sections II.A.2. and II.A.3. (Table 12), by the fortieth day of an antiDNP response in Balb/c mice the serum concentration of the clones of
immunoglobulins with the private 460-like idiotype were declining while

*Men-Spacer BGG is menadione-acetyl homocysteine-BGG.
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the concentration of immunoglobulins with the public 460 idiotype were
increased.

This means that the isoelectric focusing pattern of DNP

binding immunoglobulins observed in the serum of mice immunized by the
DM protocol should reflect a large set of DNP binding antibodies, all of
whose concentrations are changing.
Depending on the kinetics of the induction and inhibition of indi
vidual antibody producing clones, it might be expected that differences
in banding intensity would be observed in the isoelectric focusing
spectrotypes of sera from different mice of the same strain.

The

125

I-

TLD autoradiography of the serum from Balb/c mice immunized by the DM
protocol revealed banding differences among individuals.

For example,

in Figure 22a the ^ ^ I-TLD banding pattern of B 0*and B-£ sera were
identical except between pH 5.6 and 5.9.

Figure 22b is a superimposi-

tion of the densitometer tracings of the 2 day film exposure of these
sera.

Note that with B0*a faint band can be detected between peaks 3

and 4 that coincides with peak 4* in B-f.
the gel (Figure 22a) reveals more

125

A 30 day film exposure of

I-TLD binding bands.

more resemblances in the banding pattern of the two sera.

Now there are
A densito

meter tracing of the banding patterns of Btf*and Bj sera after a 30 day
film exposure (Figure 22c) now reveals that both sera have mostly identi
cally positioned peaks with variations of peak intensity between two sera.
The sera obtained from Balb/c mice immunized with the DM protocol does
not represent an "early" response to the second antigen.

Although mice

made the same antibodies, the serum concentration of each antibody varied
from mouse to mouse, as judged by the intensity of bands after isoelec
tric focusing.

The intensity differences may have represented slight
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FIGURE 22
125

The Autoradiographic
I-TLD Binding Patterns Of The "DM" Sera From
From Two Balb/cN Mice After A 2 Day and 30 Day Film Exposure

(a) Autoradiophic film patterns
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FIGURE 22 (continued)
(b)

Densitometer
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30 day film exposure
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differences in the kinetics of expression of the

125

I-TLD binding anti

body clones.
The different banding intensities observed among the various inbred
mice are analogous to those seen with the banding patterns of sera
obtained from the same mouse at different times after immunization.
Figure 23 compares the banding patterns of sera from B 0*10 days and 47
days after sequential injection of DNP-BGG and Men-BGG.

The position

of the bands are the same, only the intensities of each band are
different.
To detect DOT and menadione binding multispecific antibodies,
menadione bisulfite was employed in most of the investigations to
inhibit the binding of

125

I-TLD by the isoelectric focusing bands of

sera of Balb/c mice immunized by the DM protocol.

Very few

125

I-TLD

binding spectrotypes were found to be inhibited by menadione bisulfite.
It was finally determined that most menadione binding antibodies have
a much higher affinity for vitamin Ks (menadione thiopropionic acid)
than menadione bisulfite.

This enabled a significant number of multi

specific clones to be detected.
In Figure 24, two autoradiographic film exposures are presented to
illustrate the change in intensity of
presence and absence of vitamin Ks.

125

I-TLD binding bands in the

Each autoradiographic film had its

darkness (band intensities) measure by a densitometer.
of each band for the gels incubated only with

125

The intensities

I-TLD were measured from

the density tracings, as well as, the intensity of the bands from the
Identical gel exposed to

125

I-TLD and vitamin Ks.

A ratio of these two

intensities (called the "Ks/TLD ratio") provides a rough guide to identify
those bands which bind both haptens competitively.

Arbitrarily, a Ks/TLD
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FIGURE 23
A Comparison Of The Autoradiographic Patterns Of A Mouse Bled 10 Days
And 47 Days After DNP-BGG Immunization

(a)

The 7 day film autoradiographic film pattern
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FIGURE 23 (continued)

(b) The densitometer tracing of (a)
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FIGURE 24
The Inhibition Of

(a)

125

I-TLD Binding Bands By Vitamin Ks

The 7 day autoradiographic film exposure.
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125,.I-TLD

♦

Vitamin Kc
Analytical isoelectric focusing, gel processing, and autoradiography
were performed as described in MATERIALS AND METHODS.
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FIGURE 24 (continued)
(b)

A comparison of the densitometer tracings of the
patterns of B»> with and without Vitamin Ks.
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FIGURE 24 (continued)

(c)

A comparison of the densitometer tracings of the
I-TLD binding
patterns of
^ 4, $ 5 with and without Vitamin Ks.
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ratio greater than 0.5 was interpreted to mean that the
binding band was not inhibitable by vitamin Ks.

I-TLD

Conversely, a Ks/TLD

binding band less than or equal to 0.5 was taken to mean that the
immunoglobulins bound both TLD and vitamin Ks competitively.
The Ks/TLD ratio varied from band to band in any serum sample.
For example, in B»*of Figure 24 the Ks/TLD ratio was less than 0.5
only in those TLD binding bands whose pi was greater than pH 6.0.
The Ks/TLD ratio of the bands of B ^ ,
range were closer to 1.0.

£ 4, and %- 5 in the same pH

Thus only one of these four Balb/c mice

produced a detectable vitamin Ks and TLD double binding spectrotype
in this pH range.
The significance of this result is unclear.

Not enough of the

immunoglobulins subjected to analytic isoelectric focusing could be
eluted from the polyacrylamide gel for further characterization.
addition, attempts to label individual bands with

125

In

I-labeled Fab'

fragments of anti-idiotypic and anti-isotypic antibodies were unsuccess
ful.

The pore size of the gel was too small to allow sufficient diffu-

sion inside the gel of the

125

I-labeled Fab fragments to produce decent

labeling.
To try to circumvent this inability to characterize the idiotype
and isotype of the immunoglobulins cross-linked in analytical polyacryla
mide gels, the anti-DNP serum from one mouse was subjected to isoelectric
focusing in Sephadex G-75.

This mouse (6L 1 1 ^ 1 of Table 13) had been

immunized by the DM protocol and found to have an unusually large response
of 460-like idiotype positive immunoglobulins that bind DNP.

Five

regions of the gradient representing a range of 0.03 to 0.05 pH units were
isolated from regions where intense TLD binding bands were observed in
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the analytical isoelectric focusing gels.

All five fractions of eluted

material were found by Ouchterlony imraunodiffusion to be composed of
immunoglobulins of more than one heavy chain isotype; although in four
of the five samples only one isotype bound

125

I-TLD.

This implies that

while more than one immunoglobulin is present in each fraction, in
four of the five fractions tested immunoglobulins with only one subclass possessed detectable

125

I-TLD binding activity.

Using a phage

inhibition assay (kindly performed by Dr. H. Kalasz), the inhibition
curves seen with four of the five fractions were interpreted as being
consistent with antibodies possessing a single DNP binding constant.
The fifth fraction produced an inhibition curve whose shape was indica
tive of the presence of more than one DNP binding specificity.

While

these results suggest that four of the five fractions may have contained
only one DNP binding immunoglobulin, this conclusion cannot be made
until the immunoglobulins which comprise these bands are further charac
terized.

More than one antibody with the same subclass and antigen binding

specificity can have the same pi (183) .
These results showing that only one Balb/c mouse of four contains
a set of vitamin Ks inhibitable
interpreted in two ways:

125

I-TLD binding antibodies can be

a) all mouse sera have the same immunoglobulins

in each band but the expression of each clone of immunoglobulin varies
from mouse to mouse.

Thus a band that contains both an immunoglobulin

specific for both DNP and vitamin Ks and an immunoglobulin that binds
only DNP will have a different Ks/TLD ratio from mouse to mouse depen
ding on the relative expression of the two immunoglobulins; or b) the
expression of individual clones of antibodies in inbred mice is variable
so that different Ks/TLD ratios for bands at the same pH represents the
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the presence of different

125

I-TLD binding antibodies in each band

from mouse to mouse.
In order to test these hypotheses, nine sets of mice were mated,
producing a total of 43 offspring.

These mice were immunized with the

DM protocol to determine if recognizable patterns of vitamin Ks inhibitable

125

I-TLD binding bands could be seen.

Such patterns in Balb/c

mice might be indicative of a similar set of immunoglobulins from mouse
to mouse in this highly inbred strain.
The Ks/TLD ratio of the two and seven day film exposures were
determined for each band and the frequency of bands show Ks/TLD ratio
was less than 0.5 was noted.

Table 19 lists the average Ks/TLD ratio

of all the mice at a particular pH and the number of mice whose Ks/TLD
ratios were less than or equal to 0.5 at that pH.

Based on these deter

minations plotted in Figure 25, three positions of the pH gradient were
selected in which the largest group of distinguishable vitamin Ks inhibitable

125

I-TLD binding bands could be detected.

These vitamin Ks

inhibitable bands with a Ks/TLD ratio less than 0.5 were called:
"DM 1" for bands in the region of pH 6.5 to 6.6; "DM 2" from pH 5.9
to 6.0; and "DM 3" from pH 5.7 to 5.8.
dence of finding an
regions.

125

Table 20 summarized the inci-

I-TLD binding band in one of the three pH

53% of the mice had TLD binding bands detectable in all three

regions of the gel after 7 days incubation.
Ks inhibitable

125

The incidence of vitamin

I-TLD binding bands at these locations of the pH

gradient is summarized in Table 21.
vitamin Ks inhibitable

125

77% of the mice had at least one

I-TLD binding band in one of three pH regions

in which "DM" bands were identified.

Of the 43 mice surveyed, 9 mice had

only the DM 2 pattern of inhibition.

Six mice had both the DM 1 and DM 2
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TABLE 19

A Survey of the Vitamin Ks Inhibitable
I-TLD Binding Bands
of 43 BALB/c Mice Immunized by the "DM" Protocol3

£H

5.30
.35
.40
.45
.50
.55
.60
.65
.70
.75
.80
.85
.90
.95
6.00
.05
.10
.15
.20
.25
.30
.35
.40
.45
.50
.55
.60
.65
.70
.75
.80
.85
.90
.95
7.00
.05
.10
.15

No. of mice
with Ks/TLD
ratio < 0.5

Mean K S/TLD
ratio of
all mice

4
3
1
2
6
2
6
4
10
8
13
11
9
14
7
7
13
8
5
4
5
9
7
5
4
11
2
9
4
0
3
0
2
5
0
0
1
1

0.4
0.7
1.5
0.6
0.5
0.7
0.7
0.3
0.4
0.5
0.4
0.4
0.5
0.4
0.5
0.5
0.5
0.6
0.5
0.5
0.6
0.4
0.6
0.7
0.6
0.5
0.8
0.6
1.0
0.7
1.1
0.6
0.9
0.7
1.0
0.5
0.3
0.7

No. of mice
with band
at this pH

4
5
2
3
8
4
9
4
12
12
17
16:
12
16
12
11
18
13
9
7
9
12
17
13
15
17
10
17
15
11
11
7
8
9
1
3
3
3

% of bands
with KS/TLD
ratio < .05

100
60
50
67
75
50
67
100
83
67
76
69
75
88
58
64
72
61
56
57
56
75
4.1
38
27
65
20
53
27
0
27
0
25
45
0
0
33
33
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TABLE 19 (continued)

A Survey of the Vitamin Ks Inhibitable -*-^I-TLD Binding Bands
of 43 BALB/c Mice Immunized by the "DM" Protocol3

pH

No. of mice
with KS/TLD
ratio < 0.5

7.20
.25

0
0

a

Mean KS/TLD
ratio of
all mice

No. of mice
with band
at this pH

0.4

2

0.2

1

% of bands
with K S/TLD
ratio < .05

0
0

Ks/TLD ratio is the ratio of the intensity of the vitamin
inhibited gel to the non-inhibited gel as measured by the
Joyce-Loebl Microdensitometer. All mice were 6 weeks old
BALB/cN mice from 9 different litters.

i
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FIGURE 25
The Results Of A Survey Of 43 Balb/cN Mice For Vitamin Ks Inhibitable
i 25i _t l d Binding Bands

‘CMf

34

30

DM3
34.Z O'

24

&vi

22-q.o
£ a

20-9 u
2 Q
cO H

PH

Data derived from Table 19.
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TABLE 2 0

1 25

Number of Mice with
I-TLD Binding Bands in pH Regions
Where the "DM" Peaks Are Located3

Number of mice with bands in:

only DM1 region
3

DM1 and DM2 regions
7

DM1, DM2, DM3 regions
23

only DM2 region

only DM3 region

4

.

0

DM1 and DM3 regions

DM2 and DM3 regions

5

1

total
43

same mice as surveyed in Tables 19, 21, 22
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TABLE 2 1

Number of Mice with Vitamin Ks Inhibitable
125i-TLD Binding Bands in the "DM" Regions3

no Vitamin Ks
inhibitable
bands observed
in DM regions

inhibitable bands found only in:
DM1

DM2

DM3

DM1, DM2

DM1, DM3

DM2, DM3

10

6

DM1, DM2, DM3
4

2

6

total
43

number gels with DM1=15
DM2=24
DM3=15
DM1, DM2= 6
DM1, DM3=10
DM2, DM3=10

a Kg/TLD ratio _< 0.5 is scored as a Vitamin Ks inhibitable
125j-TLD binding band.
Same mice were surveyed as in
Tables 19, 20, 22.
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patterns in their serum and another six had both the DM 2 and DM 3
patterns.

The numbers are too small to determine whether there is

linkage between the two DM patterns.
The sera of mice having the same "DM" pattern were pooled in order
to obtain sufficient quantity of multispecific immunoglobulins for
characterization.

Before performing quantitative separations of these

immunoglobulins, each pool was subjected to isoelectric focusing by
the analytical flat plate gel technique and the Ks/TLD ratio was deter
mined for each band (Table 22).
ratios predicted of them.

None of the pools of sera had the Ks/TLD

For example, the pools of sera which had

a Ks/TLD ratio less than 0.5 for only the DM 1 bands had a Ks/TLD ratio
less than 0.5 in the regions for both the DM 1 and DM 2 bands.

This

result calls into question the validity of classifying Balb/c mice into
groups based upon the pattern of "DM" bands present in their serum.
stated in Section III.A., not all

125

As

I-TLD binding bands are detectable

under the conditions in which the experiments were performed.

By pooling

the sera of different mice, the concentration of "non-detectable" immunoglobulins may have increased enough to have its
ble by autoradiography.

125

I-TLD binding detecta

If these "non-detectable" immunoglobulins have

the same pi as other TLD binding immunoglobulins, the ratio of Ks/TLD
of a particular band will now be changed.

Thus the classification of

mouse serum in terms of their "DM" patterns may be an artifact of the
immunization protocol and of the assay used to distinguish one serum
from another.
The hypothesis that the differences in DM banding patterns were due
to some inherited mechanism which modulated the expression of particular
clones of mice and which was not uniformly operative in Balb/c mice was

te

fL
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TABLE 2 2

The KS/TLD Ratios of the "DM" Regions of Pools of Sera which were
Scored as Having the Same Vitamin Ks Inhibitable
125i _t l d Binding Band Patterns3

Expected pattern of
Vitamin Ks inhibitable
125i-TLD binding bands

DM1

DM2

DM1 only

0.2

0.3

DM2 only

0.5

0.3

no peak observed

DM3 only

0.4

0.3

no peak observed

3

KS/TLD ratios at
DM3 region

sera from same mice as in Tables 19, 20, 21; 5 pL of pooled sera
were processed in the analytical isoelectric focusing technique
with 125I-TLD and Vitamin Ks as desctibed in MATERIALS AND METHODS.
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tested.

Eight pairs of six week old Balb/c mice were mated.

Four weeks

after the first litter was born, both breeders and litters were immunized
by the DM protocol and bled.

After the breeders were bled, they were

mated again and the second set of offspring were challenged by the DM
protocol.

The DM patterns of both litters and offspring are summarized

in Table 23.

One breeding pair (//ll) had offspring with a "DM" pattern

not present in the serum of its parents.

Not enough mice were examined

to come to any conclusions regarding the inheritance of the patterns.
Work is in progress to perform spectrotype analyses of the serum
of Balb/c mice immunized sequentially with DNP-BGG and Men-Spacer-BGG.
It is expected that the early anti-menadione response of mice challenged
this way will contain the DNP and menadione multispecific immunoglobulins
that are selectively stimulated.

These multispecific immunoglobulins

will be screened by analytical isoelectric focusing and then characterized
by elution from Sephadex G-75 isoelectric focusing preparations.
In conclusion to detect the preferentially stimulated clones of
DNP and menadione double binding immunoglobulins in sera from mice that
had been immunized with DNP-BGG and Men-BGG were subjected to the
analytical isoelectric focusing gel technique.

Since Men-BGG is not

antigenic for an anti-menadione response, the sera from "DM" immunized
mice is equivalent to a 40 day immune response to a single DNP-BGG
injection.

In order for this work to be interpretable, this work has

to be repeated with Men-Spacer-BGG which is antigenic for anti-menadione
and anti-DNP responses.

Furthermore, most of the analyses were performed

with a water soluble derivative of menadione (menadione bisulfite) that
is not bound with much affinity by menadione binding immunoglobulins.
Despite these faults, it was found that the

125

I-TLD binding patterns
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TABLE 23
Location of Vitamin Ks Inhibitable 125I-TLD Binding Bands
Breeding
pair
designation
2

13
3

10

b

£

B <r*

Litter I
V*

(1 ,2 )

(2 )

2 x

(2 )

1 X (1 ,2 )
2 x (2 )

(2 )

(2 )

1 x

(0 )

1 X

(2 )

(1 ,2 )

(0)

1

x(0)

1

x

1 X

(1 ,2 )

(1 )

(1 ,2 )

(1 )

1 X (1 )

(2 )

(1 )

1 X (1 ,2 )
1 x (2 )

11

(1 )

(0 )

1 x
1 x

(1 ,2 )
(0 )

1 X (1 )
1 X (0)

12

(1 ,2 )

(1 ,2 )

1 x

(1 ,2 )

1 X (0 )
1 X (1 ,2 )

6

Litter II
£

*

1 X (0 )

3 x
1 x
1 x

(2 )
(0 )
(2 )

4 x (0)

1 x

(0 )

2 x

4 x
1 x

(0 )

2

15

a)

(

(1 )

(1 ,2 )

1 x
1 x

(2 ).
(1 )

1 X

(0 )

2 x

(1 ,2 )

3

x

2 x

(0 )
(1 )
x (1 ,2 )
(1 ,2 )
(2 )

) — means pattern of vitamin Ks inhibitable band.
0

— means no Ks/TLD ratio <_ 0.5 in any "DM" region.

1> 2, 3 — means Ks/TLD ratio £ 0.5 in DM1, DM2, or DM3 regions, respectively.
2 x — means 2 mice with same pattern.

in
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of different individual Balb/c mice varied.

This was partly due to con-

centration differences of immunoglobulins in each
By measuring the change in

125

125

I-TLD binding band.

I-TLD binding band intensity in gels that

were incubated with vitamin Ks, three sets of vitamin Ks inhibitable
125

I-TLD binding bands were detected.

Hot all Balb/c mice contained

all three bands, but most mouse sera had at least one of these bands.
Not enough mice were mated and surveyed for the presence of these
double binding spectrotypes for any conclusions to be reached regarding
a hypothesis that genetic differences may exist among the Balb/c mice
which could account for the varied expression of immunoglobulin clonal
products observed.

One major limitation of the analytical isoelectric

focusing technique is that immunoglobulins that are cross-linked inside
the polyacrylamide gels cannot have their idiotypes and isotypes detected
directly by autoradiography.

Thus while the analytical isoelectric

focusing gel technique provides a rapid screening method for the presence
of particular antigen binding antibodies with a specific isoelectric
point(s), other techniques are required to isolate the immunoglobulins
for further characterization.
Below it is shown that the analytical isoelectric focusing technique
may be used to detect RNase and DNP double binding immunoglobulins
that are preferentially induced by the sequential immunization of RNase
and DNP-BGG.
C.

The Pattern Analysis of the Serum of Balb/c Mice Imramunized
Sequentially with RNase and DNP-BGG

A second immunization protocol resulting in the referential induc
tion of multispecific antibodies is the RNase - DNP system.

A spectro-

type analysis similar to that described above for mice immunized by the

JL.
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DM protocol was performed to induce antibodies that bind DNP and
RNase.

Balb/c mice were sequentially immunized by RNase on day 0,

then with DNP-BGG on day 30, and bled on day 40.

Analytical isoelectric

focusing in polyacrylamide gels as performed with this "RD" serum.
The gels were incubated with either
While the intensities of each

125

125

I-TLD or

125

I-labeled RNase.

I-TLD binding bands varied from mouse to

mouse after a two day film exposure, the banding patterns of the different
mice resemble each other more after a 30 day incubation.
produce detectable

125

I-TLD or

125

Many sera did not

I-labeled RNase binding patterns

at all or in parts of the pH gradient.

For example in Figure 26, no

125

I-

TLD binding bands are found in serum #2 even after a 30 day film expo
sure.

More bands are seen in the 30 day film of #3 and #4 sera compared

to the two day film.
For the purposes of analysis, either antigen can be iodinated and
used as the labeled probe for double binding immunoglobulins.

Figure

27a shows that non-radioactive RNase can inhibit the binding of
in the analytical isoelectric focusing gel of RD serum.

125

I-TLD

Clearly peaks

1, 2, and 3 are DNP and RNase double binding bands, while 4 through 10
are not.

Similarly Figure 27b shows that DNP-caproic acid can inhibit

the binding of

125

I-labeled RNase by the same RD serum after it had been

subjected to isoelectric focusing in an analytical gel.
7 have their binding of RNase inhibited by 10

-4

Bands 1, 2, and

M DNP-caproic acid.

Work is in progress to characterize the RNase and DNP multispeci
fic immunoglobulins in the analytical isoelectric focusing gels.
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F IG U R E 2 6

A Comparison Of A 2 Day and 30 Day Film Exposure of "RD" Sera Subjected
To Analytical Isoelectric Focusing

albumin/

-

2 day fj|m
exposure

6.0 -

.#

. 3 0 day film
exposure

Analytical isoelectric focusing, gel processing, and autoradiography
were performed as described in MATERIALS AND METHODS.
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(a)

_4
FIGURE 27
1 x 10 M DNP-caproic acid inhibition of
in sera of "RD" immunized mice.
pH 55 5.6 5 7 585 6.0 6.2 6.4 6-5 6 6

1125,

.

I-RNase binding bands
68

6^9 7^1

I'RNase

I
N
T
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T
Y
fcrbltrcry
units)

/
' 125l-RNcse
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\
\V

DNP-caprocte A

10 M RNase inhibition of
immunized mice.

albumin

125

I-TLD binding bands in sera of "RD'

125I-7ID
3 \4
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DISCUSSION
The mechanisms of the expression and inheritance of immunoglobulin
genes are still one of the great problems in immunology.

The large

number of different antibodies that bind the same antigens and which are
simultaneously induced in an immune response precludes the use of amino
acid sequences as a means of identifying immunoglobulin gene products in
the sera of individual mice.

The purpose of this thesis is to develop a

series of V-region markers which may be used to detect individual immuno
globulin gene products in serum.

The identification of V-region deter

minants in serum was established in two ways:

a) an idiotypic approach

in which immunoglobulins were identified by their interactions with an
antiserum directed against the combining region determinants of a reference
myeloma protein that binds the same antigens as the naturally raised
immunoglobulins; and b) a fine specificity approach in which double
binding antibodies were induced by the sequential immunization with two
antigens and the double binding immunoglobulins were identified by their
isoelectric focusing patterns in polyacrylamide gels.
The anti-DNP response of mice was selected for analysis for a number
of reasons including:

a) many techniques have been developed to produce

antigens and haptens that contain the DNP moiety (41) ; b) many DNP
binding antibodies have been demonstrated to bind more than one hapten
(168); c) many Balb/c myeloma proteins have been shown to bind DNP (173,
104); d) much work has been performed to analyze the cellular interactions
required for an anti-DNP response to occur (50); and e) while much work
(38, 47, 112, 158) has been performed to characterize the DNP binding
properties of all the antibodies present in the anti-DNP sera, little work
(133) has been performed to characterize the
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expression and inheritance of individual V-region gene products in this
complex immune response.

By studying the validity of using either

the isoelectric focusing approach or the idiotypic approach to analyze
the anti-DNP response in mice, a basis for understanding the inheritance
of particular V-region gene products in this response was obtained.
For the idiotypic approach, the rabbit anti-idiotypic antibodies
directed to the combining regions of proteins 315 and 460 were isolated
and characterized.

Proteins 315 and 460 are two IgA Balb/c myeloma pro

teins that bind the haptens, DNP and menadione, and are probably two
of the most extensively studied mouse myeloma proteins (12, 35, 39, 55,
62, 84, 155, 163, 173, 174).

The anti-idiotypic antibodies directed

to these proteins were then used as reagents for the detection of "idiotype positive" immunoglobulins in mice.

In the fine specificity-iso

electric focusing approach, the isoelectric focusing patterns of DNP and
menadione (DM) and RNase and DNP (RD) double binding immunoglobulins
were characterized.

Below will be discussed the major findings of these

studies based upon both approaches and the merits of using either approach
to study an immune response.
A.

The Idiotypic Approach

The two major thrusts of the investigations presented in this thesis
were:

a) to understand to which determinants the anti-idiotypic anti

bodies to proteins 315 and 460 were directed and to understand how
changes in the immunoglobulin molecules affect the detection of the
idiotypic determinants by these antisera; and b) to use these antiidiotypic reagents as markers for V-region gene products in sera.

The

idiotype of an immunoglobulin molecule is detected by its interaction
with anti-idiotypic antibodies.

Idiotypic determinants are most probably
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those residues exposed to the surface of an immunoglobulin.

The expre

ssion of idiotypic determinants is therefore both a function of the
primary sequence and tertiary structure of the V-region of an immuno
globulin.
Anti-idiotypic sera are like most antisera in being composed of many
different antibodies that recognize various determinants of the reference
proteins to which the antisera were made.

To limit the heterogeneity

of the population of anti-idiotypic antibodies used in these studies, the
hapten elution method of Claflin and Davie (23, 25) was employed.

This

enabled the isolation of combining region complementary anti-idiotypic
antibodies to proteins 315 and 460.

Both reference myeloma proteins

315 and 460 bind DNP and menadione.

Compared to the amount of combining

region complementary anti-idiotypic antibodies eluted by vitamin Ks
and DNP-glycine, an equivalent concentration of t-boc-glycine eluted
negligible amounts of anti-idiotypic antibodies.

This shows that the

anti-idiotypic antibodies eluted with specific haptens compete with
the hapten for binding to the combining region.
Anti-315 and anti-460 idiotypic antibodies purified by the hapten
elution method have the following properties:

a) they do not compete

with anti-a serum for the reference myeloma proteins 315 (a, X) and 460
(a,

k );

also, b) they do not bind to other myeloma proteins, even with

the same H and L chain isotypes as the reference proteins (Figures 4 and
5).

The strongest evidence that these antibodies are indeed directed

against the V-regions of the reference proteins is the demonstration
that hapten could inhibit the antibodies binding to the reference mye
loma proteins.

Additional evidence of the antibodies/ idiotypic speci

ficity is that of the six DNP binding myeloma proteins surveyed (315,
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Pf

460, S23, J604, XRPC25, 195), only three interacted with the hapten
eluted antisera (315, 360, S23).
It should be emphasized that only twelve myeloma proteins* were
surveyed in this thesis.
known myeloma proteins.

This represents a very small sample of the
It is not known if hundreds of myeloma proteins

are surveyed whether "idiotype" positive proteins will be found that do
not have the same antigen speicificity as proteins 315 and 460.

How

ever, evidence has been presented that the antisera to proteins 315 and
460 can also bind to immunoglobulins in Balb/c sera that bind both D N P '
and menadione, the same antigen that the reference proteins do.

Further

more, both DNP and menadione containing antigens are able to induce these
"idiotype positive" immunoglobulins.

Like proteins 315 and 460, the idio
O
type positive immunoglobulins require at least a 22 A spacer between the
carrier and the menadione moiety before the antigen can induce idio
type positive immunoglobulins (Table 14) and before the antigen can be

bound by these idiotype positive immunoglobulins (Tables 16, 17).
In addition, it has been found that the vitamin Ks eluted antiidiotypic antibodies from a protein 315-Sepfearose column are a subset of
those anti-idiotypic antobidies that DNP-glycine elutes.

The yield

of vitamin Ks eluted antibodies is half that of DNP-glycine eluted
antibodies.

Furthermore, while DNP-glycine can elute immunoglobulin

from a column previously treated with vitamin Ks, vitamin Ks is unable
to elute antibodies from a column previously treated with DNP-glycine
(Table 8).
nity (145).

Both haptens are bound by protein 315 with the same affi
The anti-idiotypic antibodies which are eluted by DNP-gly

cine have their binding to protein 315 inhibited by both DNP-glycine and
* Proteins 315, 460, S23, 603, XRPC25, UPC10, T15, S194, 104c, 195,
FL0PC21, J604.
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vitamin Ks (Table 9).

Similarly, the vitamin Ks eluted anti-idiotypic

antibodies have their binding to protein 315 inhibited by either hapten.
Rosenstein and Richards (145) have demonstrated that DNP and menadione
moieties are bound at spatially separated sites of the combining region
O
of protein 315. The naphthoquinone rin^ is bound about 10 A "deeper"
from the surface of the molecule than DNP.

The haptens probably inhibit

the binding of anti-idiotypic antobidies by:

a) causing a change in the

V-region so that certain amino acid residues are no longer exposed to
the anti-idiotypic antibodies; or b) by competing with the hapten for
"site" specific residues.

No anti-idiotypic antibodies were eluted by

vitamin Ks from a column previously treated with DNP-glycine (Table 8).
This demonstrates that negligible anti-idiotypic antibodies to protein
315 recognize parts of the combining region for vitamin Ks, exclusive
of those parts involved with DNP-glycine binding.

Since the amino acid

residues to which the anti-idiotypic antibodies are directed are not
yet known, the reason why vitamin Ks elutes a subset of the anti-idio
typic antibodies that DNP-glycine elutes remains speculative.
As in other antigen-antibody systems, notably the p-azophenylarsonate (ARS) (99, 167), £(2-*l) levan (110, 173), and a(l->3) dextran (60,
61, 170, 173) idiotypic systems, the anti-idiotypic antibodies to pro
teins 315 and 460 could be classified into public and private anti-idio
typic specificities.

In this thesis, this classification was based on

a survey of only twelve myeloma proteins.

The "public" anti-idiotypic

antibodies to proteins 315 and 460 produced identical inhibition curves
with proteins 460, S23, and 315, and with a sub-population of DNP
binding antibodies from any mouse strain tested (Figures 5, 11).

Further

more, by chain recombination experiments between the public idiotype
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positive protein 315 and the public idiotype negative protein 603, the
residues which constitute the idiotypic determinants were shown to
reside only on the H chain of immunoglobulins (Table 10).

While there

is an absolute requirement of a L chain for the expression of the public
idiotype, the type of L chain (from proteins 603 or 315) did not affect
this expression.
S23 (a,

k ),

The fact that proteins 315 (a, X), 460 (a,

k ),

and

which contain completely different L chains (Table 24),

gave identical inhibition curves in a RIA that measured the binding of
125

I-Fab of 315 or 460 to the public anti-idiotypic antibodies also

shows that the L chain does not affect the expression of the H chainrelated public determinants (Figure 5).
The public idiotype positive 315U-603T chain recombinants did not
n.

bind hapten.

L

Here, the expression of the public idiotype was not

dependent upon a functionally intact combining region for DNP.
Table 24 is a comparison of the H and L chain N-terminal sequences
of proteins 460, 315, and S23.

The L chains of the three myeloma pro

teins are markedly different in sequence.

The H chains of these pro

teins, however, are very similar and are members of the V
(88).

HI

subgroup

The H chain sequences for proteins S23 and 460 are identical for

at least the first 20 amino acid residues.

(The H chains of proteins

S23 and 460 have only the first 20 and 40 N-terminal amino acids
sequenced, respectively).

The sequence of the H chain of protein 315

differs from proteins 460 and S23 by only 4 amino acid residues within
the first 20 amino acids.

Proteins 315 and 460 differ by an addi

tional 6 amino acid residues within the next 20 amino acid sequences.
Based on these sequence similarities in the first 20 N-terminal amino
acids of these three myeloma proteins, it is not surprising that these
f\;; V
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TABLE 2 4

A Comparison of the Amino Acid Sequences
of Proteins S23, 460, and 315.
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

Heavy Chain:
315
460
S23

asp val gin leu gin glu ser giy pro giy leu val lys pro ser
glu val gin leu gin glu ser giy pro ser leu val lys pro ser
glu val gin leu gin glu ser giy pro ser leu val lys pro ser

Light Chain:
315
460
S23

leu thr thr ser pro
pea ala val val thr glu glu ser ala
asp val val met thr gin thr pro leu ser leu thr val ser pro
asp ile val leu thr gin ser pro ala thr leu ser val thr pro
16

17

18

19

20

21

22

23

24

25

26

27 27A 27B 27C

Heavy Chain:
315
460
S23

gin ser leu ser leu thr cys ser val thr giy tyr
thr leu ser leu
giy ser
gin thr leu ser leu

Light Chain:
315
460
S23

leu thr cys arg ser ser thr
giy giy thr
ala
ser
ile ser cys arg ser ser gin leu val
giy asp
giy asp ser val ser leu ser cys
27D 27E 27F 28

29

30

31

32

33

34

35

36

37

38

Heavy Chain:
315
460

ser ile thr ser giy tyr Phe tr£ asn
asx ile thr asn giy tyr met asx

Light Chain:
315
giy ala val
460
ser

thr thr ser asn tyr ala asn trp ile glx glx
thr asx giy asx tyr leu his trp tyr leu glx

trp
trp

Sequences were obtained from Kabat et AL (88). The residues underlined
are those which differ from the sequences in the other myeloma proteins1
chains.

*
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proteins share common antigenic determinants.

However, the hard

conclusion that the first 20 amino acid residues contribute the deter
minants that the public anti-idiotypic antibodies recognizes must await
further data.
The public anti-idiotypic antibodies were also used as V-region
markers in the study of the expression and inheritance of mouse immuno
globulins that were bound by these antibodies.

Inbred strains of mice

were employed because each individual of a strain has the same genetic
composition.

The different traits among the various strains were deri

ved by segregation from a common gene pool over many generations.

Thus

differences in expression of immunoglobulin gene products between two
individuals of different strains could reflect genetic differences in
structural or regulatory genes.

The public idiotypic determinants are

present in all inbred strains tested including strains that are separated
from a common ancestor by at least a hundred generations (Table 12).
This implies either that a common V-region with this public idiotypic
marker is maintained in these strains or that more than one V-region
structure in DNP binding antibodies gives an identical interaction with
the public anti-idiotypic antibodies.

While it was shown that some

natural DNP binding antibodies have the public idiotype, it is not
known whether all public idiotype positive immunoglobulins bind DNP.
Even though the public idiotype can be found in all mouse strains,
individual strains do not produce after immunization the same concentra
tion of immunoglobulins that have the public idiotype (Table 12).
more, this determinant can be found only in mouse sera.

Further

The public

idiotypic determinants are not detected in rabbit and guinea pig antiDNP sera.

This suggests that in all strains of mice tested some of the
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DNP binding immunoglobulins are part of a family of related V-region
structures that are different from that of rabbit and guinea pig DNP
binding immunoglobulins.

These results are very similar to those of

Claflin and Davie (22, 23, 24) who developed an anti-idiotypic serum
to the phosphorylcholine binding mouse myeloma protein HOPC 8.

Their

antiserum bound to anti-phosphorylcholine antibodies from other rodents.
In addition to antibodies with public anti-idiotypic specificities,
antibodies directed to private idiotypic determinants of proteins 315
and 460 were isolated.

Public and idiotypic determinants can be found

on many immunoglobulins with the same antigenic specificities, while
private idiotypic determinants are found only on a few or just one
immunoglobulin.

In most studies including this one, the number of

myeloma proteins tested was limited.

As discussed in the INTRODUCTION,

the induction of tumors is not a random process.

Thus the scoring of a

determinant as "private" or "public" is a reflection of the skewed popu
lation of hapten binding myeloma proteins surveyed by the anti-idiotypic
serum.

This classification into private and public idiotypic determinants,

however, may have some validity since in the case of the f3(2-KL) levan
(110), ct(l->-3) dextran (136), ARS (167), and DNP idiotypic systems, more
immunoglobulins bear public than private idiotypic markers in an immune
response.
What is implied when two immunoglobulins that bind the same antigens
are determined not to share the same private idiotypic determinants?

The

expression of idiotypic determinants is dependent upon the presence of
certain residues on the surface of the immunoglobulin.
tion of both amino acid sequence and tertiary structure.

This is a func
A protein may

contain the primary structure for an idiotypic determinant, but lack
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the appropriate conformation for its expression.

In this study, both

the private 315 and private 460 idiotypic markers were shown to be
located on the H chain, but their expression was found to be modulated
by the L chain.

Protein S23 is an example of this point.

The L chain

of this immunoglobulin has a completely different sequence from the L
chain of protein 460.

The H chain sequence of both immunoglobulins

are identical for at least the first 20 amino acid residues.

Native

protein S23 does not interact with the private 460 anti-idiotypic anti
bodies.

The H chain of S23 in combination with the 460 L chain does

interact with the private 460 anti-idiotypic antibodies in an identical
manner to that of native protein 460 (Figure 9).

Furthermore, the L

chain of S23 can alter the expression of the private 460 idiotypic deter
minants in the 460„-315
ri

L

chain recombinant (Figure 9).

It is therefore

clear that the absence or alteration of an interaction of a given immuno
globulin with the private 460 or pirvate 315 anti-idiotypic antibodies
does not rule out the presence of the amino acid sequences responsible
for those determinants recognized by these antibodies.

Since the public

idiotypic determinants are not dependent on the type of L chain for
their expression (Table 10, Figure 5), the absence of an interaction
with the public anti-idiotypic antibodies implies that the heavy chain
structure required for that idiotype is not present.
The two techniques commonly employed to measure idiotypic deter
minants are RIAs and hemagglutination inhibition assays.

The RIA con

veys three essential pieces of information about the nature of the
interaction between the antigen and the antibody:

a) the shape of the

inhibition curve is a test of the antigenic identity of two antigens;
b) the position of the curve (50% inhibition point) is a measure of the
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quantity of antigen present; and c) the extent of inhibition seen with
a competitive antigen is a measure of the amount of antibodies that
recognize common determinants between the radioactively labeled anti
gen and the competitive antigen.

These studies demonstrated the impor

tance of using a RIA to measure antibody-anti-idiotypic antibody inter
actions.

If only a hemagglutination inhibition assay is used, no informa

tion about the qualitative nature of the interactions between the antiidiotypic antibodies and the recombinant molecules can be determined.
For example, by using the private 460 anti-idiotypic antibodies in a
hemagglutination inhibition assay, the titer of the 460-315
ri

L

chain

recombinant molecule would be four times lower than that of an equimolar solution of native protein 460 and of the homologous chain recom
binant of protein 460.
either:

These lower titers would then be attributed

a) to the "denaturation" of the combining region during the

process of chain recombination so that less "intact" V-regions are
present that are bound by the anti-idiotypic antibodies; or b) to the
formation of new combining region structures that interact differently
with the anti-idiotypic antibodies than the combining region determinants
of the native proteins do with the anti-idiotypic antibodies.

By RIA,

it is observed that the shapes of the inhibition curves are different
between native protein 460 and the chain recombinant, 460„-315T .
ri

the latter possibility (b) is the most likely explanation.

L

Thus

If a percentage

of the reconstituted 7S molecules were denatured and no new "idiotype
positive" structures are formed (possibility "a"), the shape of the
inhibition curves would be identical to that of the native protein but
the curve should be displaced to higher concentrations.

This in fact

was observed with the solutions of the DNP-affinity labeled preparations
of proteins 315 and 460 (page97).
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Manjula et al. (119) assayed the chain recombinants of the B(l->6)
galactan binding mouse myeloma proteins for their ability to bind hap
ten and to interact with anti-idiotypic sera.

A hemagglutination

inhibition assay was employed to test the chain recombinants for idio
type.

Most of the chain recombinants were shown to be bound by the

antiserum.

Because a hemagglutination inhibition assay only detects

the binding of antigen by antibody, nothing can be concluded about
the nature of the binding detected in this study.

From this study it

is not known how antigenically similar the idiotypic determinants of
the V-regions of the recombinant immunoglobulins are to the original
molecules, even though the recombinants still bind hapten.

In Figure

9, the 460U-315T chain recombinant is shown to be antigenically different
n

L

from the 460„-460T chain recombinant, even though both still bind
ri

L

DNP-glycine (Table 11).
Huser jet al. (70) employed a RIA to determine whether chain recom
binants of various rabbit anti-pneumococcal antibodies retained their
idiotypic determinants.

In this case, the recombinant molecules either

have an identically shaped inhibition curve or they were not bound by
the antiserum.

By employing a RIA, Carson and Weigert (19) were able

to conclude that a(1-K3) dextran binding mouse myeloma proteins, J558
and M104e were antigenically dissimilar, but they were bound by the
same anti-idiotypic antibodies.
In an earlier study, Bridges and Little (11) observed that the
homologous chain recombinants of protein 315 and 460 retained their
affinity for DNP-lysine.

They showed that the 460„-315T recombinant
ri

L

has an affinity for DNP-lysine about the same as the native protein,
but the 315-460, recombinant has a binding constant for DNP-lysine
ri

L
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at least two orders of magnitude lower than native protein 315.

Results

obtained by equilibrium dialysis to calculate the binding constant and
number of sites per molecule for the protein 315-460 chain recombinants
presented in this thesis agree with that of Bridges and Little (11)
except that the binding constant of the 460„-315T recombinant was oneri

tenth their value.

L

The reason is not clear for this difference in

binding constants between these two studies.

No example could be

found of an immunoglobulin molecule that possesses the private 315 or
private 460 idiotypic marker, but lacked a functionally intact combining
region.
Having developed two sets of private anti-idiotypic antibodies,
they were then used to survey inbred mouse strains for the presence of
immunoglobulins possessing V-regions that are marked by these antibodies
The results of this survey must be interpreted in light of the effect
of the L chain on the expression of these private 460 and private 315
idiotypic markers.

No mouse strain tested produced immunoglobulins

that were bound by the private 315 anti-idiotypic serum.
interaction may be due to:

This lack of

a) the absence of the structural genes for

the idiotype positive V-regions; b) the immunization protocols were
unable to induce these idiotype positive V-regions; or c) the masking
of these idiotype positive residues by the presence of the "wrong" L
chain as in the 46CL-S23, chain recombinant (Figure 9).
ri
L

A series of

experiments are in progress to rule out the third possibility (c) by
making H and L chain recombinants between mouse immunoglobulins and
protein 315.

Conceivably, a recombinant molecule between the H chain

of mouse immunoglobulins and the \ chain of protein 315 may possess the
private 315 idiotype.

This result would then be analogous to the find

ing of Jack jjlt a l . (77) that SJL (Ig-1^) mice lack the heteroclitic anti
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NP response which other mice with the Ig-1

allotype can make.

This is

so because SJL mice may not contain the genetic information for the X
chain needed for these antibodies.
(Ig-l

The FI offspring of an SJL and Balb/c

) mating are able to make the heteroclitic anti-NP antibodies.

Presumably the Balb/c parent provides the information for the X chain
and the SJL parent provides the information for the H chain of the
heteroclitic anti-NP response.

In this thesis an analogous experiment with

anti-DNP serum from the offspring of a C57BL x Balb/c mating were tested
for the presence of the private 315 idiotype.

No serum from the off

spring was found to contain this private 315 marker.

Thus the private

315 idiotypic determinants on the H chain were either not expressed in
these mice or they were masked by the L chain.

The chain recombination

experiments described above should rule out one of these possibilities.
In contrast to the results obtained with the private 315 idiotype,
all strains of mice tested produce some immunoglobulins in their antiDNP response that are bound by the private anti-460 idiotypic serum.
Such immunoglobulins were mostly of the yl, p, and a isotypes, although
some immunoglobulins with the y2a and the y2b isotypes could be detected
(Figure 12).

The shapes of the inhibition curves obtained by RIA, how

ever, distinguished the 460-like immunoglobulins of mice into two
groups:

a) those immunoglobulins from strains that possess the Balb/c H

chain immunoglobulin genes (the Ig-1

locus); and b) immunoglobulins

from strains that have all other H chain loci (except BAB 14 which
possesses part of the genome for the V-regions of the H chains of Balb/c
mice).

It is clear from Figure 13 that immunoglobulins from Ig-la+ posi

tive mice in RIAs that measure the private. 460 idiotypes produce better
inhibition than immunoglobulins from other mice.

The shape of the
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inhibition curve of immunoglobulins from these Ig-1

cirH

positive strains

is not identical to that of protein 460 and it resembles that of the
460„-315t chain recombinant (Figure 9).
H
L
tent with two possibilities:

The reason for this is consis-

a) in mice the "wrong" light chain is

paired with the "right" heavy chain containing the amino acid sequences
both which are identical to part of protein 460 and which the anti-idiotypic serum recognizes; or b) different idiotypic determinants in the H
and L chains of the mouse immunoglobulins are present compared to protein
460.

In the initial studies presented in this thesis, by testing the

anti-DNP sera from recombinant inbred strains (Table 12) and from the
offspring of the FI and F2 matings of the C57BL and Balb/c mice for the
private 460-like idiotypic determinants (Figure 14), this Ig-1

ct’t’

idiotype appears to be inherited as an autosomal dominant trait.
matings between Ig-1

ct*i"

linked
More

positive and negative strains are being performed

to confirm this finding.
The results clearly show that the 460-like immunoglobulins from the
Ig-1

positive strains differ from those of the non-Ig-1

3ri~

strains.

The simplest explanation for this is that the V-region sequences of the
H chains are different.

The apparent linkage of the 460-like inhibi

tion curves to an H chain allotypic marker supports this explanation;
however, it is also possible that differences in the L chains modify the
expression of the same idiotype determining residues of the H chain
of the immunoglobulins of different strains.

As summarized in Tables

3, 4, and 5, other V-region markers have been shown to be linked to the
I

H.chain allotypic loci of mice.

Work is in progress to perform chain

recombination experiments between protein 460 DNP binding immunoglobulins from non-Ig-1

mice to determine whether 460-like H chain deter-

b
J
L
^
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ainants were not detected because of the absence of the "right" L chain.
In Balb/c mice, the majority of immunoglobulins with the 460-like
Idiotypes bind DNP and menadione, but not all of these immunoglobulins
possess both the public and private 460-like determinants.
presented in this thesis show:

The data

a) a difference in the kinetics of

induction of the public and private idiotypic markers in the sera of
mice immunized with DNP; b) a difference in the H chain isotype distri
bution of immunoglobulins with the public idiotype (mostly yl, a, y with
a minor fraction that is y2a and y2b) and with the private idiotype
(mostly yl, y2a, y and a minor fraction that is a) ; and c) the isola
tion by preparative isoelectric focusing (Figure 16) of two DNP and mena
dione binding Balb/c immunoglobulins; an IgA, which contains both public
and private 460 idiotypes, and an IgGI, which contains only the private
460 idiotypes.

The immunoglobulin A resembles myeloma protein 460 by

having an identical isoelectric focusing point and by being able to be
labeled by

3
H-DNP-azide.

DNP-azide has been demonstrated to react with

two tyrosine residues of the V-region of the H chain of protein 460 as
well as with an unidentified residue of the L chain (184).

Since the

residues that determine the public and private 460-like idiotypic markers
are not known, it is not yet clear if the ability to be affinity labeled
by DNP-azide is related to the residues that are recognized by these
anti-idiotypic antibodies.

Work is in progress to further characterize

these yl and a chain containing idiotype positive immunoglobulins.
Having shown that the anti-idiotypic reagents may be used to study
the expression of V-region gene products in sera, these antibodies were
then employed to detect the public idiotypic determinants on the surface
of splenic lymphocytes.

This was done in an effort to link the expres-
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sion of specific V-regions in serum with the cellular processes involved
with immunoglobulin production.

As shown in Table 18, 1.5%. of normal

splenic lymphocytes from unimmunized mice (12 week old) possess
public 460-like idiotypic markers on their surface.

After the sequential

injection with DNP-BGG and Men-BGG by the "DM" protocol, the,number of
idiotype positive lymphocytes increases to 17%.

The results presented

In Table 18 also show that Fc-receptors are not playing a role in the
fluorescent staining of the splenic lymphocytes.

The fact that the

number of the idiotype positive lymphocytes increases with DNP-BGG
immunization implies that the idiotype positive cell surface markers
reflect a change in the lymphocyte composition of the spleen in response
to antigenic challenge.

The idiotype positive surface markers were not

isolated and the marker’s antigen binding activity was not determined
in this experiment.

It is conceivable that proteins other than the V-

•regions of immunoglobulins may contain structures that may be bound by
the-public anti-idiotypic antibodies.
ment for two reasons:

This is not likely in this experi

a) the public anti-idiotypic antibodies have

already been shown to recognize DNP and menadione binding immunoglobu
lins in the serum of these immunized mice; and b) it is unlikely that
-lymphocytes which possess non-DNP combining region determinants and
which are also "idiotype positive" are stimulated by the DNP-BGG
-immunization.
- r

- -

..

xhe fractionation of splenic lymphocytes into enriched T and B

cell subsets by nylon wool adherence (85) (Table 18) failed to demon
strate public idiotypic determinants on the surface of the enriched T
cell fraction (the non-adherent fraction).
not rule out the possibilities that:

This result, however, does

a) the density of idiotype posi-
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tive immunoglobulins on the T cell surface is so low that they cannot
be detected (for example, the la antigens cannot be detected by fluo
rescent labeling (161)); and/or b) some T cells are adherent to the
column and that these T cells include those with idiotypic determinants
on their surface.

It was determined that the nylon wool column enriched

the B cell fraction by 48% (from 48 to 71%, Table 18), yet the column
enriched the percentage of public idiotype bearing lymphocytes by 88%
(from 17 to 32%).

This difference suggests that a fraction of the nylon

wool adherent idiotype positive cells may in fact be T cells.
In conclusion, the idiotypic approach has been successful in purifying
three reagents (the private anti-315, the private anti-460, and the
public anti-315 and 460 idiotypic sera) that are complementary to the
combining regions of DNP and menadione binding immunoglobulins.

The

reagents were able to be used as probes to characterize sub-populations
of..DNP and menadione binding antibodies in an immune response.

No mouse

serum has been found that interacts with the private 315 anti-idiotypic
antibodies.

The public 315 and 460 anti-idiotypic antibodies were

shown to be species specific, i.e., all mouse strains contained DNP
binding immunoglobulins that have the public idiotype.

While all strains

contain immunoglobulins that are bound by the private 460 anti-idiotypic
antibodies, one private 460-like idiotypic determinant for the H chain
of DNP binding immunoglobulins is linked to the Ig-1
typic, locus.

H chain allo

This determinant(s) appears to be inherited as an autoso

mal dominant trait.
cyte.surface markers.

These reagents can also be employed to study lympho
-

.

Like most serological techniques the value of the idiotypic approach
is dependent upon how well defined the specificity of the anti-idiotypic
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reagents are.

Before antibodies may be used as probes for the unequi

vocal identification of an antigenic determinant(s), it must be estab
lished to what determinant(s) on the reference protein the antibodies
bind and whether the antibodies bind to determinants not found on the
reference protein.

In this thesis, the chains which contain the amino

acid residues to which the anti-idiotypic antibodies are directed were
determined.

The actual sequences were not determined.

The results of

the chain recombination experiments emphasize the importance of the RIA
in the detection of the antigenic identity between two "antigenic" pro
teins.

Like most immunoassays, the RIA measures the ability of the anti

bodies to bind to the antigens, but unlike most other assays the RIA
reveals the shape of the inhibition curve which provides a sensitive
indication of the antigenic identity between two proteins that are
bound by the same antibodies.

The results of the RIAs of the chain

recombination experiments demonstrates that the residues on the H chain
that are recognized by anti-idiotypic antibodies may not be "expressed"
if the chain is associated with the "wrong" chain.

Thus the absence of

a serological marker for the V-region of an immunoglobulin

does not

imply that the particular V-region sequences are not present.

After

having separated the anti-idiotypic antibodies into groups based on their
specificity (public and private) and after characterizing the specifici
ties of these antibodies, RIAs using these reagents were shown to be very
sensitive, highly specific, as well as, relatively easy to perform and
interpret.
The work presented in this thesis with the DNP binding myeloma
proteins helps to lay a foundation for future work with anti-idiotypic
antibodies to other antigen binding myeloma proteins and homogeneous
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antibodies a) by emphasizing the importance of the RIA in the interpre
tation of the quality of interaction between antibody and antigen; and
b) by demonstrating the effect of one immunoglobulin chain on the anti
genic expression of determinants on the other immunoglobulin chain.

As

demonstrated in this thesis, more than one immunoglobulin in a given serum
may contain idiotype positive determinants in their V-regions.

This means

that other techniques (such as isoelectric focusing) must be used to
characterize the proteins that are bound by the anti-idiotypic reagents.
Below are discussed the results and implications of the approach to
characterize DNP binding antibodies by isoelectric focusing and fine
antigen specificity analysis.
B.

The Fine Specificity and Spectrotype Analysis Approach

The antigenic specificity of an antibody is a function of the
structure of the combining region of the immunoglobulin.

The isoelectric

point of an immunoglobulin is a function of the charge of the amino acid
residues exposed to the surface of the entire molecule.

These two pro

perties of an immunoglobulin are not related to each other.

Thus a

technique that identifies both the isoelectric point and antigen speci
ficity of immunoglobulins should reduce the number of different anti
bodies in a complex immune response which have these properties.

In this

thesis, a foundation was layed for future investigations of double binding
immunoglobulins by their isoelectric focusing patterns in polyacrylamide
gels.
Most of the work described on the isoelectric focusing patterns of
multispecific immunoglobulins was performed before the results of the
idiotypic approach had been obtained and before Rosenstein and Richards
0
(145) had determined that a 22 A spacer between a solid support and mena-
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dione was required by proteins 315 and 460 for the binding of this
haptenic moiety.

Only later was it found out that despite the large

number of DNP binding antibodies that mice can make, most DNP and menadione
binding immunoglobulins have spatial requirements for the menadione moiety
similar to proteins 315 and 460.

This was determined by their ability

to precipitate only menadione containing antigens that have at least a
O
22 A spacer and by their binding only to menadione-Sepharose columns
O
with at least a 22 A spacer (Table 16). Thus as explained in the RESULTS
section (III.B.), the "wrong" antigen (Men-BGG) was employed to induce
menadione binding antibodies.

Furthermore, the "wrong" hapten (menadione

bisulfite) was employed to detect DNP and menadione double binding anti
bodies.

Menadione bisulfite was initially employed because of its high

solubility in aqueous buffer.

Only after hundreds of sera from "DM"

immunized mice had been analyzed had it been determined that vitamin Ks,
another highly soluble form of menadione, was a better hapten for the
detection of menadione binding immunoglobulins.

Thus most of the data

presented on the DNP-BGG and Men-BGG double immunized mice must be viewed
as preliminary.

Only the data from the vitamin Ks inhibited gels are

presented in this thesis.

Work is in progress to study the isoelectric

focusing patterns of the DNP and menadione binding immunoglobulins by
sequentially immunizing mice with the antigens, DNP-BGG and Men-SpacerBGG, and by detecting these double binding immunoglobulins by the vitamin
Ks inhibition of

125

I-TLD binding bands in isoelectric focusing poly

acrylamide gels.
Two different immunization protocols were employed to preferentially
induce double binding immunoglobulins in the early immune response:

the

"DM" protocol which consisted of the sequential injection of DNP-BGG and

if'"

t
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Men-BGG; and the "RD" protocol that involved the sequential injection of
RNase and DNP-BGG.
et

Previous studies by Varga et al. (168) and by Czaja

(20) have shown that significant amounts of double binding antibodies

could be raised by these protocols.
One fascinating finding of the isoelectric focusing pattern analysis
of sera from "DM" and "RD" immunized Balb/c mice was that the individual
mice of the same inbred strain produced different isoelectric focusing
banding patterns.

While it has long been known that not all mice from

highly inbred strains respond identically when antigenically challenged,
this result is still surprising.

Members of the same inbred strain of

mice should be genetically homogeneous.
many brother - sister matings.

Each strain was derived after

Theoretically immune responses of all the

Balb/c mice should be identical if they were all identically immunized.
Thus the differences of the antibody isoelectric focusing bands observed
among the different Balb/c mice might be due to:

a) environmental factors

not controlled for by the experiment (e.g. hormonal levels of the mice,
viral infections); b) heterogeneity in the population of the individual
mice for the genes that code for the immunoglobulin molecules or that
code for regulatory factors that affect the expression of individual
immunoglobulin genes; and/or c) "maternal suppression" (91), the ability
of a pregnant female to suppress the expression of particular clones
of antibodies in her offspring.
While all the Balb/c mice were immunized by the same batches of
antigens under the same conditions, it is possible that some non-controlled environmental factors affected the expression of specific immuno
globulin gene products.

One such factor was recently identified by

Dowsett e£ al. (173) who found that the IgGl and IgG2a concentrations in

ty
\!'P'
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female BAB 14 mice decrease during pregnancy.

This decrease is only

found in the BAB 14 strain and is not found in adult male BAB 14 mice
made pseudopregnant.

It is quite possible that other physiological

states in Balb/c mice affect the antigen responsiveness.
While environmental factors most likely determine the variation of
antigen responsiveness observed among highly inbred mice, another possible
source of variation is suggested by the provocative paper of Yamazaki
et al. (182).

These workers demonstrated that male mice preferentially

mate with female mice that have a different H-2 locus.

Apparently the

male mice are able to smell differences among females with different H-2
loci and the males tend to prefer the females with a non-identical H-2
locus linked odor.

According to this paper, since mice do not mate "at

random", but by odor preferentially endeavor to maintain a heterogeneous
composition of the genome of their offspring for certain loci (e.g. the
H-2 loci), it is quite possible that even after multiple generations of
inbreeding some genetic loci are still not homogeneous among the popu
lation of highly inbred mice.

The inbred mice were selected by criteria

that isolated mice with homogeneous loci in the major H-2 region; there
fore, it is doubtful that these highly inbred strains are heterogeneous
for this locus.

On the other hand, it is theoretically possible that

other non-H2 linked loci may be related to the factors involved with
mating preferences and also may be closely linked to genes that modulate
the immune response of mice (e.g. minor histocompatibility loci).

A

heterogeneous distribution of "minor" loci among individuals of highly
inbred strains could therefore also account for the differences in
immune responses observed.

Thus environmental and genetic determinants

could be factors for the heterogeneous

125

I—TLD and

125

I-RNase binding
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patterns observed in Balb/c mice.
Another possible source of variation of antigenic responsiveness
in inbred mice was suggested by Kindred and Roelants (91) who showed
that female mice immunized with TNP-BGG and DNP-BGG can suppress the antiDNP immune response of their offspring.

This suppression does not affect

all DNP binding immunoglobulins, but most DNP binding antibodies.

The

offspring's DNP binding isoelectric focusing patterns are highly restricted
and differ from one another.

"Maternal suppression" might therefore be

a source of the variable antigenic responsiveness observed among indivi
duals of the same inbred strain.
protocol, it was observed that the

In some early experiments with the "RD"
125

I-TLD binding patterns after iso

electric focusing of sera from certain offspring were greatly suppressed
compared to the parental patterns.

Later it was realized that these "non

responder" mice were the offspring of parents who had been previously
immunized by the "RD" protocol, suggesting that in this case "maternal
suppression may be operating.

Subsequently, all matings were performed

with unimmunized mice to avoid the "maternal suppressive" effect on the
offspring.
Another source of isoelectric focusing banding pattern differences
observed among the Balb/c mice is inherent to the analytical isoelectric
focusing technique employed to detect double binding immunoglobulins.
As explained in Appendix 2 and shown in Figures 21, 22, and 23, not all
hapten binding immunoglobulins are detectable under the conditions in
which the gels were processed and autoradiographed.
detect a band can be due to:

The inability to

a) insufficient quantity of immunoglobulins

present in the band; b) insufficiently high enough affinity of the immuno
globulins for the labeled hapten; and/or c) insufficiently high enough
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specific activity of the labeled hapten.
patterns of

125

I-TLD and

125

Thus variations in the banding

I-RNase binding immunoglobulins of indivi

duals of the same strain may in large part be due to concentration dif
ferences of the same immunoglobulins among the various mice.

These

points have already been discussed in section II.A. and II.B. of the
RESULTS.

The take home lesson is that the analytical isoelectric

focusing method cannot detect all immunoglobulins present and, therefore,
cannot rule out the presence of particular immunoglobulins in a given
serum sample.

Thus the usefulness of the analytical isoelectric focusing

pattern method is that of being a quick screening method for the presence
of immunoglobulins whose properties must be examined by other techniques.
Keck et al. (90) and Kreth and Williamson (98) were the first to
utilize this analytical isoelectric focusing technique for the detection
of individual antigen binding immunoglobulins.

Varga e£ al. (168) adapted

this technique for detecting DNP and RNase binding immunoglobulins.

These

workers did not demonstrate that the immunoglobulins whose double binding
specificity was detectable in the polyacrylamide gels actually represented
the binding activity of these immunoglobulins in solution.

B.N. Manjula

at Yale (pers. comm.) was able to show that proteins 315 and 460’s
affinities for DNP-lysine are unaffected by being cross-linked in the
polyacrylamide gel.

In this thesis, it was shown that, after iso

electric focusing and cross-linkage in the gel, the affinity of the
monomeric protein 315 for vitamin Ks is not affected (Figure 19).
the detection of vitamin Ks-inhibitable
inhibitable
125

125

125

Thus

I-TLD binding bands, of RNase-

I-TLD binding bands, and of DNP-caproic acid-inhibitable

I-RNase binding bands are not artifacts.

Since bands may contain more

than one immunoglobulin that binds the radioactive hapten, not all bands

I
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that contain double binding immunoglobulins may be detected.

Thus the

lack of observable inhibition by hapten does not rule out the presence
of a double binding immunoglobulin.
The immunoglobulin composition of each hapten binding band would
be better elucidated if the isotypic and idiotypic determinants of the
antibodies cross-linked inside the polyacrylamide gels could be determined.
Unfortunately to date all such efforts have been unsuccessful.

Until

such techniques are developed, the immunoglobulins from interesting
bands must be isolated by preparative isoelectric focusing which is both
very time consuming and costly in terms of the quantity of serum needed
for an analysis.

For example, the f>np<r*.+ivc

employs 100 to 250 pi of serum.

isoelectric focusing method

The maximum amount of serum isolatable

from a non-lethal bleed of a mouse is about 500 yl.

Thus any preparative

isoelectric focusing analysis greatly limits the number of experiments
that can be performed with a given sample of mouse serum.
Another difference between the preparative and analytical isoelectric
focusing techniques is that while all immunoglobulin species in mouse
sera are separated by preparative isoelectric focusing, the polyacrylamide
gel in the analytical technique excludes all non-monomeric immunoglobulins.
This means that the mixed population of immunoglobulins eluted from a
band after preparative isoelectric focusing may include many immuno
globulins not present in the antigen binding band observed in the analyt
ical gel.

For example, five of five bands eluted after the preparative

isoelectric focusing of an anti-DNP serum contained immunoglobulins with
more than one heavy chain isotype (page 166).
contained

125

Four of the five bands

I-TLD binding immunoglobulins restricted to one H chain

isotype and the immunoglobulins from these bands produced inhibition
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curves In phage inhibition assays that were consistent with the presence
of only one antigen binding specificity.

On the other hand, the fifth

band had immunoglobulins with more than one H chain isotype which bound
125

I-TLD.

The immunoglobulins from this band produced an inhibition

curve consistent with the presence of a mixture of DNP binding antibodies.
It is, therefore, not clear how the immunoglobulins eluted from preparative
isoelectric focusing relates to the

125

I-TLD binding bands observed after

analytical isoelectric focusing.
While the analytical isoelectric focusing method of detecting double
binding immunoglobulins did not use much mouse serum, the variable quality
of a given run often required the same serum sample to be processed two
or three times.

In the study presented in section II.B. of the RESULTS

(Figure 25 and Table 22), the data from 78 mice representing 11 other
litters had to be excluded because the poor quality of the gels precluded
their analysis with the densitometer.
a gel's quality were:

The two factors that mostly affect

a) the ’’age" of the iodinated hapten; and b) the

"cleanliness" of the carbon electrode.

A spotting pattern was often

observed on the autoradiograms of gels that were incubated with radioactive
haptens that had been iodinated and stored for more than ten days before
the gel was subjected to isoelectric focusing.
example of this spotting pattern.

Figure 20 shows a trivial

Often the spots obscurred the banding

pattern of the immunoglobulins, thus making the gels unsuitable for analy
sis.

If the carbon electrodes were not assiduously cleaned before each

isoelectric focusing run, the gel often developed unequal conductance
along its width.

This resulted in a non-parallel pH gradient along the

width of the gel and "warping" of the isoelectric patterns of the dif
ferent serum samples across the width of the gel.

The resulting auto-
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radiograms were unsuitable for analysis.
Provided that the appropriate precautions are taken, the analytical
isoelectric focusing technique provided a relatively fast technique for
screening multiple serum samples for the presence of particular double
binding immunoglobulins.

The radioactive hapten binding detected-in the

gels is. an accurate reflection of the binding affinity of the immuno
globulins cross-linked in the gel.
producible.

Furthermore, the technique is re

Identical isoelectric focusing patterns have been observed

for the same serum sample subjected twice to analysis with a year interval
between each sample's processing.

The weakness of the technique lies in

its inability in most instances to detect the very small quantities of
immunoglobulins that other techniques like RIA can.

Another weakness of

this procedure is that no technique has yet been developed for eluting
sufficient quantities of the immunoglobulins from the polyacrylamide gels
after isoelectric focusing which accurately reflects the antibody compo
sition of these bands.
In conclusion, the sequential immunization of mice with DNP and
menadione conjugated proteins and with RNase and DNP-BGG preferentially
stimulates double binding antibodies which may be detected by analytical
isoelectric focusing in polyacrylamide gels.

While these double binding

antibodies may be detected by this method, additional techniques are
required for the further characterization of the proteins that compose
interesting bands.

One curious finding has been that individual Balb/c

mice challenged by identical immunization protocols produce different
isoelectric focusing spectrotypes of hapten binding immunoglobulins.
This is partly due to concentration differences of each immunoglobulin
present in the sera of the various Balb/c mice.

The value of the analy-
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tical isoelectric focusing technique is that it provides a rapid screen
ing method for the presence of double binding immunoglobulins.

Undoubtedly

a combination of the analytical isoelectric focusing - fine specificity
approach and the idiotypic approach will enable the expression and inheri
tance of V-region gene products to be studied.

This thesis lays the

foundation for such studies.
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APPENDIX I
Below it is explained why the relationship
[DNP]^ q /[DNP]^,. = Ka3^5/Ka^6Q’ emPloyed in Figure 8 is valid.

[DNP]X

is the concentration of DNP-lysine which inhibits half of the binding of
myeloma protein X by the public anti-idiotypic antibodies.

K

is the
ci

affinity constant of myeloma protein X for DNP-lysine.
The binding constant, Ka, is defined as: Ka = S,/C-Sf; where S,
b

b

is the concentration of combining regions occupied by ligand and also the
concentration of ligands bound by antibody; where

is the concentra

tion of unoccupied combining regions; and c is the concentration of
unbound ligands.
Figure 8 represents a solid phase RIA which measured the binding
of

125

I-labeled Fab fragments of proteins 315 and 460 to public anti-315

idiotypic serum in the presence of various concentrations of DNP-lysine.
If the binding of ligand by the Fab fragments prevents the Fab fragments
from being bound by anti-idiotypic antibody, then at 50% binding of the
Fab by the anti-idiotypic antibody, half of the

125

I-labeled Fab frag

ments will have bound hapten.
Thus, S, = S., and
b
£
Ka = 1/c or Ka*c = 1.

Thus at 50% inhibition:

1 - Ka315-[DHP1315 = Kaw 0 -lrap]460, or
*

W

fc460 ’

As shown in Figure 8,
[DNP]^q/[DNP]^5 = 114 = 100 = ^

315/^460

(reference 145).

Thus the public anti-idiotypic antibodies are directed against combining
region determinants.

i
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A P P E N D IX I I

Below it is explained how an estimation of antibody concentration
and binding constant can be made based on the intensity of bands after
autoradiography.

The binding constant, Ka, is defined by the relation

ship :

§1

Ka = S / c - S
b
r

; where

is the concentration of binding sites filled by hapten and also the
concentration of hapten bound by antibody;
is the concentration of binding sites not filled by hapten; and
c is the concentration of hapten not bound by antibody.
Under the conditions in which the analytical isoelectric focusing
was performed only 7S immunoglobulin penetrated the gel.

It can be

assumed that these have two binding regions per immunoglobulin; therefore
the total concentration of antibody in the gel [x] is defined by:
[x] = (Sb + Sf)/2 or
Sr = 2*[x] - S, .
t
b

Therefore substituting in #1,

Ka = S,/c*(2*[x] -S.) or
b
b
#2

[x] = S,/(2-Ka-c)
b

+ S./2
b

can be estimated from the darkening of the autoradiographic film.
For example in Figure 21, it was estimated that a 1 x 6 mm filter
paper impregnated with 1800 cpm of
after a 2 day film exposure.

125

I produces a well defined band

Most antigen binding bands observed after

autoradiography have an average dimension of 1
2 mm thick.

about

The amount of radioactivity to produce a well defined band

after a 2 day film exposure would be about:
1200 cpm.

x 4 mm andthe gel is

2

2

(4 mm /6 mm ) *1800 cmp =

If this band represented the binding of

125

I-TLD in a typical

experiment in which 5 pi of serum was isoelectric focused, the gel would

212
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2X3

have been incubated with a 2 x 10
5 x 10

18

cpm/mole).

would be equivalent to 1200 cpm which is equi-

valent to 1200 cpm/8 mm
relationship #2;

-10
125
M solution of
I-TLD (sp. act.

3

8
—11
= 1.5 x 10 cpm/L = 3 x 10
M.

Substituting in

[x] = (3 x 10~1:LM)/(2-(2 x 10_10M)-Ka)

or [x] = (7.5 x 10“2)/Ka
then (7.5 x 10-2)/Ka »

+

1.5 x 10-11M.

1.5 x 10_11M.

+ (3 x 10_11M)/2,

If Ka is less than 1012M_1

Thus

#3 [x] = (7.5 x 10-2)/Ka.
But [x] is the concentration of antibody in the gel.

To determine

the initial concentration of antibody in the serum ([Ab]):
[Ab]•(serum volume) = [x]•(gel volume); or
[Ab] = [x]*(gel volume)/(serum volume) =
([(7.5 x 10 2)/Ka]*8 yl)/5 yl or
#4

[Ab] = 0.12/Ka.

Thus for an analytical

isoelectric focusing gel in which 5 yl of serum is

processed, a given intensity of atuoradiographic film may be produced by
a wide range of antibody concentrations depending on the binding constant
of that antibody for the labeled hapten,

125

I-TLD.

Based on the above calculations, below is listed the concentrations of
immunoglobulins that must be present in the
defined band after a 2

mouse serum to

produce a well

day film exposure if the antibodies have a parti-

cular binding constant for

125

I-TLD:
[Ab] (yg/ml)
1800
180

6

10

7

10

18

1.8
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It should be noted that both proteins 315 and 460 bind TLD with a
lower Ka than they do DNP-lysine.

For example, the Ka^,. for TLD is

7 x 10^M ^ (as determined by equilibrium dialysis), while for DNPlysine is 6 x 1 0 ^ - 1 (as determined by both equilibrium dialysis and
fluoresent quenching).

According to the above, a solution of protein 315

should have between 18 and 180 yg/ml for 5 yl to be subjected to isoelectric
focusing and produce a well defined
film exposure.

125

I-TLD binding band after a 2 day

In Figure 19, 5 yl of a 5 mg/ml solution of monomeric

protein 315 produced five major bands and many minor bands after analytical
isoelectric focusing with the gel being incubated with

125

I-TLD.

Each

major band, therefore, was derived from a little less than 1000 yg/ml
concentration of protein in the original protein 135 solution and was
therefore easily detectable fater a 2 day film exposure.
Similar calculations may be performed with the

125

I-RNase incubated

gels by using the specific activity and concentration of the

125

employed to develop the gels.
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I-RNase

A P P E N D IX I I I

Below is described the relationship that determines the ratio of
antigen concentrations required for a reduction of radioactive hapten
binding by a double binding immunoglobulin.

At equilibrium, for two

ligands competing for binding to the same site (111):
#1

<SL) /(SL)2 = K1 *c 1/(K2 -c 2)

; where,

(SL)^ is the concentration of combining regions filled by ligand x;
K^ is the binding constant of the antibody for ligands x; and
cx is the free hapten concentration of ligand x.
At 50% inhibition of one hapten by the other, (SL)^ = (SL)2 >

Substi

tuting in relationship #1:

{2

Kj /Kj

-

c 2 /V

If at concentration c^' more than 50% of the ligand 1 is inhibited by
ligand 2, then
#2a

K./K. < c '/ 1.
1 2
2 c

In the experiments described in section III.B. of the RESULTS, vitamin
Ks inhibitable

125

I-TLD binding bands were interpreted as bands whose

-3
intensity of film darkening in the presence of 1 x 10
M vitamin Ks
was less than or equal to half the intensity of darkening of the band
produced when the gel was incubated only with
ratio was less than or equal to 0.5).
125

125

I-TLD (i.e., the Ks/TLD

Thus for a vitamin Ks inhibitable

I-TLD binding band to be detected, the ratio of binding constants of

the antibody for both haptens should have the following relationship:
#2b

Kx /K2 < c2/cr

Under the conditions in which the gels were processed, c ^ ^ * 2 x 10 ^
and

—3
= 1 x IQ' M.

6
Thus ^

l d ^^Scs

— ^ X ^

* i,e*' an antib°dy t^iat
g
binds TLD with an affinity greater than 5 x 10 times that for vitamin

215
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216

Ks would not scored as a double binding immunoglobulin.
From relationship #2b, it is obvious that by incubating the analy
tical gels with different concentrations of ligand 1 and 2, different
populations of "double binding" antibodies will be detected.
The intensity of the

125

I-TLD binding bands will only follow this

relationship if the band is composed of one TLD binding immunoglobulin.
If two antibodies have the same pi and one does not bind vitamin Ks
then the detection of vitamin Ks inhibitable

125

I-TLD binding bands is

dependent upon the relative binding constants and concentrations of
both these immunoglobulins in the band.

(See appendix 2.)

Of course, the same relationships apply for the DNP-caproic acid
inhibitable

125

I-RNase binding bands and the RNase inhibitable

binding bands.

i

y
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